
<html lang="en"     class="pb-page"  data-request-id="3a5ac5d9-ccae-4424-95a8-92c43a1e03a6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2012.55.issue-15;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm300670q"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Designing Allosteric Regulators of Thrombin. Monosulfated Benzofuran Dimers Selectively Interact With Arg173 of Exosite 2 to Induce Inhibition" /></meta><meta name="dc.Creator" content="May H.  Abdel Aziz" /></meta><meta name="dc.Creator" content="Preetpal Singh  Sidhu" /></meta><meta name="dc.Creator" content="Aiye  Liang" /></meta><meta name="dc.Creator" content="Ji Yeong  Kim" /></meta><meta name="dc.Creator" content="Philip D.  Mosier" /></meta><meta name="dc.Creator" content="Qibing  Zhou" /></meta><meta name="dc.Creator" content="David H.  Farrell" /></meta><meta name="dc.Creator" content="Umesh R.  Desai" /></meta><meta name="dc.Description" content="Earlier, we reported on the design of sulfated benzofuran dimers (SBDs) as allosteric inhibitors of thrombin (Sidhu et al. J. Med. Chem.201154 5522–5531). To identify the site of binding of SBDs, w..." /></meta><meta name="Description" content="Earlier, we reported on the design of sulfated benzofuran dimers (SBDs) as allosteric inhibitors of thrombin (Sidhu et al. J. Med. Chem.201154 5522–5531). To identify the site of binding of SBDs, w..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 25, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300670q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300670q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300670q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300670q" /></link>
        
    
    

<title>Designing Allosteric Regulators of Thrombin. Monosulfated Benzofuran Dimers Selectively Interact With Arg173 of Exosite 2 to Induce Inhibition | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300670q" /></meta><meta property="og:title" content="Designing Allosteric Regulators of Thrombin. Monosulfated Benzofuran Dimers Selectively Interact With Arg173 of Exosite 2 to Induce Inhibition" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0007.jpeg" /></meta><meta property="og:description" content="Earlier, we reported on the design of sulfated benzofuran dimers (SBDs) as allosteric inhibitors of thrombin (Sidhu et al. J. Med. Chem.201154 5522–5531). To identify the site of binding of SBDs, we studied thrombin inhibition in the presence of exosite 1 and 2 ligands. Whereas hirudin peptide and heparin octasaccharide did not affect the IC50 of thrombin inhibition by a high affinity SBD, the presence of full-length heparin reduced inhibition potency by 4-fold. The presence of γ′ fibrinogen peptide, which recognizes Arg93, Arg97, Arg173, Arg175, and other residues, resulted in a loss of affinity that correlated with the ideal Dixon–Webb competitive profile. Replacement of several arginines and lysines of exosite 2 with alanine did not affect thrombin inhibition potency, except for Arg173, which displayed a 22-fold reduction in IC50. Docking studies suggested a hydrophobic patch around Arg173 as a plausible site of SBD binding to thrombin. The absence of the Arg173-like residue in factor Xa supported the observed selectivity of inhibition by SBDs. Cellular toxicity studies indicated that SBDs are essentially nontoxic to cells at concentrations as high as 250 mg/kg. Overall, the work presents the localization of the SBD binding site, which could lead to allosteric modulators of thrombin that are completely different from all clinically used anticoagulants." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300670q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300670q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300670q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300670q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300670q&amp;href=/doi/10.1021/jm300670q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6888-6897</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300655h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300689c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Designing Allosteric Regulators of Thrombin. Monosulfated Benzofuran Dimers Selectively Interact With Arg173 of Exosite 2 to Induce Inhibition</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=May+H.++Abdel+Aziz">May H. Abdel Aziz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Preetpal+Singh++Sidhu">Preetpal Singh Sidhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aiye++Liang">Aiye Liang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ji+Yeong++Kim">Ji Yeong Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+D.++Mosier">Philip D. Mosier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qibing++Zhou">Qibing Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+H.++Farrell">David H. Farrell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Umesh+R.++Desai">Umesh R. Desai</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Medicinal Chemistry and <sup>‡</sup>Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, Virginia 23219, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Institute for Materia Medica, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hunan 430074, P. R. China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">∥</span> <span class="aff-text">Division of Cardiovascular Medicine, School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 804-828-7328. Fax: 804-827-3664. E-mail: <a href="/cdn-cgi/l/email-protection#ee9b9c8a8b9d8f87ae988d9bc08b8a9b"><span class="__cf_email__" data-cfemail="394c4b5d5c4a5850794f5a4c175c5d4c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300670q&amp;href=/doi/10.1021%2Fjm300670q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6888–6897</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 12, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 May 2012</li><li><span class="item_label"><b>Published</b> online</span>25 July 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 August 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300670q" title="DOI URL">https://doi.org/10.1021/jm300670q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6888%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMay%2BH.%2BAbdel%2BAziz%252C%2BPreetpal%2BSingh%2BSidhu%252C%2BAiye%2BLiang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D15%26contentID%3Djm300670q%26title%3DDesigning%2BAllosteric%2BRegulators%2Bof%2BThrombin.%2BMonosulfated%2BBenzofuran%2BDimers%2BSelectively%2BInteract%2BWith%2BArg173%2Bof%2BExosite%2B2%2Bto%2BInduce%2BInhibition%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6897%26publicationDate%3DAugust%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300670q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">748</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300670q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Designing Allosteric Regulators of Thrombin. Monosulfated Benzofuran Dimers Selectively Interact With Arg173 of Exosite 2 to Induce Inhibition&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;May&quot;,&quot;last_name&quot;:&quot;H. Abdel Aziz&quot;},{&quot;first_name&quot;:&quot;Preetpal&quot;,&quot;last_name&quot;:&quot;Singh Sidhu&quot;},{&quot;first_name&quot;:&quot;Aiye&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Ji&quot;,&quot;last_name&quot;:&quot;Yeong Kim&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;D. Mosier&quot;},{&quot;first_name&quot;:&quot;Qibing&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;H. Farrell&quot;},{&quot;first_name&quot;:&quot;Umesh&quot;,&quot;last_name&quot;:&quot;R. Desai&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;6888-6897&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300670q&quot;},&quot;abstract&quot;:&quot;Earlier, we reported on the design of sulfated benzofuran dimers (SBDs) as allosteric inhibitors of thrombin (Sidhu et al. J. Med. Chem.201154 5522–5531). To identify the site of binding of SBDs, we studied thrombin inhibition in the presence of exosite 1 and 2 ligands. Whereas hirudin peptide and heparin octasaccharide did not affect the IC50 of thrombin inhibition by a high affinity SBD, the presence of full-length heparin reduced inhibition potency by 4-fold. The presence of γ′ fibrinogen peptide, which recognizes Arg93, Arg97, Arg173, Arg175, and other residues, resulted in a loss of affinity that correlated with the ideal Dixon–Webb competitive profile. Replacement of several arginines and lysines of exosite 2 with alanine did not affect thrombin inhibition potency, except for Arg173, which displayed a 22-fold reduction in IC50. Docking studies suggested a hydrophobic patch around Arg173 as a plausible site of SBD binding to thrombin. The absence of the Arg173-like residue in factor Xa supported the obse&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300670q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300670q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300670q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300670q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300670q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300670q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300670q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300670q&amp;href=/doi/10.1021/jm300670q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300670q" /></input><a href="/doi/pdf/10.1021/jm300670q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300670q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300670q%26sid%3Dliteratum%253Aachs%26pmid%3D22788964%26genre%3Darticle%26aulast%3DAbdel%2BAziz%26date%3D2012%26atitle%3DDesigning%2BAllosteric%2BRegulators%2Bof%2BThrombin.%2BMonosulfated%2BBenzofuran%2BDimers%2BSelectively%2BInteract%2BWith%2BArg173%2Bof%2BExosite%2B2%2Bto%2BInduce%2BInhibition%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D15%26spage%3D6888%26epage%3D6897%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=291833" title="Heparin">Heparin</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jmcmar.2012.55.issue-15/production/jmcmar.2012.55.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Earlier, we reported on the design of sulfated benzofuran dimers (SBDs) as allosteric inhibitors of thrombin (Sidhu et al. <i>J. Med. Chem.</i><b>2011</b><i>54</i> 5522–5531). To identify the site of binding of SBDs, we studied thrombin inhibition in the presence of exosite 1 and 2 ligands. Whereas hirudin peptide and heparin octasaccharide did not affect the IC<sub>50</sub> of thrombin inhibition by a high affinity SBD, the presence of full-length heparin reduced inhibition potency by 4-fold. The presence of γ′ fibrinogen peptide, which recognizes Arg93, Arg97, Arg173, Arg175, and other residues, resulted in a loss of affinity that correlated with the ideal Dixon–Webb competitive profile. Replacement of several arginines and lysines of exosite 2 with alanine did not affect thrombin inhibition potency, except for Arg173, which displayed a 22-fold reduction in IC<sub>50</sub>. Docking studies suggested a hydrophobic patch around Arg173 as a plausible site of SBD binding to thrombin. The absence of the Arg173-like residue in factor Xa supported the observed selectivity of inhibition by SBDs. Cellular toxicity studies indicated that SBDs are essentially nontoxic to cells at concentrations as high as 250 mg/kg. Overall, the work presents the localization of the SBD binding site, which could lead to allosteric modulators of thrombin that are completely different from all clinically used anticoagulants.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The coagulation cascade is a rich assembly of homologous serine proteases. Each enzymatic factor of the cascade recognizes a P-1 arginine residue in its target, which sets up possible crossover reactivity with enzymes of other systems too. Nature avoids these crossover reactivities, especially of macromolecular substrates, through clever engineering of the environment around the enzyme active sites. For example, thrombin contains the 60-insertion loop, the 149-insertion loop, and the bulky Trp215 residue to restrict access to its active site.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Such stringent steric and/or electronic natural gating assists in the design of small molecule, active site inhibitors. In fact, a number of scaffolds that selectively inhibit thrombin have been designed, such as pyrazole, napthylamidine, or benzimidazole scaffolds.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4-7)</a> Yet, the process remains challenging and is threatened by cross-reactivity with closely related enzymes, e.g., factor Xa, or with enzymes that exhibit too broad substrate specificity, e.g., trypsin. A significant advance in the design of thrombin inhibitors was the use of hydrophobic P-1 substituents, e.g., a halophenyl group, that interact with the Tyr228 in the S-1 pocket.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> This strategy has also been exploited in the design of rivaroxaban, a nonamidine or guanidine based factor Xa inhibitor, approved for clinical use in the EU.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">In addition to steric or electronic gating, an alternative strategy that nature exploits for engineering high selectivity is the use of exosites. A classic example of this phenomenon is thrombin cleavage of fibrinogen. In this process, the substrate binds to exosite 1 that enables its efficient cleavage.<a onclick="showRef(event, 'ref1 ref2 ref3 ref12'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref12">(1-3, 12)</a> Likewise, binding of full-length heparin in exosite 2 enables a much faster inhibition of thrombin by antithrombin–heparin complex.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> In addition to this exquisite dual recognition, exosites afford a fine opportunity of allosteric modulation of catalytic machinery. Both exosites 1 and 2 of thrombin as well as exosites of many other coagulation enzymes are coupled with the active site. Although the intricate mechanism of this coupling is not fully understood, it is known that it may involve alteration of structure of catalytic triad and/or of neighboring residues. For example, sodium binding is known to allosterically alter the conformation of the catalytic triad.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Likewise, heparin binding in exosite 2 is known to change the electrostatics around the active site with minimal change in catalytic activity.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a></div><div class="NLM_p">Although allosteric modulation of thrombin’s catalytic function by macromolecules is well established, its exploitation in the design of drug-like molecules is still in its infancy. Allosteric regulation is likely to offer a delicate control over thrombin’s procoagulant activity, which is difficult to achieve with competitive, active site inhibitors because of the drive to achieve very high potency. At a fundamental level, small molecules may be designed so that the allosteric conformational change can exhibit tailored balance between pro- and anti- coagulant activities. Another advantage of allosteric regulation is the possibility of greater specificity of recognition arising from greater differences in exosite geometries as compared to active sites. In effect, allosteric regulation promises to afford exquisite control over both specificity of recognition and efficacy of inhibition.</div><div class="NLM_p">To develop such regulators of thrombin, we started with the design of sulfated low molecular weight lignins (LMWLs), which were found to potently inhibit thrombin, factor Xa, and plasmin.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a> The oligomeric molecules targeted exosite 2 of thrombin exclusively and were the first molecules in the class of exclusive exosite 2-based allosteric modulators of thrombin.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Sulfated LMWLs prevented human blood from clotting in ex vivo assays with potency comparable to low molecular weight heparins (LMWHs) and thus represented molecules of considerable interest.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Yet, the oligomeric nature of these molecules did not bode well for clinical potential. To address this issue, we designed sulfated benzofuran monomers from sulfated LMWLs, which were found to allosterically inhibit thrombin and factor Xa, albeit with poor potency (IC<sub>50</sub> in mM range).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Subsequent advance in the design led to sulfated benzofuran dimers (SBDs) that exhibited a wide range of inhibition potencies (μM to mM) and efficacies (20–60%).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Michaelis–Menten kinetic studies revealed that the SBDs (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) reduced the maximal velocity of substrate hydrolysis without affecting the substrate’s Michaelis constant (<i>K</i><sub>M</sub>), a classic case of noncompetitive allosteric modulation of thrombin activity.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of sulfated benzofuran dimers <b>12a</b>–<b>f</b> and <b>13</b>–<b>15</b> found to potently inhibit human thrombin. The selected dimers correspond to those identified in our previous work,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and their labels (<b>12a</b>–<b>12f</b> and <b>13</b>–<b>15</b>) have been retained here to maintain consistency and ease of comparison. Most IC<sub>50</sub> values being reported here are lower than those reported earlier<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and possibly arise from differences in glycosylation pattern of human α-thrombin. Asterisks correspond to IC<sub>50</sub> values taken from the earlier report.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this work, we present detailed biochemical studies on the interaction of one of the potent SBDs with thrombin with a goal of identifying the site of binding for further rational structure-based drug design. Our work reveals that the SBD interacts with exosite 2 of thrombin but in a manner dramatically different from all known exosite 2 ligands including full-length heparin, heparin octasaccharide, sucrose octasulfate, γ′-fibrinogen peptide, and sulfated LMWLs. The localization of the binding region on thrombin, the allosteric nature of inhibition, and the cellular toxicity profile suggest that clinically relevant, allosteric modulation of thrombin based on the SBD scaffold may be achievable.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> SBD <b>12a</b>, Thrombin, Fibrinogen Peptide, Chemicals and Reagents</h3><div class="NLM_p last">SBD <b>12a</b> was synthesized as described in our earlier report<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and stored at −80 °C in solid form until use. Human α-thrombin and factor Xa were from Haematologic Technologies (Essex Junction, VT). Stock solutions of the enzymes were prepared in 20 mM sodium phosphate buffer, pH 7.4, containing 100 mM NaCl. Chromogenic substrate Spectrozyme TH (H-<span class="smallcaps smallerCapital">d</span><i>-</i>hexahydrotyrosol-Ala-Arg-<i>p</i>-nitroanilide) was purchased from American Diagnostica (Greenwich, CT). A peptide corresponding to the 20 amino acids at the carboxyl terminal of γ′-fibrinogen chain (VRPEHPAETE-Y(PO<sub>3</sub>)-DSL-Y(PO<sub>3</sub>)-PEDDL) was obtained from Dr. David Farrell.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> All other chemicals were analytical reagent grade from either Sigma Chemicals (St. Louis, MO) or Fisher (Pittsburgh, PA) and used as such. Tyr63-sulfated hirudin-(54–65), labeled as HirP in this work and labeled as 5-(carboxy)fluorescein ([5F]-Hir[54–65](SO<sub>3</sub><sup>–</sup>)) elsewhere, was a gift from Dr. Paul Bock.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Recombinant Thrombin Mutants</h3><div class="NLM_p last">Recombinant wild-type and mutant thrombins were prepared in the Rezaie laboratory, as described earlier.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> Briefly, Lys169Ala, Arg173Ala, Arg175Ala, Lys235Ala, or Arg93,97,101Ala thrombin was prepared in prothrombin-1 form by PCR mutagenesis and expression in baby hamster kidney cells (BHK) using the pNUT-PL2 expression/purification vector system. The mutants were purified to homogeneity by immunoaffinity chromatography using the Ca<sup>2+</sup>-dependent monoclonal antibody, HPC4, and activated to thrombin. The active-site concentrations of thrombin mutants were determined by an amidolytic acivity assay and stoichiometric titrations with antithrombin.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> These concentrations were within 90–100% of those expected on the basis of their absorbance at 280 nm.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Competitive Studies with Exosite 1 and Exosite 2 Ligands</h3><div class="NLM_p">The inhibition effect of sulfated benzofuran diethyl ester dimer (<b>12a</b>) on wild-type thrombin was studied in the presence of exosite 1 ligand, a 12 residue hirudin peptide containing fluorescein at its N-terminus, i.e., [5F]-Hir[54–65](SO<sub>3</sub><sup>–</sup>)<a onclick="showRef(event, 'ref20 ref26'); return false;" href="javascript:void(0);" class="ref ref20 ref26">(20, 26)</a> and abbreviated in this paper as HirP. Inhibition experiments were also performed in the presence of exosite 2 ligands, heparin octasaccharide H8, bovine heparin (UFH), and γ′-fibrinogen peptide (FibP) in a manner similar to that described above for direct thrombin inhibition. Briefly, a solution of 10 μL of the dimer (0–1000 μM) and 10 μL thrombin (4 – 10 nM) was mixed at 25 °C with 10 μL of the competitor at appropriate stock concentration in either 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% PEG 8000 or 50 mM Tris-HCl buffer, pH 7.4, containing 150 mM NaCl, 0.1% PEG 8000, and 0.02% Tween 80. The solution was incubated for 10 min followed by the addition of Spectrozyme TH and monitoring the increase in absorbance at 405 nm. The dose-dependence of the fractional residual thrombin activity at each concentration of the competitor was fitted using eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to obtain the apparent concentration of the dimer required to inhibit thrombin activity by 50% (IC<sub>50,app</sub>) and the efficacy of inhibition (Δ<i>Y</i> = <i>Y</i><sub>M</sub> – <i>Y</i><sub>0</sub>).<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/jm-2012-00670q_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p last">In this equation, <i>Y</i> is the ratio of residual thrombin activity in the presence of inhibitor to that in its absence (fractional residual activity), <i>Y</i><sub>M</sub> and <i>Y</i><sub>0</sub> are the maximum and minimum possible values of the fractional residual proteinase activity, IC<sub>50</sub> is the concentration of the inhibitor that results in 50% inhibition of enzyme activity, and HS is the Hill slope. A current version of SigmaPlot (SPSS, Inc. Chicago, IL) was used to perform nonlinear curve fitting in which IC<sub>50</sub>, <i>Y</i><sub>M</sub>, <i>Y</i><sub>0</sub>, and HS were allowed to float.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Inhibition of Recombinant Thrombin Mutants and Factor Xa</h3><div class="NLM_p last">Direct inhibition of thrombin mutants and factor Xa by sulfated benzofuran derivatives was measured through a chromogenic substrate hydrolysis assay, as reported earlier.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> The buffer used in these experiments was 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000. Sulfated benzofuran derivatives (2 to 30 μL) at concentrations ranging from 0.25 to 12.5 mM were diluted with an appropriate volume of assay buffer in PEG 20,000-coated acrylic cuvettes at 25 °C. To this solution, 5 μL of thrombin solution was added to give approximately 5 nM thrombin or 4 nM factor Xa final concentration. Following the addition of thrombin, 20 μL (thrombin) or 100 μL (factor Xa) of 1 mM Spectrozyme TH was added after 10 min incubation. The residual thrombin activity was then measured from the initial rate of increase in absorbance at 405 nm. Relative residual thrombin activity at each concentration of the inhibitor was calculated from the ratio of thrombin activity in the presence and absence of inhibitor. Logistic eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> was used to fit the dose-dependence of residual proteinase activity to obtain the apparent IC<sub>50</sub>, HS, and the efficacy Δ<i>Y</i> (= <i>Y</i><sub>M</sub> – <i>Y</i><sub>0</sub>) of inhibition.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Molecular Modeling Studies</h3><div class="NLM_p">The crystal structure of thrombin bound to its allosteric exosite 1 ligand hirugen at 1.53 Å resolution was obtained from the Protein Data Bank (PDB ID = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQ0">3EQ0</a>), as well as two additional thrombin structures (PDB IDs = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H8D">1H8D</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UUF">2UUF</a>).<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> All the residues in region of Arg173 were manually inspected to ensure that the side chains were completely resolved. Each of the acidic and basic residues was modeled in its most predominant ionization state at physiological pH (i.e., anionic Asp and Glu; cationic Arg and Lys). The inorganic salts and water molecules were deleted from the crystal structure, and hydrogen atoms were added using SYBYL 8.1 (Tripos International, St. Louis, MO). To prepare the structure for docking and scoring protocol, the newly added hydrogen atoms were energy-minimized using the Tripos Force Field (Gasteiger–Hückel charges; termination criterion of 0.05 kcal/(mol × Å) or 1 × 10<sup>5</sup> iterations; distance-dependent dielectric constant ε = 4.0).</div><div class="NLM_p">Substituted SBDs <b>12a</b>–<b>f</b> and <b>13</b>–<b>15</b>, each synthesized and studied previously,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> were prepared in SYBYL for virtual library screening. Using in-house SYBYL Programming Language (SPL) scripts, compounds contained in the resulting virtual library were postprocessed to (a) assign appropriate atom types to the sulfate groups (sulfur atom = S.o2; terminal oxygen atoms = O.co2), (b) assign an initial set of 3D coordinates using the CONCORD module within SYBYL, (c) add missing hydrogen atoms, and (d) energy-minimize the resulting structures using the Tripos Force Field as described for the protein (vide supra).</div><div class="NLM_p last">Docking of the synthesized inhibitors onto the defined binding site of the thrombin was performed using GOLD 4.1 (Cambridge Crystallographic Data Centre, Cambridge, U.K.). The binding site was defined to include all atoms within 22 Å around the Arg173 C<sup>α</sup> atom. Default parameters were employed during the GOLD docking runs with the following exceptions: a protein hydrogen bonding constraint was added such that the score was reduced by 10.0 GoldScore units if the ligand did not form an H-bond with the guanidinium group of Arg173. Amide bonds were allowed to flip. The number of GA runs was increased to 30 to more accurately screen all possible binding geometries, and early termination was disabled. The docking was driven by the GoldScore fitness function and the docked solutions were ranked based on the unmodified GoldScore obtained. To assess the reproducibility of the docked poses, the docking runs were performed in triplicate.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cellular Toxicity Studies</h3><div class="NLM_p last">Human A549 cells were obtained from American Type Culture Collection (ATCC) and maintained in growth medium at 37 °C in 5% CO<sub>2</sub> atmosphere. The growth medium was Dulbecco’s Modified Eagle Medium (Invitrogen, CA) supplemented with 10% heat-inactivated fetal bovine serum enriched with 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 0.1 mM nonessential amino acids, 25 mM HEPES buffer, 50 U/mL penicillin, and 50 μg/mL streptomycin. Stock solutions of <b>12a</b> were prepared in deionized water and stored at −20 °C. The MTT solution was prepared at 5 mg/mL in 50 mM phosphate buffered saline, pH 7.4, filtered, and stored at 4 °C. The MTT lysis buffer was prepared by dissolving 25 g of SDS in 100 mL of 50% DMF in water, and the pH was adjusted to 4.7 with a solution of 2.5% HCl in 80% acetic acid. The MTT cell viability assay was carried out as described earlier.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Briefly, A549 cells were seeded at 30,000 cells/well on a 96-well plate for 4 h before the treatment with either medium or SBDs. After incubation for 72 h, the MTT solution (10 μL) was added to each well followed by incubation for 10 h. The medium was then replaced with the lysis buffer (100 μL). After 10 h, the A<sub>570</sub> was read with a 318C-plate reader (Shanghai Sanke Instrumental Corp. Ltd., China). Background correction was performed using A<sub>690</sub> values. Statistical analyses (oneway ANOVA with Dunnett’s test) were performed by GraphPad Prism (version 4.00, GraphPad Software, San Diego, CA). Each SBD concentration was tested at least three times.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> SBDs Do Not Bind in the Anion-Binding Exosite 1 of Thrombin</h3><div class="NLM_p">To test whether SBDs bind in exosite 1 of thrombin, we selected <b>12a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a potent SBD designed in our earlier work.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Structurally, <b>12a</b> is a monosulfated benzofuran dimer containing two ethyl ester groups and is a prototypical SBD. This scaffold is dramatically different from the thousands of thrombin inhibitors being studied for improved pharmacological and safety profile.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11">(4-11)</a> It is the only small molecule scaffold that has been found to allosterically inhibit thrombin.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Interestingly, the unsulfated precursor of <b>12a</b> was completely inactive suggesting that both the anionic group and the hydrophobic backbone are important for thrombin inhibition.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Considering that anion-binding exosites 1 and 2 of thrombin recognize charged ligands, SBDs were hypothesized to induce inhibition through one of these sites. In fact, sulfated tyrosine containing hirudin, a 65 amino acid long polypeptide that binds in exosite 1 as well as active site, is known to be the most potent thrombin inhibitor.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> On the other hand, exosite 2 of thrombin prefers highly sulfated oligosaccharides.<a onclick="showRef(event, 'ref1 ref34'); return false;" href="javascript:void(0);" class="ref ref1 ref34">(1, 34)</a> The anionic density of these highly sulfated oligosaccharides is far greater than that of molecules recognizing exosite 1. A priori, this indicated that SBDs may prefer to interact with exosite 1 of thrombin.</div><div class="NLM_p">To test with <b>12a</b> binding in exosite 1, its inhibition potency was measured in the presence of a hirudin-based peptide [5F]-Hir[54–65](SO<sub>3</sub><sup>–</sup>), abbreviated as HirP, a molecule known to engage exosite 1 of thrombin. HirP binds with a dissociation constant of 28 nM under similar conditions,<a onclick="showRef(event, 'ref26 ref35'); return false;" href="javascript:void(0);" class="ref ref26 ref35">(26, 35)</a> and its presence was expected to significantly reduce the potency of <b>12a</b>, if the two molecules competed for the same binding site. Our earlier work on the effect of HirP on thrombin’s hydrolysis of Spectrozyme TH had shown that the peptide did not affect the Michaelis constant of the substrate, while increasing the catalytic efficiency of the enzyme nearly 50%.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This implied that the two molecules, HirP and <b>12a</b>, were expected to induce opposing catalytic influence (<i>V</i><sub>max</sub> effect), which afforded a convenient setup to study exosite 1 competition.</div><div class="NLM_p">The IC<sub>50</sub> was measured by quantifying thrombin’s hydrolysis of Spectrozyme TH in the presence of fixed concentration of HirP at pH 7.4 and 25 °C, as described earlier.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A standard sigmoidal dose–response profile was observed for <b>12a</b> inhibition of thrombin at all concentrations of HirP, which could be fitted by the logistic eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to obtain the potency (IC<sub>50</sub>) and efficacy (Δ<i>Y</i> = <i>Y</i><sub>M</sub> – <i>Y</i><sub>0</sub>) of inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In the absence of HirP, <b>12a</b> inhibited thrombin with an IC<sub>50</sub> of 6.2 ± 2.7 μM. In our earlier work, the IC<sub>50</sub> was found to be 61 μM.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The primary difference between our two studies was a new batch of human plasma α-thrombin. The change also resulted in a slightly lower efficacy of inhibition (from 70% to 50%) and an increased Hill slope (from ∼1.2 to ∼2.5, see Table S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). We also tested whether the ability of other SBDs to inhibit thrombin is similarly affected and found a significant decrease in the IC<sub>50</sub> of a majority of inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1). It is possible that commercial human plasma α-thrombin contains minor proportions of forms other than just α-thrombin, e.g., differentially glycosylated or partially lysed, resulting in altered inhibition potential of <b>12a</b> and other SBDs. The difference in Hill slope could also arise from changes in the glycosylation pattern of the protein. However, the substantial Hill slope of 2.5 raised a possibility that SBDs were aggregating under the assay conditions. Yet, the UV–vis absorption profile of <b>12a</b> showed a red shift of 40–50 nm only at a concentration 100-fold of the IC<sub>50</sub> value (not shown) suggesting that aggregation is not likely to be significant under the assay conditions. Thus, for the purpose of identifying changes in the inhibition potency as a function of the competitor concentration, the starting IC<sub>50</sub> served as a reasonable reference point.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Competitive effect of the hirudin peptide HirP on the inhibition of human plasma thrombin by <b>12a</b>. Residual thrombin activity was measured through Spectrozyme TH hydrolysis in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C in the presence of 0 to 103 nM of HirP. Solid lines represent fits using the logistic eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to obtain the apparent IC<sub>50</sub>, as described in <a class="ref internalNav" href="#sec2" aria-label="Experimental Procedures">Experimental Procedures</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Varying the concentration of HirP from 0 to 30 nM resulted in the no apparent change in IC<sub>50</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S1). The efficacy of inhibition increased slightly with increasing concentrations of HirP (5–10%), which may imply a coupling between exosite 1 and the SBD binding site. Together, the two results suggest that HirP and <b>12a</b> do not directly compete with each other, but the presence of HirP makes <b>12a</b> a slightly better inhibitor of thrombin. Thus, <b>12a</b> does not appear to bind in anion-binding exosite 1 of thrombin.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> SBD <b>12a</b> Does Not Compete with Heparin Octasaccharide For Binding in Exosite 2</h3><div class="NLM_p">Highly sulfated polysaccharide chains including heparin octasaccharide H8, low-molecular weight heparin, full-length heparin, and chondroitin sulfate utilize anion-binding exosite 2 to bind to thrombin.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> The major difference in how these polysaccharide ligands recognize thrombin is their span of interaction domain. Whereas H8 recognizes primarily Arg233, Lys235, Lys236, and Lys240, the full-length polymer recognizes in addition Arg93, Arg101, and Arg165 residues. None of these ligands affect the proteolytic activity of thrombin (not shown), which implies that inhibition assays could be used for exosite 2 competitive studies. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A shows the dose–response curves of <b>12a</b> inhibiting thrombin in the presence of H8 at pH 7.4 and 25 °C. As the concentration of H8 was increased from 0 to 10 μM, the IC<sub>50</sub> of thrombin inhibition increased from 2.7 to 3.7 μM (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S1). This inconsequential change in potency was accompanied by no noticeable change in the efficacy of inhibition in the presence of H8. Thus, H8 does not compete with <b>12a</b> for binding to thrombin suggesting that the sulfated benzofuran does not recognize Arg233, Lys235, Lys236, or Lys240. This is not too unexpected considering the widely different structural features of the two molecules. H8 is a highly anionic polysaccharide, while <b>12a</b> is a fairly hydrophobic small molecule with one negative charge, but interestingly, the results suggest that, while exosite 1 and <b>12a</b> binding site appear to be slightly coupled (described above), a similar increase in efficacy was not detected in H8 and <b>12a</b> competition experiments.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Competitive effect of heparin octasaccharide H8 (A) and unfractionated heparin UFH (B) on the inhibition of human plasma thrombin by <b>12a</b> in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C in the presence of 0 to 10 μM H8 and 0 to 48 μM UFH. Solid lines represent fits using the logistic eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to obtain the apparent IC<sub>50</sub>, as described in <a class="ref internalNav" href="#sec2" aria-label="Experimental Procedures">Experimental Procedures</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> SDB <b>12a</b> Competes Partially with Full-Length Heparin</h3><div class="NLM_p last">To assess whether <b>12a</b> interacts with other exosite 2 residues, e.g., Arg93, Arg101, and Arg165, we studied competition with the full-length heparin. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B shows the inhibition profile in the presence of 0 to 48 μM UFH. In contrast to H8, the sigmoidal dose–response profiles displayed a slight shift to the right with increasing concentration of UFH suggesting a noticeable competitive phenomenon. The IC<sub>50</sub> of <b>12a</b> inhibition of thrombin at pH 7.4 and 25 °C was found to increase from 8.8 μM in the absence of UFH to 36.1 μM in the presence of 48 μM UFH (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S1). This represents a maximal decrease in potency of 4.1-fold at a UFH concentration ∼5-times higher than the <i>K</i><sub>D</sub> of thrombin–UFH complex.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> This suggests that, although UFH competes with SBD, the competition is inefficient or partial.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> SBD <b>12a</b> Competes with γ′-Fibrinogen Peptide for Binding to Thrombin</h3><div class="NLM_p">The absence of competition for binding to thrombin with H8 eliminated Lys236 and Lys240 as the site of interaction for <b>12a</b>. Yet, partial competition observed with UFH suggested recognition of one or more electropositive residues of exosite 2, which is a fairly extensive domain with a large number of basic residues. To further narrow the domain of recognition, competition with γ′-fibrinogen peptide (FibP) was studied. FibP is known to bind in exosite 2 by interacting with residues that bind to H8 (Arg126, Lys235, Lys236, and Lys240),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> while also interacting with Arg93, Arg97, Arg173, and Arg175 as demonstrated by NMR studies.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This makes FibP a useful probe for studying the interaction with this group of arginines that lie beyond the H8 binding site. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A shows the dose–response profiles of <b>12a</b> inhibition of thrombin in the presence of 0 to 6.5 μM FibP. A distinct shift in the inhibition profiles was observed as the concentration of FibP increased suggesting strong competition between the two ligands for thrombin binding. The apparent IC<sub>50</sub> increased from 7.9 μM in the absence to 118 μM in the presence of 6.5 μM FibP (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S1).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Competitive effect of the γ′-fibrinogen peptide on the inhibition of human plasma thrombin by <b>12a</b> in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C in the presence of 0 to 6.5 μM of the peptide. Solid lines represent fits using the logistic eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to obtain the apparent IC<sub>50</sub>, as described in <a class="ref internalNav" href="#sec2" aria-label="Experimental Procedures">Experimental Procedures</a>. (B) Comparison of the predicted (shaded bars) and observed (unshaded bars) IC<sub>50,app</sub>. Error bars represent ±2 SE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A more quantitative test of competitive binding is the Dixon–Webb relationship (eq <a class="ref internalNav" href="#eq2" aria-label="2">2</a>), which predicts the effect of competition on a measured equilibrium parameter (<i>K</i><sub>D</sub> or IC<sub>50</sub>). In this equation, <i>K</i><sub>FibP</sub> is the dissociation constant of thrombin–FibP complex, which was earlier measured to be 0.63 μM under similar conditions.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a><span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/jm-2012-00670q_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span></div><div class="NLM_p last">The IC<sub>50,app</sub> predicted using eq <a class="ref internalNav" href="#eq2" aria-label="2">2</a> for <b>12a</b> inhibition of thrombin in the presence of varying concentrations of FibP are listed in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S2, and Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B shows a comparison of the observed and predicted IC<sub>50,app</sub>. The measured IC<sub>50,app</sub> is consistently higher than those predicted for FibP competition suggesting a strong competitive effect. The reason for the more-than-predicted competitive effect of FibP is not clear; however, it is possible that a small change in the affinity of FibP for thrombin under the current experimental conditions is the cause. Yet overall, competition with FibP indicates that <b>12a</b> binds in exosite 2 in a region away from the H8 binding residues and most probably with one or more of Arg93, Arg97, Arg173, and Arg175.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Sulfated Benzofuran <b>12a</b> Interacts with a Single Arginine, Arg173, of Exosite 2</h3><div class="NLM_p">To identify the basic residues that might play an important role in the dimer recognition, we studied the inhibition of five thrombin mutants containing single and triple replacement of Arg and/or Lys to Ala. The preparation of these recombinant thrombins has been described earlier,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> and each mutant was screened for direct inhibition by <b>12a</b> in a manner similar to that used for the wild-type form. The dose–response profiles of three of the four single-point mutants studied in this work were essentially identical to the recombinant wild-type enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The IC<sub>50</sub> measured for Arg175Ala, Lys169Ala, and Lys235Ala thrombins ranged from 4.9 μM to 9.0 μM, while that measured for the recombinant wild-type enzyme was 5.5 μM (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S2). The triple-point mutant Arg93,97,101Ala had a comparable IC<sub>50</sub> of 5.0 μM suggesting none of the three amino acids contribute to <b>12a</b> binding. This was quite different from our results with macromolecular sulfated LMWLs, which primarily relied on Arg93 and Arg175 for mediating their inhibitory role.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Although the above-mentioned basic residues do not contribute to <b>12a</b> recognition, the site-directed thrombin mutants were inhibited more than the wild-type enzyme. For example, the efficacy of <b>12a</b> inhibition (i.e., Δ<i>Y</i>) increased to ∼70% for the triple mutant in comparison to ∼30% for wild-type recombinant enzyme (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S2).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Dose–response profiles for <b>12a</b> inhibition of recombinant wild-type and mutant thrombins in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C. Solid lines represent sigmoidal dose–response fits of eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">One particular thrombin mutant, Arg173Ala, was dramatically different. It displayed a 22-fold increase in IC<sub>50</sub> compared to the wild-type enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table S2). This suggested that Arg173 was essential for thrombin binding and inhibition by <b>12a</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> It is striking that a single residue, of the 12 electropositive residues present in exosite 2 of thrombin, was found to be critical for <b>12a</b> interaction. This explains the critical role of the 5-sulfate, observed earlier,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> in mediating the inhibitory effect of all SBDs. Further, <b>12a</b> inhibition of human factor Xa was found to be impaired by at least an order of magnitude (IC<sub>50,fXa</sub> > 300 μM, see below). This result is readily explainable considering that residue 173 in factor Xa is a serine, instead of an arginine. Likewise, factor VIIa contains a serine at position 173 and was also not targeted by <b>12a</b> (data not shown). In combination, the results indicate a high level of specificity that supports a strong possibility of developing allosteric modulators.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Molecular Docking Identifies a Single Plausible Binding Geometry for <b>12a</b> on Thrombin</h3><div class="NLM_p">To identify a plausible binding geometry of sulfated benzofuran dimers on thrombin, we employed a molecular docking and scoring approach. We have previously utilized a genetic algorithm (GA)-based strategy relying on the automated docking routine GOLD to understand how highly sulfated oligosaccharides recognize proteins.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> This approach was also exploited to study the recognition of antithrombin by sulfated LMWLs,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> which are the parent molecules for the SBDs being studied here. Hence, we chose to employ GOLD-based identification of plausible binding site and geometry of <b>12a</b> on human plasma thrombin.</div><div class="NLM_p">The GOLD-based docking and scoring approach utilizes a GA to iteratively derive the best binding geometry for each ligand in a predefined binding site. Our recent work on the recognition of sulfated LMWLs binding to thrombin mutants revealed that hydrophobic patches in the vicinity of Arg93 may be involved.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Considering this, we hypothesized that hydrophobic region(s) near Arg173, which has been implicated by the Arg173Ala thrombin mutant studies presented here, would be important for recognition of <b>12a</b> and related SBDs. Several GA docking runs were thus performed to assess how well <b>12a</b> could be recognized by the binding site regions surrounding Arg173. Each GA docking run was performed using a constraint that encouraged the guanidine group of Arg173 to hydrogen bond with the sulfate group of SBD (see <a class="ref internalNav" href="#sec2" aria-label="Experimental Procedures">Experimental Procedures</a>). GOLD-based docking suggested that the region around Arg173 of thrombin was strikingly complementary to <b>12a</b>. In this site, <b>12a</b> bound in an extended, flat conformation. Supporting this interaction is the hydrophobic area of thrombin located between Arg173 and its active site (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), which recognizes <b>12a</b>’s benzofuran rings and their substituents (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figures S2 and S3). To cross-check whether the localization remains independent of thrombin’s crystal structure, we performed GOLD-based docking studies on <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQ0">3EQ0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H8D">1H8D</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UUF">2UUF</a><a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> structures that had been acquired with high resolution (1.5–2.5 Å) and displayed well-defined side chains around Arg173. In each of these docking runs, <b>12a</b> bound in an essentially identical orientation.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Connolly surface of thrombin (PDB ID = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQ0">3EQ0</a>), showing the location of several electropositive basic residues, including those contributing to exosite 2 and the γ′-fibrinogen peptide binding site (purple patches). The putative binding site and mode of the lead sulfated benzofuran dimer <b>12a</b> is rendered as a yellow surface and shows the high degree of shape complementarity with its putative binding site. The thrombin light chain (yellow ribbon) and hirudin peptide denoting the location of exosite 1 (red ribbon) are also shown. (B) The same 3D image rotated by 90°, further highlighting the high degree of shape complementarity between the ligand dimer and its proposed binding site. The active site is displayed with a hydropathic potential map (blue = hydrophilic, green = amphipathic, and brown = hydrophobic) with the nucleophilic serine S195 shown as a red patch. The S1 and S4 substrate specificity pockets are indicated; the hydrophobic S4 pocket is occluded because it is occupied by the ethyl group of the 3′-ethyl ester of <b>12a</b>. (C) Expanded view of the interaction of <b>12a</b> with it putative binding site as shown in panel B. The ligand is rendered as a ball-and-stick figure, and binding site residues are rendered as capped sticks. All binding site side chains within 5 Å of <b>12a</b> are displayed. Hydrogen bonds between Arg173 and the ligand sulfate group are shown as green dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Sulfated Benzofuran <b>12a</b> Does Not Inhibit Factor Xa</h3><div class="NLM_p">To further support the site of SBD binding on thrombin, we compared the crystal structures of thrombin and factor Xa, especially exosite 2, to identify similarities and differences. Factor Xa does not contain an Arg 173-like residue in this region suggesting that <b>12a</b> can be expected to not inhibit this highly homologous serine protease. Direct inhibition of human factor Xa was performed in a manner similar to thrombin. The dose–response profile showed essentially no decrease in factor Xa activity (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). These results strongly support the allosteric, hydrophobic binding site capped with Arg173 as a site for the small SBD binding to thrombin.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose–response profiles for <b>12a</b> inhibition of human plasma alpha-thrombin and human plasma factor Xa in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C. Solid lines show sigmoidal dose–response fit of eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to thrombin data or linear trendline fit to factor Xa data. See text for details.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> SBDs are Essentially Nontoxic to Cells</h3><div class="NLM_p">The above work highlights that SBDs are pharmacologically novel entities, the fundamental basis for which is their unique structure. This implied that, for further pharmaceutical development, a critical question to address was whether the SBD scaffold is tolerated well by cells. To address this, the effect of <b>12a</b> on the human lung A549 cell line was studied. Human A549 cells were cultured in a 96-well microplate in the presence of varying concentrations of <b>12a</b>. Following exposure of cells to <b>12a</b> for 120 h, MTT assay for cell viability was performed according to literature reports.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> The proportion of viable cells remaining at the end of this exposure was obtained spectrophotometrically (A<sub>570</sub>) using a reference of viable cells in the wells containing medium alone. The viabilities of human A549 cells in the presence of <b>12a</b> were not significantly different by one-way ANOVA statistical analysis with Dunnet’s test (<i>P</i> > 0.05) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). These results indicate that <b>12a</b>, and most probably other SBDs, do not induce any significant toxicity up to ∼420 μM, a concentration more than 80-fold higher than the IC<sub>50</sub> of thrombin inhibition. This concentration roughly corresponds to a dose of 250 mg/kg, a fairly high dosage level for a pharmaceutical agent.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cell toxicity studies with <b>12a</b>. The viability of human A549 after 120 h of incubation at 37 °C with varying concentrations of <b>12a</b> was studied using MTT cell viability assay. Cell viability was measured spectrophotometrically using absorbance at 570 nm, as described in <a class="ref internalNav" href="#sec2" aria-label="Experimental Procedures">Experimental Procedures</a>. Error bars represent standard deviation measured in three experiments at each concentration studied.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">No small, drug-like molecules have been designed as of yet that function as allosteric modulators of thrombin. Our SBDs, which were designed as mimetics of heparin, are the first small hydrophobic molecules that allosterically reduce thrombin’s catalytic activity.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Discovering allosteric modulators is challenging because identifying exosites that are energetically coupled to the active site in an agonistic or antagonistic manner is not routinely possible. More importantly, even if such an exosite was known, designing molecules that fit the site snugly is challenging because the classical, allosteric induced-fit mechanism would require good recognition of both the native and conformationally altered states.</div><div class="NLM_p">The advantage with thrombin is that it is a highly pliable enzyme. The presence of multiple exosites in thrombin enhances the likelihood of discovering small molecule allosteric regulators. However, such probabilistic advantage does not imply automatic translation into drug-like molecule design, and thrombin is no exception. The scenario with other coagulation enzymes, such as factors Xa, IXa, and XIa, is also similar. Yet, allosteric regulation of these enzymes offers phenomenal opportunity to induce tailored conformational change so as to maintain a delicate balance between bleeding and clotting tendencies, especially in the disordered state. With this goal in mind, we designed sulfated LMWLs from which were designed SBDs.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23 ref24">(19-24)</a></div><div class="NLM_p">This work suggests that SBDs appear to utilize a hydrophobic region between around Arg173 and thrombin’s active site (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Although designed as mimetics of heparin, SBDs do not engage the traditional exosite 2 ligand residues including Arg101, Arg126, Lys235, Lys236, and Lys240. SBDs recognize Arg173, a heparin-binding residue. Yet, the predicted binding mode and orientation of <b>12a</b> is likely to be dramatically different from that of polymeric heparin with its chain oriented along the highly electropositive surface.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In fact, <b>12a</b> binds in a region different from that predicted for sulfated LMWLs, which appear to bind in a linear hydrophobic segment present in exosite 2 on either side of residues Arg93 and Arg101.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">SBD <b>12a</b> does not compete with the chromogenic substrate and yet reduces the rate of substrate hydrolysis<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> suggesting that the new binding site is energetically coupled to the active site. The affinity of <b>12a</b> for thrombin at pH 7.4 and 25 °C is approximately 6 μM, which implies a reasonably high affinity interaction. In fact, other than the antithrombin-binding heparin pentasaccharide, which binds with an affinity of ∼50 nM,<a onclick="showRef(event, 'ref14 ref42'); return false;" href="javascript:void(0);" class="ref ref14 ref42">(14, 42)</a> no small sulfated molecule is known to bind with such high affinity.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> A recent study of a group of synthetic heparin octasaccharides that target herpes virus glycoproteins with ∼20 μM affinity further support this observation.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The reason for the very high affinity of antithrombin-binding heparin pentasaccharide is marvelous engineering by nature over millions of years. Thus, the ∼6 μM affinity of <b>12a</b>, which is ∼1000-fold higher than that of its monomer precursor,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> is a good lead. In fact, the putative binding site presents excellent opportunities advancing the design. For example, Lys224 and Arg221A are within 8 Å of the carboxylic acid ester (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Likewise, several hydrophobic residues are also available for targeting.</div><div class="NLM_p">Molecule <b>12a</b> reduces thrombin’s catalytic activity by only about 50% in comparison to other active site and exosite 1 inhibitors that display efficacy of nearly 100%.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> This implies that <b>12a</b> does not completely inhibit the procoagulant signal. Whereas this could be traditionally considered as a defect of design, considering the problems of overanticoagulation induced by thrombin inhibitors, the less than perfect reduction in catalytic activity of thrombin may serve to create the fine balance between procoagulant and anticoagulant signals. More importantly, detailed inhibition profiles reveal that some SBDs exhibit efficacies of greater than 50%, while for others, it is between 10 and 20%.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The variability in the efficacy of thrombin inhibition suggests that the equilibrium between the native and conformationally altered state is tunable, and optimally designed molecule(s) may be effective in treating varying levels of pro-coagulant tendencies.</div><div class="NLM_p">A feature of critical interest for developing effective anticoagulants is the extent of their adverse effects, e.g., organ toxicity, in addition to bleeding complications.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> A major advantage of SBDs appears to be the low in vitro cellular toxicity, which may translate into high efficacy to toxicity ratio. The reason for the low cellular toxicity noted with SBD is not clear at present, but it is likely to be the considerable water solubility of the monosulfated molecule. We predict that an advanced derivative of <b>12a</b> that is designed to interact with Lys224, Arg221A, and other polar amino acids will possess an even better safety profile.</div><div class="NLM_p">The discovery of the new allosteric binding pocket and the benzofuran scaffold that is able to bind tightly and regulate thrombin activity raises many questions before a clinically viable candidate can be realized. For example, it is well established that the presence of FibP does not affect thrombin cleavage of fibrinogen<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> but reduces the cleavage of other thrombin substrates such as factor V, factor VIII, platelet glycoprotein 1, and PAR1. Our earlier work has shown that SBDs inhibit clotting of human plasma, which implies that the presence of this molecule reduces the rate of fibrinogen cleavage by thrombin,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> but if these molecules also reduce platelet glycoprotein 1 and PAR1 cleavage, SBDs may function as dual antiplatelet and anticoagulant agents. This does not necessarily imply a distinct advantage because of the possibility of introducing bleeding risk. Future studies will clarify these involved aspects.</div><div class="NLM_p last">Overall, this work presents a new specific, hydrophobic binding pocket near Arg173 that is energetically coupled to the active site and a group of small, synthetic, hydrophobic molecules that recognize this site with reasonably high affinity. An appropriately designed allosteric SBD inhibitor could prevent the hemorrhagic complications and avoid narrow dosing regimens that are characteristic of thrombin active site inhibitors.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19"><a href="/doi/suppl/10.1021/jm300670q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Thrombin inhibition by sulfated benzofuran dimer (SBD) <b>12a</b>; thrombin inhibition by SBDs; inhibition of recombinant wild-type and mutant thrombins by <b>12a</b>; putative binding mode for <b>12a</b>; GOLD binding site definitions for <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQ0">3EQ0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H8D">1H8D</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UUF">2UUF</a>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300670q/suppl_file/jm300670q_si_001.pdf">jm300670q_si_001.pdf (2.25 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300670q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Umesh R. Desai</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry and ‡Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond,
Virginia 23219, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Institute for Materia Medica,
College of Life Science and Technology, Huazhong University
of Science and Technology, Wuhan, Hunan 430074, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">Division of Cardiovascular
Medicine,
School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#740106101107151d340217015a111001"><span class="__cf_email__" data-cfemail="f88d8a9c9d8b9991b88e9b8dd69d9c8d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">May H. Abdel Aziz</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry and ‡Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond,
Virginia 23219, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Institute for Materia Medica,
College of Life Science and Technology, Huazhong University
of Science and Technology, Wuhan, Hunan 430074, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">Division of Cardiovascular
Medicine,
School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Preetpal Singh Sidhu</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry and ‡Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond,
Virginia 23219, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Institute for Materia Medica,
College of Life Science and Technology, Huazhong University
of Science and Technology, Wuhan, Hunan 430074, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">Division of Cardiovascular
Medicine,
School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aiye Liang</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry and ‡Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond,
Virginia 23219, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Institute for Materia Medica,
College of Life Science and Technology, Huazhong University
of Science and Technology, Wuhan, Hunan 430074, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">Division of Cardiovascular
Medicine,
School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ji Yeong Kim</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry and ‡Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond,
Virginia 23219, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Institute for Materia Medica,
College of Life Science and Technology, Huazhong University
of Science and Technology, Wuhan, Hunan 430074, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">Division of Cardiovascular
Medicine,
School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip D. Mosier</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry and ‡Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond,
Virginia 23219, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Institute for Materia Medica,
College of Life Science and Technology, Huazhong University
of Science and Technology, Wuhan, Hunan 430074, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">Division of Cardiovascular
Medicine,
School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qibing Zhou</span> - <span class="hlFld-Affiliation affiliation">Institute for Materia Medica,
College of Life Science and Technology, Huazhong University
of Science and Technology, Wuhan, Hunan 430074, P. R.
China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David H. Farrell</span> - <span class="hlFld-Affiliation affiliation">Division of Cardiovascular
Medicine,
School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1272e1430-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60443" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60443" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants HL090586, HL099420, and HL107152 from the National Institutes of Health. We thank Drs. Paul Bock of Vanderbilt University for providing HirP and H. Tonie Wright of Virginia Commonwealth University for helpful discussions. We thank Dr. Alireza Rezaie of St. Louis School of Medicine for supplying recombinant thrombin mutants.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i21" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i21"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i22" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i22"> Abbreviations Used</h2><tr><td class="NLM_term">LMWL</td><td class="NLM_def"><p class="first last">low molecular weight lignin</p></td></tr><tr><td class="NLM_term">LMWH</td><td class="NLM_def"><p class="first last">low molecular weight heparin</p></td></tr><tr><td class="NLM_term">SBD</td><td class="NLM_def"><p class="first last">sulfated benzofuran dimer</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Huntington, J. A.</span><span> </span><span class="NLM_article-title">Molecular recognition mechanisms of thrombin</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1861</span><span class="NLM_x">–</span> <span class="NLM_lpage">1872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1111%2Fj.1538-7836.2005.01363.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=16102053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFKjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=1861-1872&author=J.+A.+Huntington&title=Molecular+recognition+mechanisms+of+thrombin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition mechanisms of thrombin</span></div><div class="casAuthors">Huntington, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1861-1872</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Thrombin (I) is the final protease generated in the blood coagulation cascade, and is the only factor capable of cleaving fibrinogen to create a fibrin clot.  Unlike every other coagulation protease, I is composed solely of its serine protease domain, so that once formed it can diffuse freely to encounter a large no. of potential substrates.  Thus, I serves many functions in hemostasis through the specific cleavage of at least a dozen substrates.  The soln. of the crystal structure of I some 15 yr ago revealed a deep active site cleft and 2 adjacent basic exosites, and it was clear that I must utilize these unique features in recognizing its substrates.  Just how this occurs is still being investigated, but recent data from thrombin mutant libraries and crystal structures combine to paint the clearest picture to date of the mol. determinants of substrate recognition by I.  In almost all cases, both thrombin exosites are involved, either through direct interaction with the substrate protein or through indirect interaction with a 3rd cofactor mol.  The purpose of this article is to summarize recent biochem. and structural data in order to provide insight into the I mol. recognition events at the heart of hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0qOc7mUtmo7Vg90H21EOLACvtfcHk0lhQwff_iHMEcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFKjs7k%253D&md5=6b8e25d8ae4735c050c01ab60f9f410c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2005.01363.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2005.01363.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuntington%26aufirst%3DJ.%2BA.%26atitle%3DMolecular%2520recognition%2520mechanisms%2520of%2520thrombin%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2005%26volume%3D3%26spage%3D1861%26epage%3D1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bode, W.</span><span> </span><span class="NLM_article-title">The structure of thrombin: A Janus-headed proteinase</span> <span class="citation_source-journal">Semin. Thromb. Hemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1055%2Fs-2006-939551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=16673263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD28XltFagtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2006&pages=16-31&author=W.+Bode&title=The+structure+of+thrombin%3A+A+Janus-headed+proteinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of thrombin: a Janus-headed proteinase</span></div><div class="casAuthors">Bode, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Thrombosis and Hemostasis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">16-31</span>CODEN:
                <span class="NLM_cas:coden">STHMBV</span>;
        ISSN:<span class="NLM_cas:issn">0094-6176</span>.
    
            (<span class="NLM_cas:orgname">Thieme Medical Publishers, Inc.</span>)
        </div><div class="casAbstract">A review.  Through a series of successive, cascade-like proteinase activation and amplification steps, any vascular injury triggers a rapid burst of α-thrombin (α-I), a trypsin-like serine proteinase.  I, the main executioner of the coagulation cascade, has procoagulant as well as anticoagulant and antifibrinolytic properties.  It exhibits quite diverse physiol. functions, but also gives rise to several thrombotic disorders, such as thromboembolism, myocardial infarction, and stroke, thus making it an attractive target for antithrombotic agents.  I interacts specifically with several protein substrates, receptors, cofactors, inhibitors, carbohydrates, and modulators.  I cleaves fibrinogen, blood-coagulation factors XI (FXI) and FXIII, cofactors V and VIII, and I receptors; uses thrombomodulin to activate protein C and I-activatable-fibrinolysis inhibitor; is inhibited by heparin cofactor II and antithrombin III with the help of acidic carbohydrates; and its activity/specificity is modulated by Na+.  A large no. of crystal structures of α-I in complexes with synthetic polypeptides and protein inhibitors, substrate fragments, cofactors, and carbohydrates have displayed extended recognition sites on the thrombin surface, reflecting the versatility and multifunctional specificity of this remarkable proteinase.  These structures essentially show that the I surface can be subdivided into several functional regions, which recognize different chem. moieties.  By using different combinations of these surface elements, I can interact with a variety of mols. with high specificity, accounting for its multifunctional properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTN3vK3UP3TLVg90H21EOLACvtfcHk0lj0HXBzF8hLHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltFagtL0%253D&md5=544cc01df029e6f98432cb1b3a393ecb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-939551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-939551%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DW.%26atitle%3DThe%2520structure%2520of%2520thrombin%253A%2520A%2520Janus-headed%2520proteinase%26jtitle%3DSemin.%2520Thromb.%2520Hemostasis%26date%3D2006%26volume%3D32%26spage%3D16%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Di Cera, E.</span><span> </span><span class="NLM_article-title">Thrombin</span> <span class="citation_source-journal">Mol. Aspects Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1016%2Fj.mam.2008.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=18329094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFOrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=203-254&author=E.+Di+Cera&title=Thrombin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin</span></div><div class="casAuthors">Di Cera, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-254</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Thrombin is a Na+-activated, allosteric serine protease that plays opposing functional roles in blood coagulation.  Binding of Na+ is the major driving force behind the procoagulant, prothrombotic and signaling functions of the enzyme, but is dispensable for cleavage of the anticoagulant protein C. The anticoagulant function of thrombin is under the allosteric control of the cofactor thrombomodulin.  Much has been learned on the mechanism of Na+ binding and recognition of natural substrates by thrombin.  Recent structural advances have shed light on the remarkable mol. plasticity of this enzyme and the mol. underpinnings of thrombin allostery mediated by binding to exosite I and the Na+ site.  This review summarizes our current understanding of the mol. basis of thrombin function and allosteric regulation.  The basic information emerging from recent structural, mutagenesis and kinetic investigation of this important enzyme is that thrombin exists in three forms, E*, E and E:Na+, that interconvert under the influence of ligand binding to distinct domains.  The transition between the Na+-free slow form E and the Na+-bound fast form E:Na+ involves the structure of the enzyme as a whole, and so does the interconversion between the two Na+-free forms E* and E.  E* is most likely an inactive form of thrombin, unable to interact with Na+ and substrate.  The complexity of thrombin function and regulation has gained this enzyme pre-eminence as the prototypic allosteric serine protease.  Thrombin is now looked upon as a model system for the quant. anal. of biol. important enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7AGMa1hrZV7Vg90H21EOLACvtfcHk0lj0HXBzF8hLHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFOrsLw%253D&md5=de9bebd7f7bee2afbf1d1dedb9b458e4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2008.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2008.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCera%26aufirst%3DE.%26atitle%3DThrombin%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2008%26volume%3D29%26spage%3D203%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Steinmetzer, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturzebecher, J.</span><span> </span><span class="NLM_article-title">Progress in the development of synthetic thrombin inhibitors as new orally active anticoagulants</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.2174%2F0929867043364540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=15379714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVeltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2297-2321&author=T+Steinmetzerauthor=J.+Sturzebecher&title=Progress+in+the+development+of+synthetic+thrombin+inhibitors+as+new+orally+active+anticoagulants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of synthetic thrombin inhibitors as new orally active anticoagulants</span></div><div class="casAuthors">Steinmetzer, Torsten; Stuerzebecher, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2297-2321</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The trypsin-like serine protease thrombin is a multifunctional key enzyme at the final step of the coagulation cascade and is involved in the regulation of hemostasis and thrombosis.  An increased activation of coagulation can result in severe thromboembolic disorders, one of the major reasons responsible for mortality and morbidity in western world.  Therefore, an effective, safe, and orally available thrombin inhibitor could be a useful anticoagulant drug for the daily prophylaxis of venous and arterial thrombosis and prevention of myocardial infarction for high-risk patients.  Synthetic thrombin inhibitors have a long history; initial compds. were derived from electrophilic ketone- and aldehyde-analogs of arginine.  First potent leads of non-covalent inhibitors were developed in the early 80s, which were further optimized in the 90s, after the x-ray structure of thrombin became available.  In the meantime a huge no. of highly active and selective inhibitors was published, however, only a few of them have an appropriate pharmacokinetic and pharmacodynamic overall profile, which could justify their further development.  Very recently, with Ximelagatran a first orally available thrombin inhibitor was approved in France for the prevention of venous thromboembolic events in major orthopedic surgery after successful clin. phase III.  However, it still has to be awaited, whether the extensive clin. use of Ximelagatran can demonstrate for the first time that direct thrombin inhibitors offer a real benefit in terms of efficacy and safety over established antithrombotic therapies.  This review summarizes the current status of synthetic thrombin inhibitors with a focus on more recently published and promising new compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpmjPQRw9su7Vg90H21EOLACvtfcHk0lj0HXBzF8hLHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVeltLk%253D&md5=f510afc34f2f7b162c671e6bd9adad52</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867043364540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364540%26sid%3Dliteratum%253Aachs%26aulast%3DSteinmetzer%26aufirst%3DT%26aulast%3DSturzebecher%26aufirst%3DJ.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520synthetic%2520thrombin%2520inhibitors%2520as%2520new%2520orally%2520active%2520anticoagulants%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D2297%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Saiah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, C.</span><span> </span><span class="NLM_article-title">Small molecule coagulation cascade inhibitors in the clinic</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.2174%2F156802605775009702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=16375748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD28XislSlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1677-1695&author=E.+Saiahauthor=C.+Soares&title=Small+molecule+coagulation+cascade+inhibitors+in+the+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule coagulation cascade inhibitors in the clinic</span></div><div class="casAuthors">Saiah, Eddine; Soares, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1677-1695</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Venous thromboembolic disease, including deep vein thrombosis and pulmonary embolism, is a cause of significant mortality and morbidity.  For several decades, anticoagulant options for the treatment and prevention of thrombosis have been limited mainly to agents such as unfractionated heparin and oral vitamin K antagonists such as warfarin.  Although these therapies have proven benefits, they also have important limitations that result in their under-use in routine clin. practice.  A variety of novel anticoagulants with improved pharmacol. and clin. profiles are in development, offering benefits over traditional therapies.  Specifically, progress has been made in the development of small mol. Factor Xa inhibitors and thrombin inhibitors.  The most advanced drugs reviewed include DPC-423, DPC-602, razaxaban, GSK's 813893, Portola's Xa inhibitors (formerly Millennium), otamixaban, DU-176b, KFA-1982, BAY-59-7939, DX-9065a, YM-150, LY-517717, Exanta, 3DP's thrombin inhibitors, SSR-182289, LB-30057, LB-30870, BIBR-1048 and Merck's thrombin inhibitors.  With their potentially consistent and predictable pharmacol. profile, oral formulation, and decreased need for coagulation monitoring, these new agents will likely increase the use and duration of anticoagulation treatment in thromboembolic disorders and reduce the burden assocd. with long-term management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA1yTRmR_ZfbVg90H21EOLACvtfcHk0ljDPHd3inMPQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislSlsLc%253D&md5=f1f06363e4ec89a2bdbf181a1c58057b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F156802605775009702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605775009702%26sid%3Dliteratum%253Aachs%26aulast%3DSaiah%26aufirst%3DE.%26aulast%3DSoares%26aufirst%3DC.%26atitle%3DSmall%2520molecule%2520coagulation%2520cascade%2520inhibitors%2520in%2520the%2520clinic%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1677%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Smallheer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span> </span><span class="NLM_article-title">Recent advances in coagulation serine protease inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=189-208&author=J.+M.+Smallheerauthor=M.+L.+Quan&title=Recent+advances+in+coagulation+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmallheer%26aufirst%3DJ.%2BM.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26atitle%3DRecent%2520advances%2520in%2520coagulation%2520serine%2520protease%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D189%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Straub, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehrig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span> </span><span class="NLM_article-title">Oral, direct thrombin and factor Xa inhibitors: The replacement of warfarin, leeches and pig intestines?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4574</span><span class="NLM_x">–</span> <span class="NLM_lpage">4590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4574-4590&author=A.+Straubauthor=S.+Roehrigauthor=A.+Hillisch&title=Oral%2C+direct+thrombin+and+factor+Xa+inhibitors%3A+The+replacement+of+warfarin%2C+leeches+and+pig+intestines%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStraub%26aufirst%3DA.%26aulast%3DRoehrig%26aufirst%3DS.%26aulast%3DHillisch%26aufirst%3DA.%26atitle%3DOral%252C%2520direct%2520thrombin%2520and%2520factor%2520Xa%2520inhibitors%253A%2520The%2520replacement%2520of%2520warfarin%252C%2520leeches%2520and%2520pig%2520intestines%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D4574%26epage%3D4590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Tucker, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumma, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisko, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskin, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dancheck, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3210</span><span class="NLM_x">–</span> <span class="NLM_lpage">3219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9801713" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3210-3219&author=T.+J.+Tuckerauthor=S.+F.+Bradyauthor=W.+C.+Lummaauthor=S.+D.+Lewisauthor=S.+J.+Gardellauthor=A.+M.+Naylor-Olsenauthor=Y.+W.+Yanauthor=J.+T.+Siskoauthor=K.+J.+Staufferauthor=B.+J.+Lucasauthor=J.+J.+Lynchauthor=J.+J.+Cookauthor=M.+T.+Stranieriauthor=M.+A.+Holahanauthor=E.+A.+Lyleauthor=E.+P.+Baskinauthor=I.+W.+Chenauthor=K.+B.+Dancheckauthor=J.+A.+Kruegerauthor=C.+M.+Cooperauthor=J.+P.+Vacca&title=Design+and+synthesis+of+a+series+of+potent+and+orally+bioavailable+noncovalent+thrombin+inhibitors+that+utilize+nonbasic+groups+in+the+P1+position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm9801713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9801713%26sid%3Dliteratum%253Aachs%26aulast%3DTucker%26aufirst%3DT.%2BJ.%26aulast%3DBrady%26aufirst%3DS.%2BF.%26aulast%3DLumma%26aufirst%3DW.%2BC.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DYan%26aufirst%3DY.%2BW.%26aulast%3DSisko%26aufirst%3DJ.%2BT.%26aulast%3DStauffer%26aufirst%3DK.%2BJ.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DBaskin%26aufirst%3DE.%2BP.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DDancheck%26aufirst%3DK.%2BB.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DCooper%26aufirst%3DC.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520series%2520of%2520potent%2520and%2520orally%2520bioavailable%2520noncovalent%2520thrombin%2520inhibitors%2520that%2520utilize%2520nonbasic%2520groups%2520in%2520the%2520P1%2520position%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3210%26epage%3D3219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicore, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1N-benzylamides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1353-1357&author=C.+S.+Burgeyauthor=K.+A.+Robinsonauthor=T.+A.+Lyleauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=R.+C.+A.+Isaacsauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=J.+A.+Kruegerauthor=R.+Singhauthor=C.+Miller-Steinauthor=R.+B.+Whiteauthor=B.+Wongauthor=E.+A.+Lyleauthor=M.+T.+Stranieriauthor=J.+J.+Cookauthor=D.+R.+McMastersauthor=J.+M.+Pellicoreauthor=S.+Palauthor=A.+A.+Wallaceauthor=F.+C.+Claytonauthor=D.+Bohnauthor=D.+C.+Welshauthor=J.+J.+Lynchauthor=Y.+W.+Yanauthor=Z.+G.+Chenauthor=L.+Kuoauthor=S.+J.+Gardellauthor=J.+A.+Shaferauthor=J.+P.+Vacca&title=Pharmacokinetic+optimization+of+3-amino-6-chloropyrazinone+acetamide+thrombin+inhibitors.+Implementation+of+P3+pyridine+N-oxides+to+deliver+an+orally+bioavailable+series+containing+P1N-benzylamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DRobinson%26aufirst%3DK.%2BA.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DPellicore%26aufirst%3DJ.%2BM.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DClayton%26aufirst%3DF.%2BC.%26aulast%3DBohn%26aufirst%3DD.%26aulast%3DWelsh%26aufirst%3DD.%2BC.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DY.%2BW.%26aulast%3DChen%26aufirst%3DZ.%2BG.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DPharmacokinetic%2520optimization%2520of%25203-amino-6-chloropyrazinone%2520acetamide%2520thrombin%2520inhibitors.%2520Implementation%2520of%2520P3%2520pyridine%2520N-oxides%2520to%2520deliver%2520an%2520orally%2520bioavailable%2520series%2520containing%2520P1N-benzylamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1353%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michener, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span> </span><span class="NLM_article-title">P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 position</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1535</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1532-1535&author=R.+C.+A.+Isaacsauthor=C.+L.+Newtonauthor=K.+J.+Cutronaauthor=S.+P.+Mercerauthor=B.+D.+Dorseyauthor=C.+M.+McDonoughauthor=J.+J.+Cookauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=E.+A.+Lyleauthor=J.+J.+Lynchauthor=C.+Miller-Steinauthor=M.+T.+Michenerauthor=A.+A.+Wallaceauthor=R.+B.+Whiteauthor=B.+K.+Wong&title=P3+optimization+of+functional+potency%2C+in+vivo+efficacy+and+oral+bioavailability+in+3-aminopyrazinone+thrombin+inhibitors+bearing+non-charged+groups+at+the+P1+position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMcDonough%26aufirst%3DC.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DMichener%26aufirst%3DM.%2BT.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%2BK.%26atitle%3DP3%2520optimization%2520of%2520functional%2520potency%252C%2520in%2520vivo%2520efficacy%2520and%2520oral%2520bioavailability%2520in%25203-aminopyrazinone%2520thrombin%2520inhibitors%2520bearing%2520non-charged%2520groups%2520at%2520the%2520P1%2520position%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1532%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Straub, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehrig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span> </span><span class="NLM_article-title">Entering the era of non-basic P1 site groups: Discovery of Xarelto (TM) (Rivaroxaban)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.2174%2F156802610790725506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=20166954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1ent7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=257-269&author=A.+Straubauthor=S.+Roehrigauthor=A.+Hillisch&title=Entering+the+era+of+non-basic+P1+site+groups%3A+Discovery+of+Xarelto+%28TM%29+%28Rivaroxaban%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Entering the era of non-basic P1 site groups: discovery of Xarelto (Rivaroxaban)</span></div><div class="casAuthors">Straub, Alexander; Roehrig, Susanne; Hillisch, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-269</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Several clin. candidates have now emerged as a result of an intense search for orally available, antithrombotic factor Xa inhibitors.  This review highlights the discovery of Xarelto (Rivaroxaban) starting from an initial tetrahydrophthalimide screening hit.  The major breakthrough was the finding that a chlorothiophene moiety can undergo an interaction in the S1 binding site thus leading to high potency combined with favorable oral bioavailability.  The binding mode of this P1 moiety is discussed, and further non-basic S1 binders of this new type are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT5ggNM_-LK7Vg90H21EOLACvtfcHk0lgXExXN_2B0DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1ent7c%253D&md5=b718422cb8e344222a9935d1ea7b5fd8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F156802610790725506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790725506%26sid%3Dliteratum%253Aachs%26aulast%3DStraub%26aufirst%3DA.%26aulast%3DRoehrig%26aufirst%3DS.%26aulast%3DHillisch%26aufirst%3DA.%26atitle%3DEntering%2520the%2520era%2520of%2520non-basic%2520P1%2520site%2520groups%253A%2520Discovery%2520of%2520Xarelto%2520%2528TM%2529%2520%2528Rivaroxaban%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D257%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bock, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panizzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhamme, I. M. A.</span><span> </span><span class="NLM_article-title">Exosites in the substrate specificity of blood coagulation reactions</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1111%2Fj.1538-7836.2007.02496.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=17635714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFGltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=81-94&issue=Suppl.+1&author=P.+E.+Bockauthor=P.+Panizziauthor=I.+M.+A.+Verhamme&title=Exosites+in+the+substrate+specificity+of+blood+coagulation+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Exosites in the substrate specificity of blood coagulation reactions</span></div><div class="casAuthors">Bock, P. E.; Panizzi, P.; Verhamme, I. M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">81-94</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The specificity of blood coagulation proteinases for substrate, inhibitor, and effector recognition is mediated by exosites on the surfaces of the catalytic domains, phys. sepd. from the catalytic site.  Some thrombin ligands bind specifically to either exosite I or II, while others engage both exosites.  The involvement of different, overlapping constellations of exosite residues enables binding of structurally diverse ligands.  The flexibility of the thrombin structure is central to the mechanism of complex formation and the specificity of exosite interactions.  Encounter complex formation is driven by electrostatic ligand-exosite interactions, followed by conformational rearrangement to a stable complex.  Exosites on some zymogens are in low affinity proexosite states and are expressed concomitant with catalytic site activation.  The requirement for exosite expression controls the specificity of assembly of catalytic complexes on the coagulation pathway, such as the membrane-bound factor Xa·factor Va (prothrombinase) complex, and prevents premature assembly.  Substrate recognition by prothrombinase involves a two-step mechanism with initial docking of prothrombin to exosites, followed by a conformational change to engage the FXa catalytic site.  Prothrombin and its activation intermediates bind prothrombinase in two alternative conformations detd. by the zymogen to proteinase transition that are hypothesized to involve prothrombin (pro)exosite I interactions with FVa, which underpin the sequential activation pathway.  The role of exosites as the major source of substrate specificity has stimulated development of exosite-targeted anticoagulants for treatment of thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCsviTVt8YZLVg90H21EOLACvtfcHk0lgXExXN_2B0DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFGltL4%253D&md5=79e7e7dce61d91af62c6a679dcf46a4d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2007.02496.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2007.02496.x%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DP.%2BE.%26aulast%3DPanizzi%26aufirst%3DP.%26aulast%3DVerhamme%26aufirst%3DI.%2BM.%2BA.%26atitle%3DExosites%2520in%2520the%2520substrate%2520specificity%2520of%2520blood%2520coagulation%2520reactions%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2007%26volume%3D5%26issue%3DSuppl.%25201%26spage%3D81%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Olson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub-Segall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedsted, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hérault, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björk, I.</span><span> </span><span class="NLM_article-title">Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1160%2FTH04-06-0384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=15543318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVegs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2004&pages=929-939&author=S.+T.+Olsonauthor=R.+Swansonauthor=E.+Raub-Segallauthor=T.+Bedstedauthor=M.+Sadriauthor=M.+Petitouauthor=J.+P.+H%C3%A9raultauthor=J.+M.+Herbertauthor=I.+Bj%C3%B6rk&title=Accelerating+ability+of+synthetic+oligosaccharides+on+antithrombin+inhibition+of+proteinases+of+the+clotting+and+fibrinolytic+systems.+Comparison+with+heparin+and+low-molecular-weight+heparin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin</span></div><div class="casAuthors">Olson, Steven T.; Swanson, Richard; Raub-Segall, Elke; Bedsted, Tina; Sadri, Morvardi; Petitou, Maurice; Herault, Jean-Pascal; Herbert, Jean-Marc; Bjoerk, Ingemar</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">The abilities of three synthetic oligosaccharides to accelerate antithrombin inhibition of ten clotting or fibrinolytic proteinases were compared with those of unfractionated, fractionated high-affinity and low-mol.-wt. heparins.  The results show that the anticoagulant effects of the latter three heparins under conditions approximating physiol. are exerted almost exclusively by acceleration of the inactivation of thrombin, factor Xa and factor IXa to near diffusion-controlled rate consts. of ∼106 - 107 M-1·s-1.  All other proteinases are inhibited with at least 20-fold lower rate consts.  The anticoagulant ability of the synthetic regular (fondaparinux) and high-affinity (idraparinux) pentasaccharides is due to a common mechanism, involving acceleration of only factor Xa inhibition to rate consts. of ∼106 M-1·s-1.  A synthetic hexadecasaccharide, contg. both the pentasaccharide sequence and a proteinase binding site, exerts its anticoagulant effect by accelerating antithrombin inactivation of both thrombin and factor Xa to rate consts. of ∼106 - 107 M-1·s-1, although thrombin appears to be the more important target.  In contrast, factor IXa inhibition is appreciably less stimulated.  The conformational change of antithrombin induced both by the pentasaccharides and longer heparins contributes substantially, ∼150-500-fold, to accelerating the inactivation of factors Xa, IXa and VIIa and moderately, ∼50-fold, to that of factor XIIa and tissue plasminogen activator inhibition.  The bridging effect due to binding of antithrombin and proteinase to the same, long heparin chain is dominating, ∼1000-3000-fold, for thrombin inhibition and is appreciably smaller, although up to ∼250-350-fold, for the inactivation of factors IXa and XIa.  These results establish the proteinase targets of heparin derivs. currently used in or considered for thrombosis therapy and give new insights into the mechanism of heparin acceleration of antithrombin inhibition of proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8EE8x1bq4bLVg90H21EOLACvtfcHk0lhRvttUq2egaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVegs77O&md5=7139e941c229736a3251bee5db57db94</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1160%2FTH04-06-0384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH04-06-0384%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DS.%2BT.%26aulast%3DSwanson%26aufirst%3DR.%26aulast%3DRaub-Segall%26aufirst%3DE.%26aulast%3DBedsted%26aufirst%3DT.%26aulast%3DSadri%26aufirst%3DM.%26aulast%3DPetitou%26aufirst%3DM.%26aulast%3DH%25C3%25A9rault%26aufirst%3DJ.%2BP.%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26aulast%3DBj%25C3%25B6rk%26aufirst%3DI.%26atitle%3DAccelerating%2520ability%2520of%2520synthetic%2520oligosaccharides%2520on%2520antithrombin%2520inhibition%2520of%2520proteinases%2520of%2520the%2520clotting%2520and%2520fibrinolytic%2520systems.%2520Comparison%2520with%2520heparin%2520and%2520low-molecular-weight%2520heparin%26jtitle%3DThromb.%2520Haemostasis%26date%3D2004%26volume%3D92%26spage%3D929%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">New antithrombin-based anticoagulants</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1002%2Fmed.10058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=14705167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlelsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=151-181&author=U.+R.+Desai&title=New+antithrombin-based+anticoagulants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New antithrombin-based anticoagulants</span></div><div class="casAuthors">Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-181</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Clin. used anticoagulants are inhibitors of enzymes involved in the coagulation pathway, primarily thrombin and factor Xa.  These agents can be either direct or indirect inhibitors of clotting enzymes.  Heparin-based anticoagulants are indirect inhibitors that enhance the proteinase inhibitory activity of a natural anticoagulant, antithrombin.  Despite its phenomenal success, current anticoagulation therapy suffers from the risk of serious bleeding.  The need for safer and more effective antithrombotic agents clearly exists.  The past decade has seen enormous effort directed toward discovering and/or designing new mols. with anticoagulant activity.  These new mols. can be classified into (a) antithrombin and its mutants, (b) natural polysaccharides, (c) synthetic modified heparins and heparin-mimics, (d) synthetic oligosaccharides, and (e) synthetic non-sugar antithrombin activators.  This review focuses on these efforts in designing or discovering new mols. that act through the antithrombin pathway of anticoagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaN2m5pWF4ErVg90H21EOLACvtfcHk0lhRvttUq2egaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlelsr8%253D&md5=ea7d72a23b2a2424d8dddb8034289b1e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fmed.10058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10058%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DNew%2520antithrombin-based%2520anticoagulants%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2004%26volume%3D24%26spage%3D151%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Di Cera, E.</span><span> </span><span class="NLM_article-title">Thrombin: A paradigm for enzymes allosterically activated by monovalent cations</span> <span class="citation_source-journal">C. R. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1016%2Fj.crvi.2004.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=15656349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOntLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2004&pages=1065-1076&author=E.+Di+Cera&title=Thrombin%3A+A+paradigm+for+enzymes+allosterically+activated+by+monovalent+cations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin: a paradigm for enzymes allosterically activated by monovalent cations</span></div><div class="casAuthors">Di Cera, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Comptes Rendus Biologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1065-1076</span>CODEN:
                <span class="NLM_cas:coden">CRBOCM</span>;
        ISSN:<span class="NLM_cas:issn">1631-0691</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review.  Enzymes activated by monovalent cations are abundantly represented in plants and in the animal world.  The mechanism of activation involves the formation of a ternary intermediate with the enzyme-substrate complex, or the binding of the cation to an allosteric site in the protein.  Thrombin is a Na+-activated enzyme with procoagulant, anticoagulant, and signaling roles.  The binding of Na+ influences thrombin function allosterically and offers a paradigm for regulatory control of protease activity and specificity.  Here, the authors review the mol. basis of thrombin allostery as has recently emerged from mutagenesis and structural studies.  The role of Na+ in blood coagulation and the evolution of serine proteases are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodBkmXnuoI-7Vg90H21EOLACvtfcHk0lhRvttUq2egaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOntLfJ&md5=ed867219f2955b80bdc745a799899bef</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.crvi.2004.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.crvi.2004.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCera%26aufirst%3DE.%26atitle%3DThrombin%253A%2520A%2520paradigm%2520for%2520enzymes%2520allosterically%2520activated%2520by%2520monovalent%2520cations%26jtitle%3DC.%2520R.%2520Biol.%26date%3D2004%26volume%3D327%26spage%3D1065%26epage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Evans, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, J. D.</span><span> </span><span class="NLM_article-title"><i>p</i>-Aminobenzamidine as a fluorescent probe for the active site of serine proteases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">3014</span><span class="NLM_x">–</span> <span class="NLM_lpage">3017</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=3014-3017&author=S.+A.+Evansauthor=S.+T.+Olsonauthor=J.+D.+Shore&title=p-Aminobenzamidine+as+a+fluorescent+probe+for+the+active+site+of+serine+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DS.%2BA.%26aulast%3DOlson%26aufirst%3DS.%2BT.%26aulast%3DShore%26aufirst%3DJ.%2BD.%26atitle%3Dp-Aminobenzamidine%2520as%2520a%2520fluorescent%2520probe%2520for%2520the%2520active%2520site%2520of%2520serine%2520proteases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D3014%26epage%3D3017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ng, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinsey, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiserman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijeyewickrema, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R. N.</span><span> </span><span class="NLM_article-title">The effects of exosite occupancy on the substrate specificity of thrombin</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">489</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=489&publication_year=2009&pages=48-54&author=N.+M.+Ngauthor=N.+S.+Quinseyauthor=A.+Y.+Matthewsauthor=D.+Kaisermanauthor=L.+C.+Wijeyewickremaauthor=P.+I.+Birdauthor=P.+E.+Thompsonauthor=R.+N.+Pike&title=The+effects+of+exosite+occupancy+on+the+substrate+specificity+of+thrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DN.%2BM.%26aulast%3DQuinsey%26aufirst%3DN.%2BS.%26aulast%3DMatthews%26aufirst%3DA.%2BY.%26aulast%3DKaiserman%26aufirst%3DD.%26aulast%3DWijeyewickrema%26aufirst%3DL.%2BC.%26aulast%3DBird%26aufirst%3DP.%2BI.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DPike%26aufirst%3DR.%2BN.%26atitle%3DThe%2520effects%2520of%2520exosite%2520occupancy%2520on%2520the%2520substrate%2520specificity%2520of%2520thrombin%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D489%26spage%3D48%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Desai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boothello, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarsdale, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Interaction of thrombin with sucrose octasulfate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6973</span><span class="NLM_x">–</span> <span class="NLM_lpage">6982</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi2004526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=6973-6982&author=B.+J.+Desaiauthor=R.+S.+Boothelloauthor=A.+Y.+Mehtaauthor=J.+N.+Scarsdaleauthor=H.+T.+Wrightauthor=U.+R.+Desai&title=Interaction+of+thrombin+with+sucrose+octasulfate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi2004526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2004526%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DB.%2BJ.%26aulast%3DBoothello%26aufirst%3DR.%2BS.%26aulast%3DMehta%26aufirst%3DA.%2BY.%26aulast%3DScarsdale%26aufirst%3DJ.%2BN.%26aulast%3DWright%26aufirst%3DH.%2BT.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DInteraction%2520of%2520thrombin%2520with%2520sucrose%2520octasulfate%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D6973%26epage%3D6982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Monien, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghuraman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Novel chemo-enzymatic oligomers of cinnamic acids as direct and indirect inhibitors of coagulation proteinases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7988</span><span class="NLM_x">–</span> <span class="NLM_lpage">7998</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=7988-7998&author=B.+H.+Monienauthor=B.+L.+Henryauthor=A.+Raghuramanauthor=M.+Hindleauthor=U.+R.+Desai&title=Novel+chemo-enzymatic+oligomers+of+cinnamic+acids+as+direct+and+indirect+inhibitors+of+coagulation+proteinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonien%26aufirst%3DB.%2BH.%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DRaghuraman%26aufirst%3DA.%26aulast%3DHindle%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DNovel%2520chemo-enzymatic%2520oligomers%2520of%2520cinnamic%2520acids%2520as%2520direct%2520and%2520indirect%2520inhibitors%2520of%2520coagulation%2520proteinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D7988%26epage%3D7998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monien, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">A novel allosteric pathway of thrombin inhibition. Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">31891</span><span class="NLM_x">–</span> <span class="NLM_lpage">31899</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=31891-31899&author=B.+L.+Henryauthor=B.+H.+Monienauthor=P.+E.+Bockauthor=U.+R.+Desai&title=A+novel+allosteric+pathway+of+thrombin+inhibition.+Exosite+II+mediated+potent+inhibition+of+thrombin+by+chemo-enzymatic%2C+sulfated+dehydropolymers+of+4-hydroxycinnamic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DMonien%26aufirst%3DB.%2BH.%26aulast%3DBock%26aufirst%3DP.%2BE.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DA%2520novel%2520allosteric%2520pathway%2520of%2520thrombin%2520inhibition.%2520Exosite%2520II%2520mediated%2520potent%2520inhibition%2520of%2520thrombin%2520by%2520chemo-enzymatic%252C%2520sulfated%2520dehydropolymers%2520of%25204-hydroxycinnamic%2520acids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D31891%26epage%3D31899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakkar, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Characterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acids</span> <span class="citation_source-journal">Blood Coagulation Fibrinolysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1097%2FMBC.0b013e328304e077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=20523162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitleqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=27-34&author=B.+L.+Henryauthor=J.+N.+Thakkarauthor=E.+J.+Martinauthor=D.+F.+Brophyauthor=U.+R.+Desai&title=Characterization+of+the+plasma+and+blood+anticoagulant+potential+of+structurally+and+mechanistically+novel+oligomers+of+4-hydroxycinnamic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acids</span></div><div class="casAuthors">Henry, Brian L.; Thakkar, Jay N.; Martin, Erika J.; Brophy, Donald F.; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Coagulation & Fibrinolysis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-34</span>CODEN:
                <span class="NLM_cas:coden">BLFIE7</span>;
        ISSN:<span class="NLM_cas:issn">0957-5235</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Recently, we designed sulfated dehydropolymers (DHPs) of 4-hydroxycinnamic acids that displayed interesting anticoagulant properties.  Structurally and mechanistically, sulfated DHPs are radically different from all the anticoagulants studied to date.  To assess whether their unique mechanism and structure is worth exploiting for further rational design of homogeneous DHP-based mols., we investigated their anticoagulant potential in human plasma and blood using a range of clotting assays.  Sulfated DHPs prolong plasma clotting times, prothrombin and activated partial thromboplastin times at concns. comparable to the clin. used low-mol.-wt. heparin, enoxaparin.  Fibrin formation studies on human plasma show that there is a structural dependence of anticoagulant action.  Human whole blood studies using thromboelastog. and hemostasis anal. system indicate that they are 17-140-fold less potent than enoxaparin.  These results demonstrate that sulfated DHPs possess good in-vitro and ex-vivo activity, which will likely be improved through a rational design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybqugq2Ap7LVg90H21EOLACvtfcHk0liF8okSh5Iyqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitleqsA%253D%253D&md5=f61c7241dafc2299f5abec30d1a926b7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2FMBC.0b013e328304e077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMBC.0b013e328304e077%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DThakkar%26aufirst%3DJ.%2BN.%26aulast%3DMartin%26aufirst%3DE.%2BJ.%26aulast%3DBrophy%26aufirst%3DD.%2BF.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DCharacterization%2520of%2520the%2520plasma%2520and%2520blood%2520anticoagulant%2520potential%2520of%2520structurally%2520and%2520mechanistically%2520novel%2520oligomers%2520of%25204-hydroxycinnamic%2520acids%26jtitle%3DBlood%2520Coagulation%2520Fibrinolysis%26date%3D2009%26volume%3D20%26spage%3D27%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel Aziz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Sulfated, low molecular weight lignins are potent inhibitors of plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1160%2FTH09-07-0454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=20024500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2010&pages=507-515&author=B.+L.+Henryauthor=M.+Abdel+Azizauthor=Q.+Zhouauthor=U.+R.+Desai&title=Sulfated%2C+low+molecular+weight+lignins+are+potent+inhibitors+of+plasmin%2C+in+addition+to+thrombin+and+factor+Xa%3A+Novel+opportunity+for+controlling+complex+pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfated, low-molecular-weight lignins are potent inhibitors of plasmin, in addition to thrombin and factor Xa: novel opportunity for controlling complex pathologies</span></div><div class="casAuthors">Henry, Brian L.; Aziz, May Abdel; Zhou, Qibing; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">507-515</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Recently we prepd. sulfated, low-mol.-wt. lignins (LMWLs) to mimic the biol. activities of heparin and heparan sulfate.  Chemo-enzymically prepd. sulfated LMWLs represent a library of diverse non-sugar, arom. mols. with structures radically different from the heparins, and have been found to potently inhibit thrombin and factor Xa.  To assess their effect on the fibrinolytic system, we studied the interaction of LMWLs with human plasmin.  Enzyme inhibition studies indicate that the three sulfated LMWLs studied inhibit plasmin with IC50 values in the range of 0.24 and 1.3 μM, which are marginally affected in the presence of antithrombin.  Similarly, plasmin degrdn. of polymeric fibrin is also inhibited by sulfated LMWLs.  Michaelis-Menten kinetic studies indicate that maximal velocity of hydrolysis of chromogenic substrates decreases nearly 70% in the presence of LMWLs, while the effect on Michaelis const. is dependent on the nature of the substrate.  Competitive binding studies indicate that the sulfated LMWLs compete with full-length heparin.  Comparison with thrombin-heparin crystal structure identifies an anionic region on plasmin as a plausible sulfated LMWL binding site.  Overall, the chemoenzymic origin coupled with coagulation and fibrinolysis inhibition properties of sulfated LMWLs present novel opportunities for designing new pharmaceutical agents that regulate complex pathologies in which both systems are known to play important roles such as disseminated intravascular coagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvoagpT-SNEbVg90H21EOLACvtfcHk0lgPxU7e341E-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKrs7c%253D&md5=4170b8af3158622be2ce7c113d305306</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1160%2FTH09-07-0454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH09-07-0454%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DAbdel%2BAziz%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DSulfated%252C%2520low%2520molecular%2520weight%2520lignins%2520are%2520potent%2520inhibitors%2520of%2520plasmin%252C%2520in%2520addition%2520to%2520thrombin%2520and%2520factor%2520Xa%253A%2520Novel%2520opportunity%2520for%2520controlling%2520complex%2520pathologies%26jtitle%3DThromb.%2520Haemostasis%26date%3D2010%26volume%3D103%26spage%3D507%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Verghese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4126</span><span class="NLM_x">–</span> <span class="NLM_lpage">4129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4126-4129&author=J.+Vergheseauthor=A.+Liangauthor=P.+S.+Sidhuauthor=M.+Hindleauthor=Q.+Zhouauthor=U.+R.+Desai&title=First+steps+in+the+direction+of+synthetic%2C+allosteric%2C+direct+inhibitors+of+thrombin+and+factor+Xa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerghese%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DSidhu%26aufirst%3DP.%2BS.%26aulast%3DHindle%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DFirst%2520steps%2520in%2520the%2520direction%2520of%2520synthetic%252C%2520allosteric%252C%2520direct%2520inhibitors%2520of%2520thrombin%2520and%2520factor%2520Xa%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4126%26epage%3D4129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Sidhu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel Aziz, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Rational design of potent, small, synthetic allosteric inhibitors of thrombin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5531</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2005767" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5522-5531&author=P.+S.+Sidhuauthor=A.+Liangauthor=A.+Y.+Mehtaauthor=M.+H.+Abdel+Azizauthor=Q.+Zhouauthor=U.+R.+Desai&title=Rational+design+of+potent%2C+small%2C+synthetic+allosteric+inhibitors+of+thrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm2005767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2005767%26sid%3Dliteratum%253Aachs%26aulast%3DSidhu%26aufirst%3DP.%2BS.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMehta%26aufirst%3DA.%2BY.%26aulast%3DAbdel%2BAziz%26aufirst%3DM.%2BH.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DRational%2520design%2520of%2520potent%252C%2520small%252C%2520synthetic%2520allosteric%2520inhibitors%2520of%2520thrombin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5522%26epage%3D5531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lovely, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moaddel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, D. H.</span><span> </span><span class="NLM_article-title">Fibrinogen gamma′ chain binds thrombin exosite II</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1046%2Fj.1538-7836.2003.00027.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=12871549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=124-131&author=R.+S.+Lovelyauthor=M.+Moaddelauthor=D.+H.+Farrell&title=Fibrinogen+gamma%E2%80%B2+chain+binds+thrombin+exosite+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fibrinogen γ' chain binds thrombin exosite II</span></div><div class="casAuthors">Lovely, R. S.; Moaddel, M.; Farrell, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-131</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A high-affinity thrombin-binding site in an alternately processed fibrinogen variant, the γA/γ' isoform, is characterized in this report.  The binding site has been shown to be situated between γ' 414 and 427, and Tyr418 and 422 in this part of the γ' chain are known to be sulfated.  A synthetic peptide corresponding to the γ' chain carboxyl terminus is shown to bind thrombin with a Kd = 0.63 ±0.16 μmol L-1.  Maximum binding of this peptide requires neg. charges on Tyr418 and 422.  Competitive binding studies with hirudin peptides, heparin and DNA aptamers specific for thrombin exosites I or II indicate thrombin binds to the γ' peptide via exosite II.  Thus, thrombin binding to the γ' chain leaves exosite I and the active site accessible to substrates.  This may explain why fibrin-bound thrombin can retain enzymic activity, and why fibrin-bound thrombin is heparin-resistant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFMedtHvbS57Vg90H21EOLACvtfcHk0lgPxU7e341E-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFyqtb4%253D&md5=d5f66f8fca518eb3dc79a7ff3b12ac7c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1046%2Fj.1538-7836.2003.00027.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1538-7836.2003.00027.x%26sid%3Dliteratum%253Aachs%26aulast%3DLovely%26aufirst%3DR.%2BS.%26aulast%3DMoaddel%26aufirst%3DM.%26aulast%3DFarrell%26aufirst%3DD.%2BH.%26atitle%3DFibrinogen%2520gamma%25E2%2580%25B2%2520chain%2520binds%2520thrombin%2520exosite%2520II%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2003%26volume%3D1%26spage%3D124%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bock, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjork, I.</span><span> </span><span class="NLM_article-title">Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite I</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">19837</span><span class="NLM_x">–</span> <span class="NLM_lpage">19845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=19837-19845&author=P.+E.+Bockauthor=S.+T.+Olsonauthor=I.+Bjork&title=Inactivation+of+thrombin+by+antithrombin+is+accompanied+by+inactivation+of+regulatory+exosite+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DP.%2BE.%26aulast%3DOlson%26aufirst%3DS.%2BT.%26aulast%3DBjork%26aufirst%3DI.%26atitle%3DInactivation%2520of%2520thrombin%2520by%2520antithrombin%2520is%2520accompanied%2520by%2520inactivation%2520of%2520regulatory%2520exosite%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D19837%26epage%3D19845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmon, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaie, A. R.</span><span> </span><span class="NLM_article-title">Influence of arginines 93, 97, and 101 of thrombin to its functional specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span><span class="NLM_issue">36</span><span class="NLM_x">) </span> <span class="NLM_fpage">8969</span><span class="NLM_x">–</span> <span class="NLM_lpage">8976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=8969-8976&issue=36&author=X.+Heauthor=J.+Yeauthor=C.+T.+Esmonauthor=A.+R.+Rezaie&title=Influence+of+arginines+93%2C+97%2C+and+101+of+thrombin+to+its+functional+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DEsmon%26aufirst%3DC.%2BT.%26aulast%3DRezaie%26aufirst%3DA.%2BR.%26atitle%3DInfluence%2520of%2520arginines%252093%252C%252097%252C%2520and%2520101%2520of%2520thrombin%2520to%2520its%2520functional%2520specificity%26jtitle%3DBiochemistry%26date%3D1997%26issue%3D36%26spage%3D8969%26epage%3D8976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaie, A. R.</span><span> </span><span class="NLM_article-title">Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: Possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=17549291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVChsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=899-906&author=L.+Yangauthor=A.+R.+Rezaie&title=Calcium-binding+sites+of+the+thrombin-thrombomodulin-protein+C+complex%3A+Possible+implications+for+the+effect+of+platelet+factor+4+on+the+activation+of+vitamin+K-dependent+coagulation+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors</span></div><div class="casAuthors">Yang, Likui; Rezaie, Alireza R.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">899-906</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">The Ca2+-dependent of protein C activation by thrombin in complex with thrombomodulin (TM) contg. chondroitin sulfate (CS) exhibits satn. at ∼0.5-1 mM Ca2+, but with TM lacking CS, it has a distinct optimum at ∼0.1 mM Ca2+.  Since the substrate protein nC has multiple Ca2+-binding sites, and the co-factor TM also interacts with Ca2+, the basis for differences in Ca2+ effect on protein C activation by thrombin in complex with TM contg. or lacking CS is not known.  In this study, by using full-length and Gla-domainless mutants of protein C whose activation by thrombin is independent of either Ca2+ or both Ca2+ and TM, we demonstrate that (i) the Ca2+ occupancy of a high-affinity binding site in Tm is essential for the high-affinity interaction of the cofactor with thrombin, (ii) the Ca2+ occupancy of a binding site (KD ∼ 50 μM) in the catalytic domain of protein C is required for the substrate recognition by the thrombin-TM complex, however, at this concn. of Ca2+ the Gla domain of protein C is not folded properly and thus interacts with exosite-2 of thrombin in complex with TM that lacks CS but not with TM that contains CS, and finally (iii) platelet factor 4 can non-specifically interact with the Gla domain of protein C and other coagulation factors to influence their activation only at subphysiol. concns. of Ca2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbCk6sxak7LLVg90H21EOLACvtfcHk0lhkg0SzC8yPBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVChsbY%253D&md5=7a06199554ed46ab8dbd5d0b13a7fbf0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DRezaie%26aufirst%3DA.%2BR.%26atitle%3DCalcium-binding%2520sites%2520of%2520the%2520thrombin-thrombomodulin-protein%2520C%2520complex%253A%2520Possible%2520implications%2520for%2520the%2520effect%2520of%2520platelet%2520factor%25204%2520on%2520the%2520activation%2520of%2520vitamin%2520K-dependent%2520coagulation%2520factors%26jtitle%3DThromb.%2520Haemostasis%26date%3D2007%26volume%3D97%26spage%3D899%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Skordalakes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair-Green, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scully, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husdson, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakkar, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span> </span><span class="NLM_article-title">Inhibition of human α-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2001&pages=549-555&author=E.+Skordalakesauthor=G.+G.+Dodsonauthor=D.+S.+Clair-Greenauthor=C.+A.+Goodwinauthor=M.+F.+Scullyauthor=H.+R.+Husdsonauthor=V.+V.+Kakkarauthor=J.+J.+Deadman&title=Inhibition+of+human+%CE%B1-thrombin+by+a+phosphonate+tripeptide+proceeds+via+a+metastable+pentacoordinated+phosphorus+intermediate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkordalakes%26aufirst%3DE.%26aulast%3DDodson%26aufirst%3DG.%2BG.%26aulast%3DClair-Green%26aufirst%3DD.%2BS.%26aulast%3DGoodwin%26aufirst%3DC.%2BA.%26aulast%3DScully%26aufirst%3DM.%2BF.%26aulast%3DHusdson%26aufirst%3DH.%2BR.%26aulast%3DKakkar%26aufirst%3DV.%2BV.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26atitle%3DInhibition%2520of%2520human%2520%25CE%25B1-thrombin%2520by%2520a%2520phosphonate%2520tripeptide%2520proceeds%2520via%2520a%2520metastable%2520pentacoordinated%2520phosphorus%2520intermediate%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2001%26volume%3D311%26spage%3D549%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ahmed, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakeley, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruickshank, D. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helliwell, J. R.</span><span> </span><span class="NLM_article-title">The determination of protonation states in proteins</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=906-922&author=H.+U.+Ahmedauthor=M.+P.+Blakeleyauthor=M.+Cianciauthor=D.+W.+J.+Cruickshankauthor=J.+A.+Hubbardauthor=J.+R.+Helliwell&title=The+determination+of+protonation+states+in+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DH.%2BU.%26aulast%3DBlakeley%26aufirst%3DM.%2BP.%26aulast%3DCianci%26aufirst%3DM.%26aulast%3DCruickshank%26aufirst%3DD.%2BW.%2BJ.%26aulast%3DHubbard%26aufirst%3DJ.%2BA.%26aulast%3DHelliwell%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520determination%2520of%2520protonation%2520states%2520in%2520proteins%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2007%26volume%3D63%26spage%3D906%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuniga, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tombes, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. K.</span><span> </span><span class="NLM_article-title">Mixed inhibition of P450 3A4 as a chemoprotective mechanism against aflatoxin B1-induced cytotoxicity with <i>cis</i>-terpenones</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700363s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=732-738&author=Q.+Zhouauthor=L.+Zhangauthor=M.+A.+Zunigaauthor=R.+M.+Tombesauthor=J.+K.+Stewart&title=Mixed+inhibition+of+P450+3A4+as+a+chemoprotective+mechanism+against+aflatoxin+B1-induced+cytotoxicity+with+cis-terpenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Ftx700363s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700363s%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZuniga%26aufirst%3DM.%2BA.%26aulast%3DTombes%26aufirst%3DR.%2BM.%26aulast%3DStewart%26aufirst%3DJ.%2BK.%26atitle%3DMixed%2520inhibition%2520of%2520P450%25203A4%2520as%2520a%2520chemoprotective%2520mechanism%2520against%2520aflatoxin%2520B1-induced%2520cytotoxicity%2520with%2520cis-terpenones%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D732%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. J.</span><span> </span><span class="NLM_article-title"><i>cis</i>-Terpenones as an effective chemopreventive agent against aflatoxin B1-induced cytotoxicity and TCDD-induced P450 1A/B activity in HepG2 cells</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1419</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx0601307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=1415-1419&author=Q.+Zhouauthor=H.+Xieauthor=L.+Zhangauthor=J.+K.+Stewartauthor=X.+X.+Guauthor=J.+J.+Ryan&title=cis-Terpenones+as+an+effective+chemopreventive+agent+against+aflatoxin+B1-induced+cytotoxicity+and+TCDD-induced+P450+1A%2FB+activity+in+HepG2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Ftx0601307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx0601307%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DStewart%26aufirst%3DJ.%2BK.%26aulast%3DGu%26aufirst%3DX.%2BX.%26aulast%3DRyan%26aufirst%3DJ.%2BJ.%26atitle%3Dcis-Terpenones%2520as%2520an%2520effective%2520chemopreventive%2520agent%2520against%2520aflatoxin%2520B1-induced%2520cytotoxicity%2520and%2520TCDD-induced%2520P450%25201A%252FB%2520activity%2520in%2520HepG2%2520cells%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2006%26volume%3D19%26spage%3D1415%26epage%3D1419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Liu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">10648</span><span class="NLM_x">–</span> <span class="NLM_lpage">10649</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0735002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos1Kks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=10648-10649&author=C.+C.+Liuauthor=E.+Brustadauthor=W.+Liuauthor=P.+G.+Schultz&title=Crystal+structure+of+a+biosynthetic+sulfo-hirudin+complexed+to+thrombin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Biosynthetic Sulfo-hirudin Complexed to Thrombin</span></div><div class="casAuthors">Liu, Chang C.; Brustad, Eric; Liu, Wenshe; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10648-10649</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The leech-derived anticoagulant hirudin is post-translationally sulfated on tyrosine 63, resulting in a >10-fold increase in its affinity for thrombin.  We report the structure of a biosynthetic sulfo-hirudin complexed to thrombin solved to 1.84 Å resoln. and show that sulfation is responsible for a salt bridge and an extended hydrogen-bond network that taken together account for the increased affinity of sulfo-hirudin for thrombin.  We also identify a divalent cation binding site at the interface between the two subunits of α-thrombin that may modulate the physiol. activity of thrombin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXIk1NhU0PgrVg90H21EOLACvtfcHk0licOasiRa7d2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos1Kks7g%253D&md5=9983cc5e752d94430b55199a530c0cea</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja0735002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0735002%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DBrustad%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DCrystal%2520structure%2520of%2520a%2520biosynthetic%2520sulfo-hirudin%2520complexed%2520to%2520thrombin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D10648%26epage%3D10649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Carter, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntington, J. A.</span><span> </span><span class="NLM_article-title">Crystal structure of thrombin bound to heparin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">2745</span><span class="NLM_x">–</span> <span class="NLM_lpage">2749</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=2745-2749&author=W.+J.+Carterauthor=E.+Camaauthor=J.+A.+Huntington&title=Crystal+structure+of+thrombin+bound+to+heparin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DW.%2BJ.%26aulast%3DCama%26aufirst%3DE.%26aulast%3DHuntington%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520thrombin%2520bound%2520to%2520heparin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D2745%26epage%3D2749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Verhamme, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollefsen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, P. E.</span><span> </span><span class="NLM_article-title">Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">6788</span><span class="NLM_x">–</span> <span class="NLM_lpage">6798</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=6788-6798&author=I.+M.+Verhammeauthor=S.+T.+Olsonauthor=D.+M.+Tollefsenauthor=P.+E.+Bock&title=Binding+of+exosite+ligands+to+human+thrombin.+Re-evaluation+of+allosteric+linkage+between+thrombin+exosites+I+and+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerhamme%26aufirst%3DI.%2BM.%26aulast%3DOlson%26aufirst%3DS.%2BT.%26aulast%3DTollefsen%26aufirst%3DD.%2BM.%26aulast%3DBock%26aufirst%3DP.%2BE.%26atitle%3DBinding%2520of%2520exosite%2520ligands%2520to%2520human%2520thrombin.%2520Re-evaluation%2520of%2520allosteric%2520linkage%2520between%2520thrombin%2520exosites%2520I%2520and%2520II%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D6788%26epage%3D6798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Pineda, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosesson, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cera, E.</span><span> </span><span class="NLM_article-title">Crystal structure of thrombin in complex with fibrinogen gamma′ peptide</span> <span class="citation_source-journal">Biophys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2007&pages=556-559&author=A.+O.+Pinedaauthor=Z.+W.+Chenauthor=F.+Marinoauthor=F.+S.+Mathewsauthor=M.+W.+Mosessonauthor=E.+Di+Cera&title=Crystal+structure+of+thrombin+in+complex+with+fibrinogen+gamma%E2%80%B2+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPineda%26aufirst%3DA.%2BO.%26aulast%3DChen%26aufirst%3DZ.%2BW.%26aulast%3DMarino%26aufirst%3DF.%26aulast%3DMathews%26aufirst%3DF.%2BS.%26aulast%3DMosesson%26aufirst%3DM.%2BW.%26aulast%3DDi%2BCera%26aufirst%3DE.%26atitle%3DCrystal%2520structure%2520of%2520thrombin%2520in%2520complex%2520with%2520fibrinogen%2520gamma%25E2%2580%25B2%2520peptide%26jtitle%3DBiophys.%2520Chem.%26date%3D2007%26volume%3D125%26spage%3D556%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Sabo, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, M. C.</span><span> </span><span class="NLM_article-title">Conformational analysis of gamma′ peptide (410–427) interactions with thrombin anion binding exosite II</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">7434</span><span class="NLM_x">–</span> <span class="NLM_lpage">7445</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi060360k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=7434-7445&author=T.+M.+Saboauthor=D.+H.+Farrellauthor=M.+C.+Maurer&title=Conformational+analysis+of+gamma%E2%80%B2+peptide+%28410%E2%80%93427%29+interactions+with+thrombin+anion+binding+exosite+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fbi060360k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060360k%26sid%3Dliteratum%253Aachs%26aulast%3DSabo%26aufirst%3DT.%2BM.%26aulast%3DFarrell%26aufirst%3DD.%2BH.%26aulast%3DMaurer%26aufirst%3DM.%2BC.%26atitle%3DConformational%2520analysis%2520of%2520gamma%25E2%2580%25B2%2520peptide%2520%2528410%25E2%2580%2593427%2529%2520interactions%2520with%2520thrombin%2520anion%2520binding%2520exosite%2520II%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D7434%26epage%3D7445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Abdel Aziz, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Identification of the site of binding of sulfated, low molecular weight lignins on thrombin</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">413</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2011&pages=348-352&author=M.+H.+Abdel+Azizauthor=P.+D.+Mosierauthor=U.+R.+Desai&title=Identification+of+the+site+of+binding+of+sulfated%2C+low+molecular+weight+lignins+on+thrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel%2BAziz%26aufirst%3DM.%2BH.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DIdentification%2520of%2520the%2520site%2520of%2520binding%2520of%2520sulfated%252C%2520low%2520molecular%2520weight%2520lignins%2520on%2520thrombin%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D413%26spage%3D348%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Raghuraman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Understanding dermatan sulfate-heparin cofactor II interaction through virtual library screening</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100048y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=281-285&author=A.+Raghuramanauthor=P.+D.+Mosierauthor=U.+R.+Desai&title=Understanding+dermatan+sulfate-heparin+cofactor+II+interaction+through+virtual+library+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fml100048y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100048y%26sid%3Dliteratum%253Aachs%26aulast%3DRaghuraman%26aufirst%3DA.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DUnderstanding%2520dermatan%2520sulfate-heparin%2520cofactor%2520II%2520interaction%2520through%2520virtual%2520library%2520screening%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D281%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Raghuraman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Finding a needle in a haystack: Development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3553</span><span class="NLM_x">–</span> <span class="NLM_lpage">3562</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060092o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3553-3562&author=A.+Raghuramanauthor=P.+D.+Mosierauthor=U.+R.+Desai&title=Finding+a+needle+in+a+haystack%3A+Development+of+a+combinatorial+virtual+screening+approach+for+identifying+high+specificity+heparin%2Fheparan+sulfate+sequence%28s%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm060092o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060092o%26sid%3Dliteratum%253Aachs%26aulast%3DRaghuraman%26aufirst%3DA.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DFinding%2520a%2520needle%2520in%2520a%2520haystack%253A%2520Development%2520of%2520a%2520combinatorial%2520virtual%2520screening%2520approach%2520for%2520identifying%2520high%2520specificity%2520heparin%252Fheparan%2520sulfate%2520sequence%2528s%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3553%26epage%3D3562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnasamy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Interaction of antithrombin with sulfated, low molecular weight lignins: Opportunities for potent, selective modulation of antithrombin function</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">20897</span><span class="NLM_x">–</span> <span class="NLM_lpage">20908</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1074%2Fjbc.M109.013359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=19497853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFWrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=20897-20908&author=B.+L.+Henryauthor=J.+Connellauthor=A.+Liangauthor=C.+Krishnasamyauthor=U.+R.+Desai&title=Interaction+of+antithrombin+with+sulfated%2C+low+molecular+weight+lignins%3A+Opportunities+for+potent%2C+selective+modulation+of+antithrombin+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of Antithrombin with Sulfated, Low Molecular Weight Lignins: Opportunities for potent, selective modulation of antithrombin function</span></div><div class="casAuthors">Henry, Brian L.; Connell, Justin; Liang, Aiye; Krishnasamy, Chandravel; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">20897-20908</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Antithrombin, a major regulator of coagulation and angiogenesis, is known to interact with several natural sulfated polysaccharides.  Previously, we prepd. sulfated low mol. wt. variants of natural lignins, called sulfated dehydrogenation polymers (DHPs), which have now been found to exhibit interesting antithrombin binding properties.  Sulfated DHPs represent a library of diverse noncarbohydrate arom. scaffolds that possess structures completely different from heparin and heparan sulfate.  Fluorescence binding studies indicate that sulfated DHPs bind to antithrombin with micromolar affinity under physiol. conditions.  Salt dependence of binding affinity indicates that the antithrombin-sulfated DHP interaction involves a massive 80-87% non-ionic component to the free energy of binding.  Competitive binding studies with heparin pentasaccharide, epicatechin sulfate, and full-length heparin indicate that sulfated DHPs bind to both the pentasaccharide-binding site and extended heparin-binding site of antithrombin.  Affinity capillary electrophoresis resolves a limited no. of peaks of antithrombin co-complexes suggesting preferential binding of selected DHP structures to the serpin.  Computational genetic algorithm-based virtual screening study shows that only one sulfated DHP structure, out of the 11 present in a library of plausible sequences, bound in the heparin-binding site with a high calcd. score supporting selectivity of recognition.  Enzyme inhibition studies indicate that only one of the three sulfated DHPs studied is a potent inhibitor of free factor VIIa in the presence of antithrombin.  Overall, the chemo-enzymic origin and antithrombin binding properties of sulfated DHPs present novel opportunities for potent and selective modulation of the serpin function, esp. for inhibiting the initiation phase of hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJzRobE-rxrVg90H21EOLACvtfcHk0lj_bsB7FZda2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFWrtLs%253D&md5=3bc6731c6b26fd573c57bff3ba2d09fb</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.013359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.013359%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DConnell%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DKrishnasamy%26aufirst%3DC.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DInteraction%2520of%2520antithrombin%2520with%2520sulfated%252C%2520low%2520molecular%2520weight%2520lignins%253A%2520Opportunities%2520for%2520potent%252C%2520selective%2520modulation%2520of%2520antithrombin%2520function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D20897%26epage%3D20908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Desai, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björk, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. T.</span><span> </span><span class="NLM_article-title">Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">7478</span><span class="NLM_x">–</span> <span class="NLM_lpage">7487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=7478-7487&author=U.+R.+Desaiauthor=M.+Petitouauthor=I.+Bj%C3%B6rkauthor=S.+T.+Olson&title=Mechanism+of+heparin+activation+of+antithrombin.+Role+of+individual+residues+of+the+pentasaccharide+activating+sequence+in+the+recognition+of+native+and+activated+states+of+antithrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DU.%2BR.%26aulast%3DPetitou%26aufirst%3DM.%26aulast%3DBj%25C3%25B6rk%26aufirst%3DI.%26aulast%3DOlson%26aufirst%3DS.%2BT.%26atitle%3DMechanism%2520of%2520heparin%2520activation%2520of%2520antithrombin.%2520Role%2520of%2520individual%2520residues%2520of%2520the%2520pentasaccharide%2520activating%2520sequence%2520in%2520the%2520recognition%2520of%2520native%2520and%2520activated%2520states%2520of%2520antithrombin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D7478%26epage%3D7487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Capila, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Heparin-protein interactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=391-412&author=I.+Capilaauthor=R.+J.+Linhardt&title=Heparin-protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapila%26aufirst%3DI.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DHeparin-protein%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D391%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Gandhi, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancera, R. L.</span><span> </span><span class="NLM_article-title">The structure of glycosaminoglycans and their interactions with proteins</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1111%2Fj.1747-0285.2008.00741.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=19090915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFemtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2008&pages=455-482&author=N.+S.+Gandhiauthor=R.+L.+Mancera&title=The+structure+of+glycosaminoglycans+and+their+interactions+with+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of glycosaminoglycans and their interactions with proteins</span></div><div class="casAuthors">Gandhi, Neha S.; Mancera, Ricardo L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">455-482</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Glycosaminoglycans (GAGs) are important complex carbohydrates that participate in many biol. processes through the regulation of their various protein partners.  Biochem., structural biol., and mol. modeling approaches have assisted in understanding the mol. basis of such interactions, creating an opportunity to capitalize on the large structural diversity of GAGs in the discovery of new drugs.  The complexity of GAG-protein interactions is in part due to the conformational flexibility and underlying sulfation patterns of GAGs, the role of metal ions, and the effect of pH on the affinity of binding.  Here, the authors review the current understanding of the structure of GAGs and their interactions with proteins, including the basic structures and functions of GAGs and their proteoglycans, their clin. significance, the 3-dimensional features of GAGs, their interactions with proteins, and the mol. modeling of heparin-binding sites and GAG-protein interactions.  This review focuses on some key aspects of GAG structure-function relations using classical examples that illustrate the specificity of GAG-protein interactions, such as growth factors, antithrombin, cytokines, and cell adhesion mols.  New approaches to the development of GAG mimetics as possible new glycotherapeutics are also briefly covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9VesUjaoKrVg90H21EOLACvtfcHk0liO--TEGGLLyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFemtLrF&md5=954f3518d48d0d1ed01b9707540da8b2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2008.00741.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2008.00741.x%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DN.%2BS.%26aulast%3DMancera%26aufirst%3DR.%2BL.%26atitle%3DThe%2520structure%2520of%2520glycosaminoglycans%2520and%2520their%2520interactions%2520with%2520proteins%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2008%26volume%3D72%26spage%3D455%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hu, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zulueta, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, S. C.</span><span> </span><span class="NLM_article-title">Synthesis of 3-<i>O</i>-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1038%2Fnchem.1073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=21697878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslSktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=557-563&author=Y.+P.+Huauthor=S.+Y.+Linauthor=C.+Y.+Huangauthor=M.+M.+Zuluetaauthor=J.+Y.+Liuauthor=W.+Changauthor=S.+C.+Hung&title=Synthesis+of+3-O-sulfonated+heparan+sulfate+octasaccharides+that+inhibit+the+herpes+simplex+virus+type+1+host-cell+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction</span></div><div class="casAuthors">Hu, Yu-Peng; Lin, Shu-Yi; Huang, Cheng-Yen; Zulueta, Medel Manuel L.; Liu, Jing-Yuan; Chang, Wen; Hung, Shang-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">557-563</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cell surface carbohydrates play significant roles in a no. of biol. important processes.  Heparan sulfate, for instance, is a ubiquitously distributed poly-sulfated polysaccharide that is involved, among other things, in the initial step of herpes simplex virus type 1 (HSV-1) infection.  The virus interacts with cell-surface heparan sulfate to facilitate host-cell attachment and entry.  3-O-Sulfonated heparan sulfate has been found to function as an HSV-1 entry receptor.  Achieving a complete understanding of these interactions requires the chem. synthesis of such oligosaccharides, but this remains challenging.  Here, we present a convenient approach for the synthesis of two irregular 3-O-sulfonated heparan sulfate octasaccharides, making use of a key disaccharide intermediate to acquire different building blocks for the oligosaccharide chain assembly.  Despite substantial structural differences, the prepd. 3-O-sulfonated sugars blocked viral infection in a dosage-dependent manner with remarkable similarity to one another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpueHc_-p6T_rVg90H21EOLACvtfcHk0liO--TEGGLLyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslSktLw%253D&md5=5a5507475f68fcc76cebf345cc7360a7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1073%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%2BP.%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DHuang%26aufirst%3DC.%2BY.%26aulast%3DZulueta%26aufirst%3DM.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DHung%26aufirst%3DS.%2BC.%26atitle%3DSynthesis%2520of%25203-O-sulfonated%2520heparan%2520sulfate%2520octasaccharides%2520that%2520inhibit%2520the%2520herpes%2520simplex%2520virus%2520type%25201%2520host-cell%2520interaction%26jtitle%3DNat.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D557%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Keisu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, T. B.</span><span> </span><span class="NLM_article-title">Drug-induced liver injury in humans: the case of ximelagatran</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1007%2F978-3-642-00663-0_13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=20020269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVymsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=407-418&author=M.+Keisuauthor=T.+B.+Andersson&title=Drug-induced+liver+injury+in+humans%3A+the+case+of+ximelagatran"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced liver injury in humans: the case of ximelagatran</span></div><div class="casAuthors">Keisu, M.; Andersson, T. B.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">Adverse Drug Reactions</span>),
    <span class="NLM_cas:pages">407-418</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Ximelagatran was the first orally available direct thrombin inhibitor under clin. development that also reached the market.  Ximelagatran was tested in an extensive clin. program.  Short-term use (< 12 days) in humans including the phase III clin. trials did not indicate any hepatotoxic potential.  Increased hepatic enzyme levels were first obsd. at a higher frequency when evaluating the long-term (>35 days) use of ximelagatran (incidence of >3 × upper limit of normal (ULN) plasma ALT was 7.9%).  The frequency of elevated total bilirubin levels was similar in the ximelagatran and the comparator groups.  However, the combination of ALT > 3 × ULN and total bilirubin > 2 × ULN was 0.5% among patients treated with ximelagatran and 0.1% among patients in the comparator group.  Symptoms such as fever and rash potentially indicating hypersensitivity (immunol. type of reaction) were low and did not differ between ximelagatran and the comparators.  The withdrawal of ximelagatran from the market and termination of the ximelagatran development program was triggered by safety data from a 35-day study, indicating that severe hepatic injury in a patient could develop after exposure to the drug has been completed and that regular liver function monitoring may not mitigate the possible risk of severe hepatic injury.  As for many drugs causing liver injury, the std. preclin. toxicol. studies provided no indication that ximelagatran affected hepatic functions.  In addn., extensive investigations using human-based in vitro models have not been able to define mechanisms explaining the pattern of hepatic injury obsd. in long-term clin. trials.  A pharmacogenomic study provided evidence that the ALT increases were assocd. with major histocompatibility complex (MHC) alleles DRB1'07 and DQA1*02 suggesting a possible immunogenic pathogenesis.  This example provides important clues to the mechanism of idiosyncratic drug-induced liver toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8MnjfyasU1bVg90H21EOLACvtfcHk0lg6wQfHTkCo7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVymsr8%253D&md5=8713782d6f002abd9d8f8ca6aa41d7e0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-00663-0_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-00663-0_13%26sid%3Dliteratum%253Aachs%26aulast%3DKeisu%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DT.%2BB.%26atitle%3DDrug-induced%2520liver%2520injury%2520in%2520humans%253A%2520the%2520case%2520of%2520ximelagatran%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2010%26spage%3D407%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Stewart, R. A.</span><span> </span><span class="NLM_article-title">Clinical trials of direct thrombin and factor Xa inhibitors in atrial fibrillation</span> <span class="citation_source-journal">Curr. Opin. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1097%2FHCO.0b013e3283477dbc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=21537165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A280%3ADC%252BC3MrosFWitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=294-299&author=R.+A.+Stewart&title=Clinical+trials+of+direct+thrombin+and+factor+Xa+inhibitors+in+atrial+fibrillation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials of direct thrombin and factor Xa inhibitors in atrial fibrillation</span></div><div class="casAuthors">Stewart Ralph Ah</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in cardiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">294-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  To review the large phase 3 clinical trials that compare direct thrombin or factor Xa inhibitors with dose-adjusted warfarin in patients with atrial fibrillation who have an increased risk of stroke.  RECENT FINDINGS:  In large clinical trials, the oral direct thrombin inhibitor ximelagatran and the long-acting factor Xa inhibitor idraparinux were effective for reducing the risk of thromboembolic stroke, but were not marketed because of liver toxicity and excessive bleeding, respectively.  In separate clinical trials, the oral direct thrombin inhibitor dabigatran etexilate and the short-acting oral factor Xa inhibitor rivaroxaban were noninferior or superior to dose-adjusted warfarin for prevention of thromboembolic stroke and systemic embolism, without increasing the risk of bleeding, and were well tolerated.  Apixaban, another oral factor Xa inhibitor, is effective in reducing thromboembolic stroke compared with aspirin alone.  Results of a trial comparing apixaban with dose-adjusted warfarin are awaited.  SUMMARY:  Dabigatran and rivaroxaban are effective, safe alternatives to dose-adjusted warfarin for reducing thromboembolic risk in patients with atrial fibrillation at high risk of stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx4ePwplhfgcNIRw0GKUoEfW6udTcc2ebD5bPxaRNyMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrosFWitQ%253D%253D&md5=77d68d4f6838b446aa14aa81b3bd10ec</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1097%2FHCO.0b013e3283477dbc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHCO.0b013e3283477dbc%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DR.%2BA.%26atitle%3DClinical%2520trials%2520of%2520direct%2520thrombin%2520and%2520factor%2520Xa%2520inhibitors%2520in%2520atrial%2520fibrillation%26jtitle%3DCurr.%2520Opin.%2520Cardiol.%26date%3D2011%26volume%3D26%26spage%3D294%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Lovely, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rein, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jouihan, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshkov, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakke, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, D. H.</span><span> </span><span class="NLM_article-title">GammaA/gamma′ fibrinogen inhibits thrombin-induced platelet aggregation</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=18989528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVGlsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2008&pages=837-846&author=R.+S.+Lovelyauthor=C.+M.+Reinauthor=T.+C.+Whiteauthor=S.+A.+Jouihanauthor=L.+K.+Boshkovauthor=A.+C.+Bakkeauthor=O.+J.+McCartyauthor=D.+H.+Farrell&title=GammaA%2Fgamma%E2%80%B2+fibrinogen+inhibits+thrombin-induced+platelet+aggregation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">γA/γ' fibrinogen inhibits thrombin-induced platelet aggregation</span></div><div class="casAuthors">Lovely, Rehana S.; Rein, Chantelle M.; White, Tara C.; Jouihan, Sari A.; Boshkov, Lynn K.; Bakke, Antony C.; McCarty, Owen J.; Farrell, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">837-846</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">The minor γA/γ' fibrinogen isoform contains a high affinity binding site for thrombin exosite II that is lacking in the major γA/γA fibrinogen isoform.  We therefore investigated the biol. consequences of the γ' chain binding to thrombin.  Thrombin-induced platelet aggregation was inhibited by γA/γ' fibrinogen.  Carboxyl terminal peptide fragment γ'410-427 from the γ' chain was also inhibitory, with an IC50 of ∼200 μM in whole blood plasma.  Deletion of the peptide from either the amino or carboxyl end significantly decreased inhibition.  In contrast to thrombin-induced platelet aggregation, aggregation induced by epinephrine, ADP, arachidonic acid, or SFLLRN peptide showed little inhibition by the γ' peptide.  The inhibition of thrombin-induced platelet aggregation was not due to direct inhibition of the thrombin active site, since cleavage of a small peptidyl substrate was 91% of normal even in the presence of 1 mM γ'410-427.  The γ'410-427 peptide blocked platelet adhesion to immobilized thrombin under both static and flow conditions, blocked sol. thrombin binding to platelet GPIbα, and inhibited PAR1 cleavage by thrombin.  These results suggest that the γ' chain of fibrinogen inhibits thrombin-induced platelet aggregation by binding to thrombin exosite II.  Thrombin that is bound to the γ' chain is thereby prevented from activating platelets, while retaining its amidolytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjEBsVTE_Lv7Vg90H21EOLACvtfcHk0lg6wQfHTkCo7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVGlsrfE&md5=a9695160f21959339543a583d12e8547</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovely%26aufirst%3DR.%2BS.%26aulast%3DRein%26aufirst%3DC.%2BM.%26aulast%3DWhite%26aufirst%3DT.%2BC.%26aulast%3DJouihan%26aufirst%3DS.%2BA.%26aulast%3DBoshkov%26aufirst%3DL.%2BK.%26aulast%3DBakke%26aufirst%3DA.%2BC.%26aulast%3DMcCarty%26aufirst%3DO.%2BJ.%26aulast%3DFarrell%26aufirst%3DD.%2BH.%26atitle%3DGammaA%252Fgamma%25E2%2580%25B2%2520fibrinogen%2520inhibits%2520thrombin-induced%2520platelet%2520aggregation%26jtitle%3DThromb.%2520Haemostasis%26date%3D2008%26volume%3D100%26spage%3D837%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Adams, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everse, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, K. G.</span><span> </span><span class="NLM_article-title">Predicting the pharmacology of thrombin inhibitors</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1046%2Fj.1538-7836.2003.00127.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=12871372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFSgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=1024-1027&author=T.+E.+Adamsauthor=S.+J.+Everseauthor=K.+G.+Mann&title=Predicting+the+pharmacology+of+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting the pharmacology of thrombin inhibitors</span></div><div class="casAuthors">Adams, T. E.; Everse, S. J.; Mann, K. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1024-1027</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Thrombotic disorders can lead to uncontrolled thrombin generation and clot formation within the circulatory system leading to vascular thrombosis.  Direct inhibitors of thrombin have been developed and tested in clin. trials for the treatment of a variety of these thrombotic disorders.  The bleeding complications obsd. during these trials have raised questions about their clin. use.  The development of a computer-based model of coagulation using the kinetic rates of individual reactions and concns. of the constituents involved in each reaction within blood has made it possible to study coagulation pathologies in silico.  We present an extension of our initial model of coagulation to include several specific thrombin inhibitors.  Using this model we have studied the effect of a variety of inhibitors on thrombin generation and compared these results with the clin. obsd. data.  The data suggest that numerical models will be useful in predicting the effectiveness of inhibitors of coagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSj1Mo6EPK67Vg90H21EOLACvtfcHk0ljotzKjJ3h0Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFSgtbc%253D&md5=082fc651e040a9afc41a46e9565b1833</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1538-7836.2003.00127.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1538-7836.2003.00127.x%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DT.%2BE.%26aulast%3DEverse%26aufirst%3DS.%2BJ.%26aulast%3DMann%26aufirst%3DK.%2BG.%26atitle%3DPredicting%2520the%2520pharmacology%2520of%2520thrombin%2520inhibitors%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2003%26volume%3D1%26spage%3D1024%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Rahaman
Navaz Gangji, Nehru Viji Sankaranarayanan, James Elste, Rami A. Al-Horani, Daniel K. Afosah, Rachel Joshi, Vaibhav Tiwari, <span class="NLM_string-name hlFld-ContribAuthor">Umesh R. Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Herpes Simplex Virus-1 Entry into Human Cells by Nonsaccharide Glycosaminoglycan Mimetics. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (8)
                                     , 797-802. <a href="https://doi.org/10.1021/acsmedchemlett.7b00364" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00364%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhibition%252Bof%252BHerpes%252BSimplex%252BVirus-1%252BEntry%252Binto%252BHuman%252BCells%252Bby%252BNonsaccharide%252BGlycosaminoglycan%252BMimetics%26aulast%3DGangji%26aufirst%3DRahaman%2BNavaz%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D03092017%26date%3D16072018%26date%3D19072018%26date%3D16072018%26volume%3D9%26issue%3D8%26spage%3D797%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel K.  Afosah</span>, <span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Nehru Viji  Sankaranarayanan</span>, and <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, Allosteric Inhibition of Human Plasmin by Sulfated Non-Saccharide Glycosaminoglycan Mimetics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 641-657. <a href="https://doi.org/10.1021/acs.jmedchem.6b01474" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01474%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252BAllosteric%252BInhibition%252Bof%252BHuman%252BPlasmin%252Bby%252BSulfated%252BNon-Saccharide%252BGlycosaminoglycan%252BMimetics%26aulast%3DAfosah%26aufirst%3DDaniel%2BK.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D10102016%26date%3D05012017%26date%3D26012017%26date%3D15122016%26volume%3D60%26issue%3D2%26spage%3D641%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rio S.  Boothello</span>, <span class="hlFld-ContribAuthor ">Aurijit  Sarkar</span>, <span class="hlFld-ContribAuthor ">Vy My  Tran</span>, <span class="hlFld-ContribAuthor ">Thao Kim Nu  Nguyen</span>, <span class="hlFld-ContribAuthor ">Nehru Viji  Sankaranarayanan</span>, <span class="hlFld-ContribAuthor ">Akul Y.  Mehta</span>, <span class="hlFld-ContribAuthor ">AlHumaidi  Alabbas</span>, <span class="hlFld-ContribAuthor ">Spencer  Brown</span>, <span class="hlFld-ContribAuthor ">Alessandro  Rossi</span>, <span class="hlFld-ContribAuthor ">April C.  Joice</span>, <span class="hlFld-ContribAuthor ">Caitlin P.  Mencio</span>, <span class="hlFld-ContribAuthor ">Maritza V.  Quintero</span>, <span class="hlFld-ContribAuthor ">Balagurunathan  Kuberan</span>, and <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemoenzymatically Prepared Heparan Sulfate Containing Rare 2-O-Sulfonated Glucuronic Acid Residues. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (6)
                                     , 1485-1494. <a href="https://doi.org/10.1021/acschembio.5b00071" title="DOI URL">https://doi.org/10.1021/acschembio.5b00071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b00071%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DChemoenzymatically%252BPrepared%252BHeparan%252BSulfate%252BContaining%252BRare%252B2-O-Sulfonated%252BGlucuronic%252BAcid%252BResidues%26aulast%3DBoothello%26aufirst%3DRio%2BS.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D13062014%26date%3D05032015%26date%3D17032015%26date%3D19062015%26date%3D05032015%26volume%3D10%26issue%3D6%26spage%3D1485%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nuligonda  Thirupathi</span>, <span class="hlFld-ContribAuthor ">Madala  Hari Babu</span>, <span class="hlFld-ContribAuthor ">Vikas  Dwivedi</span>, <span class="hlFld-ContribAuthor ">Ruchir  Kant</span>, and <span class="hlFld-ContribAuthor ">Maddi  Sridhar Reddy</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Tandem Intramolecular Oxy/Amino-Palladation/Isocyanide Insertion: Synthesis of α-Benzofuranyl/Indolylacetamides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (11)
                                     , 2908-2911. <a href="https://doi.org/10.1021/ol501048x" title="DOI URL">https://doi.org/10.1021/ol501048x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol501048x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol501048x%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BTandem%252BIntramolecular%252BOxy%25252FAmino-Palladation%25252FIsocyanide%252BInsertion%25253A%252BSynthesis%252Bof%252B%2525CE%2525B1-Benzofuranyl%25252FIndolylacetamides%26aulast%3DThirupathi%26aufirst%3DNuligonda%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D10042014%26date%3D12052014%26date%3D06062014%26volume%3D16%26issue%3D11%26spage%3D2908%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malaika D.  Argade</span>, <span class="hlFld-ContribAuthor ">Akul Y.  Mehta</span>, <span class="hlFld-ContribAuthor ">Aurijit  Sarkar</span>, and <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Inhibition of Human Factor XIa: Discovery of Monosulfated Benzofurans as a Class of Promising Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (8)
                                     , 3559-3569. <a href="https://doi.org/10.1021/jm5002698" title="DOI URL">https://doi.org/10.1021/jm5002698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5002698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5002698%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BInhibition%252Bof%252BHuman%252BFactor%252BXIa%25253A%252BDiscovery%252Bof%252BMonosulfated%252BBenzofurans%252Bas%252Ba%252BClass%252Bof%252BPromising%252BInhibitors%26aulast%3DArgade%26aufirst%3DMalaika%2BD.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D25022014%26date%3D07042014%26date%3D24042014%26date%3D25032014%26volume%3D57%26issue%3D8%26spage%3D3559%26epage%3D3569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Preetpal Singh  Sidhu</span>, <span class="hlFld-ContribAuthor ">May H.  Abdel Aziz</span>, <span class="hlFld-ContribAuthor ">Aurijit  Sarkar</span>, <span class="hlFld-ContribAuthor ">Akul Y.  Mehta</span>, <span class="hlFld-ContribAuthor ">Qibing  Zhou</span>, and <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>  . </span><span class="cited-content_cbyCitation_article-title">Designing Allosteric Regulators of Thrombin. Exosite 2 Features Multiple Subsites That Can Be Targeted by Sulfated Small Molecules for Inducing Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (12)
                                     , 5059-5070. <a href="https://doi.org/10.1021/jm400369q" title="DOI URL">https://doi.org/10.1021/jm400369q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400369q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400369q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252BAllosteric%252BRegulators%252Bof%252BThrombin.%252BExosite%252B2%252BFeatures%252BMultiple%252BSubsites%252BThat%252BCan%252BBe%252BTargeted%252Bby%252BSulfated%252BSmall%252BMolecules%252Bfor%252BInducing%252BInhibition%26aulast%3DSidhu%26aufirst%3DPreetpal%2BSingh%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D12032013%26date%3D13062013%26date%3D27062013%26date%3D29052013%26volume%3D56%26issue%3D12%26spage%3D5059%26epage%3D5070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajesh  Karuturi</span>, <span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Shrenik C.  Mehta</span>, <span class="hlFld-ContribAuthor ">David  Gailani</span>, and <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Allosteric Modulators of Factor XIa by Targeting Hydrophobic Domains Adjacent to Its Heparin-Binding Site. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (6)
                                     , 2415-2428. <a href="https://doi.org/10.1021/jm301757v" title="DOI URL">https://doi.org/10.1021/jm301757v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301757v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301757v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAllosteric%252BModulators%252Bof%252BFactor%252BXIa%252Bby%252BTargeting%252BHydrophobic%252BDomains%252BAdjacent%252Bto%252BIts%252BHeparin-Binding%252BSite%26aulast%3DKaruturi%26aufirst%3DRajesh%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D28112012%26date%3D18032013%26date%3D28032013%26date%3D01032013%26volume%3D56%26issue%3D6%26spage%3D2415%26epage%3D2428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Pooja  Ponnusamy</span>, <span class="hlFld-ContribAuthor ">Akul Y.  Mehta</span>, <span class="hlFld-ContribAuthor ">David  Gailani</span>, and <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>  . </span><span class="cited-content_cbyCitation_article-title">Sulfated Pentagalloylglucoside Is a Potent, Allosteric, and Selective Inhibitor of Factor XIa. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (3)
                                     , 867-878. <a href="https://doi.org/10.1021/jm301338q" title="DOI URL">https://doi.org/10.1021/jm301338q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301338q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301338q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSulfated%252BPentagalloylglucoside%252BIs%252Ba%252BPotent%25252C%252BAllosteric%25252C%252Band%252BSelective%252BInhibitor%252Bof%252BFactor%252BXIa%26aulast%3DAl-Horani%26aufirst%3DRami%2BA.%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D17092012%26date%3D28012013%26date%3D14022013%26date%3D14012013%26volume%3D56%26issue%3D3%26spage%3D867%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Schmitz</span>, <span class="hlFld-ContribAuthor ">Charlotte A.  Bäuml</span>, <span class="hlFld-ContribAuthor ">Diana  Imhof</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of blood coagulation factor XIII. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2020,</strong> <em>605 </em>, 113708. <a href="https://doi.org/10.1016/j.ab.2020.113708" title="DOI URL">https://doi.org/10.1016/j.ab.2020.113708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2020.113708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2020.113708%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DInhibitors%252Bof%252Bblood%252Bcoagulation%252Bfactor%252BXIII%26aulast%3DSchmitz%26aufirst%3DThomas%26date%3D2020%26volume%3D605%26spage%3D113708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel K.  Afosah</span>, <span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (21)
                                     , 3412-3447. <a href="https://doi.org/10.2174/0929867325666181120101147" title="DOI URL">https://doi.org/10.2174/0929867325666181120101147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666181120101147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666181120101147%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DSulfated%252BNon-Saccharide%252BGlycosaminoglycan%252BMimetics%252Bas%252BNovel%252BDrug%252BDiscovery%252BPlatform%252Bfor%252BVarious%252BPathologies%26aulast%3DAfosah%26aufirst%3DDaniel%2BK.%26date%3D2020%26volume%3D27%26issue%3D21%26spage%3D3412%26epage%3D3447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianqian  Zhen</span>, <span class="hlFld-ContribAuthor ">Dayun  Huang</span>, <span class="hlFld-ContribAuthor ">Yinlin  Shao</span>, <span class="hlFld-ContribAuthor ">Tianxing  Cheng</span>, <span class="hlFld-ContribAuthor ">Jiuxi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Direct halosulfenylation of benzo[
              b
              ]furans: a metal-free synthesis of 3-halo-2-thiobenzo[
              b
              ]furans. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (47)
                                     , 9204-9210. <a href="https://doi.org/10.1039/C8OB02680G" title="DOI URL">https://doi.org/10.1039/C8OB02680G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02680G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02680G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDirect%252Bhalosulfenylation%252Bof%252Bbenzo%25255B%252Bb%252B%25255Dfurans%25253A%252Ba%252Bmetal-free%252Bsynthesis%252Bof%252B3-halo-2-thiobenzo%25255B%252Bb%252B%25255Dfurans%26aulast%3DZhen%26aufirst%3DQianqian%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D47%26spage%3D9204%26epage%3D9210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">May H.  Abdel Aziz</span>, <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Novel heparin mimetics reveal cooperativity between exosite 2 and sodium-binding site of thrombin. </span><span class="cited-content_cbyCitation_journal-name">Thrombosis Research</span><span> <strong>2018,</strong> <em>165 </em>, 61-67. <a href="https://doi.org/10.1016/j.thromres.2018.03.013" title="DOI URL">https://doi.org/10.1016/j.thromres.2018.03.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.thromres.2018.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.thromres.2018.03.013%26sid%3Dliteratum%253Aachs%26jtitle%3DThrombosis%2520Research%26atitle%3DNovel%252Bheparin%252Bmimetics%252Breveal%252Bcooperativity%252Bbetween%252Bexosite%252B2%252Band%252Bsodium-binding%252Bsite%252Bof%252Bthrombin%26aulast%3DAbdel%2BAziz%26aufirst%3DMay%2BH.%26date%3D2018%26volume%3D165%26spage%3D61%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel K.  Afosah</span>, <span class="hlFld-ContribAuthor ">Stephen  Verespy</span>, <span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Rio S.  Boothello</span>, <span class="hlFld-ContribAuthor ">Rajesh  Karuturi</span>, <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (6)
                                     , 1101-1105. <a href="https://doi.org/10.1016/j.bmcl.2018.01.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.01.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.01.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.01.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bsmall%252Bgroup%252Bof%252Bsulfated%252Bbenzofurans%252Binduces%252Bsteady-state%252Bsubmaximal%252Binhibition%252Bof%252Bthrombin%26aulast%3DAfosah%26aufirst%3DDaniel%2BK.%26date%3D2018%26volume%3D28%26issue%3D6%26spage%3D1101%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanyan  Liu</span>, <span class="hlFld-ContribAuthor ">Jianjie  Fu</span>, <span class="hlFld-ContribAuthor ">Wenxiao  Pan</span>, <span class="hlFld-ContribAuthor ">Qiao  Xue</span>, <span class="hlFld-ContribAuthor ">Xian  Liu</span>, <span class="hlFld-ContribAuthor ">Aiqian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of thrombin by functionalized C 60 nanoparticles revealed via in vitro assays and in silico studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Environmental Sciences</span><span> <strong>2018,</strong> <em>63 </em>, 285-295. <a href="https://doi.org/10.1016/j.jes.2017.08.013" title="DOI URL">https://doi.org/10.1016/j.jes.2017.08.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jes.2017.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jes.2017.08.013%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Environmental%2520Sciences%26atitle%3DInhibition%252Bof%252Bthrombin%252Bby%252Bfunctionalized%252BC%252B60%252Bnanoparticles%252Brevealed%252Bvia%252Bin%252Bvitro%252Bassays%252Band%252Bin%252Bsilico%252Bstudies%26aulast%3DLiu%26aufirst%3DYanyan%26date%3D2018%26volume%3D63%26spage%3D285%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leyla  Yurttaş</span>, <span class="hlFld-ContribAuthor ">Usama  Abu Mohsen</span>, <span class="hlFld-ContribAuthor ">Yeşim  Ozkan</span>, <span class="hlFld-ContribAuthor ">Simla  Cobanoglu</span>, <span class="hlFld-ContribAuthor ">Serkan  Levent</span>, <span class="hlFld-ContribAuthor ">Zafer Asım  Kaplancikli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of some dibenzofuran-piperazine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (6)
                                     , 1177-1183. <a href="https://doi.org/10.3109/14756366.2015.1108971" title="DOI URL">https://doi.org/10.3109/14756366.2015.1108971</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2015.1108971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2015.1108971%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsome%252Bdibenzofuran-piperazine%252Bderivatives%26aulast%3DYurtta%25C5%259F%26aufirst%3DLeyla%26date%3D2016%26date%3D2015%26volume%3D31%26issue%3D6%26spage%3D1177%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Rajesh  Karuturi</span>, <span class="hlFld-ContribAuthor ">Michael  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel K.  Afosah</span>, <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>, . </span><span class="cited-content_cbyCitation_article-title">Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (7)
                                     , e0160189. <a href="https://doi.org/10.1371/journal.pone.0160189" title="DOI URL">https://doi.org/10.1371/journal.pone.0160189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0160189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0160189%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DAllosteric%252BInhibition%252Bof%252BFactor%252BXIIIa.%252BNon-Saccharide%252BGlycosaminoglycan%252BMimetics%25252C%252Bbut%252BNot%252BGlycosaminoglycans%25252C%252BExhibit%252BPromising%252BInhibition%252BProfile%26aulast%3DAl-Horani%26aufirst%3DRami%2BA.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D7%26spage%3De0160189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Calvin H.  Yeh</span>, <span class="hlFld-ContribAuthor ">Alan R.  Stafford</span>, <span class="hlFld-ContribAuthor ">Beverly A.  Leslie</span>, <span class="hlFld-ContribAuthor ">James C.  Fredenburgh</span>, <span class="hlFld-ContribAuthor ">Jeffrey I.  Weitz</span>, . </span><span class="cited-content_cbyCitation_article-title">Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , e0157471. <a href="https://doi.org/10.1371/journal.pone.0157471" title="DOI URL">https://doi.org/10.1371/journal.pone.0157471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0157471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0157471%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DDabigatran%252Band%252BArgatroban%252BDiametrically%252BModulate%252BThrombin%252BExosite%252BFunction%26aulast%3DYeh%26aufirst%3DCalvin%2BH.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3De0157471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdullah M.A.  Al Majid</span>, <span class="hlFld-ContribAuthor ">Assem  Barakat</span>, <span class="hlFld-ContribAuthor ">Yahia Nasser  Mabkhot</span>, <span class="hlFld-ContribAuthor ">Mohamed H.M.  Al-Agamy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, and characterization of a new series of sulfite and sulfate derivatives of d-Mannitol. </span><span class="cited-content_cbyCitation_journal-name">Journal of Saudi Chemical Society</span><span> <strong>2016,</strong> <em>20 </em>
                                    (3)
                                     , 307-312. <a href="https://doi.org/10.1016/j.jscs.2013.10.011" title="DOI URL">https://doi.org/10.1016/j.jscs.2013.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jscs.2013.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jscs.2013.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Saudi%2520Chemical%2520Society%26atitle%3DSynthesis%25252C%252Band%252Bcharacterization%252Bof%252Ba%252Bnew%252Bseries%252Bof%252Bsulfite%252Band%252Bsulfate%252Bderivatives%252Bof%252Bd-Mannitol%26aulast%3DAl%2BMajid%26aufirst%3DAbdullah%2BM.A.%26date%3D2016%26volume%3D20%26issue%3D3%26spage%3D307%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen  Verespy III</span>, <span class="hlFld-ContribAuthor ">Akul Y.  Mehta</span>, <span class="hlFld-ContribAuthor ">Daniel  Afosah</span>, <span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Partial Inhibition of Monomeric Proteases. Sulfated Coumarins Induce Regulation, not just Inhibition, of Thrombin. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep24043" title="DOI URL">https://doi.org/10.1038/srep24043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep24043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep24043%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAllosteric%252BPartial%252BInhibition%252Bof%252BMonomeric%252BProteases.%252BSulfated%252BCoumarins%252BInduce%252BRegulation%25252C%252Bnot%252Bjust%252BInhibition%25252C%252Bof%252BThrombin%26aulast%3DVerespy%2BIII%26aufirst%3DStephen%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinqiang  Liao</span>, <span class="hlFld-ContribAuthor ">Pengfeng  Guo</span>, <span class="hlFld-ContribAuthor ">Qinlin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Au-catalyzed synthesis of benzofurans from phenols and alkynes using molecular oxygen. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Communications</span><span> <strong>2016,</strong> <em>77 </em>, 22-25. <a href="https://doi.org/10.1016/j.catcom.2016.01.009" title="DOI URL">https://doi.org/10.1016/j.catcom.2016.01.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.catcom.2016.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.catcom.2016.01.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Communications%26atitle%3DAu-catalyzed%252Bsynthesis%252Bof%252Bbenzofurans%252Bfrom%252Bphenols%252Band%252Balkynes%252Busing%252Bmolecular%252Boxygen%26aulast%3DLiao%26aufirst%3DJinqiang%26date%3D2016%26volume%3D77%26spage%3D22%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Afshin  Yazdani-Elah-Abadi</span>, <span class="hlFld-ContribAuthor ">Razieh  Mohebat</span>, <span class="hlFld-ContribAuthor ">Malek-Taher  Maghsoodlou</span>. </span><span class="cited-content_cbyCitation_article-title">Theophylline as the catalyst for the diastereoselective synthesis of trans-1,2-dihydrobenzo[a]furo[2,3-c]phenazines in water. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (87)
                                     , 84326-84333. <a href="https://doi.org/10.1039/C6RA18750A" title="DOI URL">https://doi.org/10.1039/C6RA18750A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA18750A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA18750A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DTheophylline%252Bas%252Bthe%252Bcatalyst%252Bfor%252Bthe%252Bdiastereoselective%252Bsynthesis%252Bof%252Btrans-1%25252C2-dihydrobenzo%25255Ba%25255Dfuro%25255B2%25252C3-c%25255Dphenazines%252Bin%252Bwater%26aulast%3DYazdani-Elah-Abadi%26aufirst%3DAfshin%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D87%26spage%3D84326%26epage%3D84333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Wei  He</span>, <span class="hlFld-ContribAuthor ">Wei-Chen  Dai</span>, <span class="hlFld-ContribAuthor ">Nian-Guang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (6)
                                     , 11046-11062. <a href="https://doi.org/10.3390/molecules200611046" title="DOI URL">https://doi.org/10.3390/molecules200611046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules200611046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules200611046%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDevelopment%252Bof%252BOrally%252BActive%252BThrombin%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BThrombotic%252BDisorder%252BDiseases%26aulast%3DHe%26aufirst%3DLi-Wei%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D6%26spage%3D11046%26epage%3D11062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Rajesh  Karuturi</span>, <span class="hlFld-ContribAuthor ">Stephen  Verespy</span>, <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Glycosaminoglycan Mimetics Through Sulfation of Polyphenols. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 49-67. <a href="https://doi.org/10.1007/978-1-4939-1714-3_7" title="DOI URL">https://doi.org/10.1007/978-1-4939-1714-3_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-1714-3_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-1714-3_7%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Bof%252BGlycosaminoglycan%252BMimetics%252BThrough%252BSulfation%252Bof%252BPolyphenols%26aulast%3DAl-Horani%26aufirst%3DRami%2BA.%26date%3D2015%26date%3D2014%26spage%3D49%26epage%3D67%26pub%3DSpringer%2520New%2520York%26atitle%3DGlycosaminoglycans%26aulast%3DBalagurunathan%26aufirst%3DKuberan%26date%3D2015%26volume%3D1229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rami  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Rajesh  Karuturi</span>, <span class="hlFld-ContribAuthor ">Domonique  White</span>, <span class="hlFld-ContribAuthor ">Umesh  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Plasmin Regulation through Allosteric, Sulfated, Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (1)
                                     , 608-624. <a href="https://doi.org/10.3390/molecules20010608" title="DOI URL">https://doi.org/10.3390/molecules20010608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules20010608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules20010608%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPlasmin%252BRegulation%252Bthrough%252BAllosteric%25252C%252BSulfated%25252C%252BSmall%252BMolecules%26aulast%3DAl-Horani%26aufirst%3DRami%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D1%26spage%3D608%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Preetpal Singh  Sidhu</span>, <span class="hlFld-ContribAuthor ">Qibing  Zhou</span>, <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">A simple, general approach of allosteric coagulation enzyme inhibition through monosulfated hydrophobic scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (24)
                                     , 5716-5720. <a href="https://doi.org/10.1016/j.bmcl.2014.10.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.10.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.10.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.10.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bsimple%25252C%252Bgeneral%252Bapproach%252Bof%252Ballosteric%252Bcoagulation%252Benzyme%252Binhibition%252Bthrough%252Bmonosulfated%252Bhydrophobic%252Bscaffolds%26aulast%3DSidhu%26aufirst%3DPreetpal%2BSingh%26date%3D2014%26volume%3D24%26issue%3D24%26spage%3D5716%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances on Plasmin Inhibitors for the Treatment of Fibrinolysis-Related Disorders. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2014,</strong> <em>34 </em>
                                    (6)
                                     , 1168-1216. <a href="https://doi.org/10.1002/med.21315" title="DOI URL">https://doi.org/10.1002/med.21315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21315%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRecent%252BAdvances%252Bon%252BPlasmin%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BFibrinolysis-Related%252BDisorders%26aulast%3DAl-Horani%26aufirst%3DRami%2BA.%26date%3D2014%26date%3D2014%26volume%3D34%26issue%3D6%26spage%3D1168%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Correia-da-Silva</span>, <span class="hlFld-ContribAuthor ">Emília  Sousa</span>, <span class="hlFld-ContribAuthor ">Madalena M. M.  Pinto</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Sulfated Flavonoids and other Polyphenols as Drugs: Nature as an Inspiration. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2014,</strong> <em>34 </em>
                                    (2)
                                     , 223-279. <a href="https://doi.org/10.1002/med.21282" title="DOI URL">https://doi.org/10.1002/med.21282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21282%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEmerging%252BSulfated%252BFlavonoids%252Band%252Bother%252BPolyphenols%252Bas%252BDrugs%25253A%252BNature%252Bas%252Ban%252BInspiration%26aulast%3DCorreia-da-Silva%26aufirst%3DMarta%26date%3D2014%26date%3D2013%26volume%3D34%26issue%3D2%26spage%3D223%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongling  Zhan</span>, <span class="hlFld-ContribAuthor ">Jiao  Sun</span>, <span class="hlFld-ContribAuthor ">Yan  Feng</span>, <span class="hlFld-ContribAuthor ">Weiwei  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical Study on the Allosteric Regulation of an Oligomeric Protease from Pyrococcus horikoshii by Cl− Ion. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (2)
                                     , 1828-1842. <a href="https://doi.org/10.3390/molecules19021828" title="DOI URL">https://doi.org/10.3390/molecules19021828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules19021828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules19021828%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTheoretical%252BStudy%252Bon%252Bthe%252BAllosteric%252BRegulation%252Bof%252Ban%252BOligomeric%252BProtease%252Bfrom%252BPyrococcus%252Bhorikoshii%252Bby%252BCl%2525E2%252588%252592%252BIon%26aulast%3DZhan%26aufirst%3DDongling%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D2%26spage%3D1828%26epage%3D1842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Umesh R  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">The promise of sulfated synthetic small molecules as modulators of glycosaminoglycan function. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (12)
                                     , 1363-1366. <a href="https://doi.org/10.4155/fmc.13.117" title="DOI URL">https://doi.org/10.4155/fmc.13.117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.117%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bpromise%252Bof%252Bsulfated%252Bsynthetic%252Bsmall%252Bmolecules%252Bas%252Bmodulators%252Bof%252Bglycosaminoglycan%252Bfunction%26aulast%3DDesai%26aufirst%3DUmesh%2BR%26date%3D2013%26volume%3D5%26issue%3D12%26spage%3D1363%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of sulfated benzofuran dimers <b>12a</b>–<b>f</b> and <b>13</b>–<b>15</b> found to potently inhibit human thrombin. The selected dimers correspond to those identified in our previous work,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and their labels (<b>12a</b>–<b>12f</b> and <b>13</b>–<b>15</b>) have been retained here to maintain consistency and ease of comparison. Most IC<sub>50</sub> values being reported here are lower than those reported earlier<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and possibly arise from differences in glycosylation pattern of human α-thrombin. Asterisks correspond to IC<sub>50</sub> values taken from the earlier report.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Competitive effect of the hirudin peptide HirP on the inhibition of human plasma thrombin by <b>12a</b>. Residual thrombin activity was measured through Spectrozyme TH hydrolysis in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C in the presence of 0 to 103 nM of HirP. Solid lines represent fits using the logistic eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to obtain the apparent IC<sub>50</sub>, as described in <a class="ref internalNav" href="#sec2" aria-label="Experimental Procedures">Experimental Procedures</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Competitive effect of heparin octasaccharide H8 (A) and unfractionated heparin UFH (B) on the inhibition of human plasma thrombin by <b>12a</b> in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C in the presence of 0 to 10 μM H8 and 0 to 48 μM UFH. Solid lines represent fits using the logistic eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to obtain the apparent IC<sub>50</sub>, as described in <a class="ref internalNav" href="#sec2" aria-label="Experimental Procedures">Experimental Procedures</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Competitive effect of the γ′-fibrinogen peptide on the inhibition of human plasma thrombin by <b>12a</b> in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C in the presence of 0 to 6.5 μM of the peptide. Solid lines represent fits using the logistic eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to obtain the apparent IC<sub>50</sub>, as described in <a class="ref internalNav" href="#sec2" aria-label="Experimental Procedures">Experimental Procedures</a>. (B) Comparison of the predicted (shaded bars) and observed (unshaded bars) IC<sub>50,app</sub>. Error bars represent ±2 SE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Dose–response profiles for <b>12a</b> inhibition of recombinant wild-type and mutant thrombins in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C. Solid lines represent sigmoidal dose–response fits of eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Connolly surface of thrombin (PDB ID = <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQ0">3EQ0</a>), showing the location of several electropositive basic residues, including those contributing to exosite 2 and the γ′-fibrinogen peptide binding site (purple patches). The putative binding site and mode of the lead sulfated benzofuran dimer <b>12a</b> is rendered as a yellow surface and shows the high degree of shape complementarity with its putative binding site. The thrombin light chain (yellow ribbon) and hirudin peptide denoting the location of exosite 1 (red ribbon) are also shown. (B) The same 3D image rotated by 90°, further highlighting the high degree of shape complementarity between the ligand dimer and its proposed binding site. The active site is displayed with a hydropathic potential map (blue = hydrophilic, green = amphipathic, and brown = hydrophobic) with the nucleophilic serine S195 shown as a red patch. The S1 and S4 substrate specificity pockets are indicated; the hydrophobic S4 pocket is occluded because it is occupied by the ethyl group of the 3′-ethyl ester of <b>12a</b>. (C) Expanded view of the interaction of <b>12a</b> with it putative binding site as shown in panel B. The ligand is rendered as a ball-and-stick figure, and binding site residues are rendered as capped sticks. All binding site side chains within 5 Å of <b>12a</b> are displayed. Hydrogen bonds between Arg173 and the ligand sulfate group are shown as green dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose–response profiles for <b>12a</b> inhibition of human plasma alpha-thrombin and human plasma factor Xa in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl<sub>2</sub>, and 0.1% polyethylene glycol (PEG) 8000 at 25 °C. Solid lines show sigmoidal dose–response fit of eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to thrombin data or linear trendline fit to factor Xa data. See text for details.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/medium/jm-2012-00670q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cell toxicity studies with <b>12a</b>. The viability of human A549 after 120 h of incubation at 37 °C with varying concentrations of <b>12a</b> was studied using MTT cell viability assay. Cell viability was measured spectrophotometrically using absorbance at 570 nm, as described in <a class="ref internalNav" href="#sec2" aria-label="Experimental Procedures">Experimental Procedures</a>. Error bars represent standard deviation measured in three experiments at each concentration studied.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300670q/production/images/large/jm-2012-00670q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300670q&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04176" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04176" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Huntington, J. A.</span><span> </span><span class="NLM_article-title">Molecular recognition mechanisms of thrombin</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1861</span><span class="NLM_x">–</span> <span class="NLM_lpage">1872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1111%2Fj.1538-7836.2005.01363.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=16102053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFKjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=1861-1872&author=J.+A.+Huntington&title=Molecular+recognition+mechanisms+of+thrombin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition mechanisms of thrombin</span></div><div class="casAuthors">Huntington, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1861-1872</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Thrombin (I) is the final protease generated in the blood coagulation cascade, and is the only factor capable of cleaving fibrinogen to create a fibrin clot.  Unlike every other coagulation protease, I is composed solely of its serine protease domain, so that once formed it can diffuse freely to encounter a large no. of potential substrates.  Thus, I serves many functions in hemostasis through the specific cleavage of at least a dozen substrates.  The soln. of the crystal structure of I some 15 yr ago revealed a deep active site cleft and 2 adjacent basic exosites, and it was clear that I must utilize these unique features in recognizing its substrates.  Just how this occurs is still being investigated, but recent data from thrombin mutant libraries and crystal structures combine to paint the clearest picture to date of the mol. determinants of substrate recognition by I.  In almost all cases, both thrombin exosites are involved, either through direct interaction with the substrate protein or through indirect interaction with a 3rd cofactor mol.  The purpose of this article is to summarize recent biochem. and structural data in order to provide insight into the I mol. recognition events at the heart of hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0qOc7mUtmo7Vg90H21EOLACvtfcHk0lhgN9PaNJAhyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFKjs7k%253D&md5=6b8e25d8ae4735c050c01ab60f9f410c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2005.01363.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2005.01363.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuntington%26aufirst%3DJ.%2BA.%26atitle%3DMolecular%2520recognition%2520mechanisms%2520of%2520thrombin%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2005%26volume%3D3%26spage%3D1861%26epage%3D1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bode, W.</span><span> </span><span class="NLM_article-title">The structure of thrombin: A Janus-headed proteinase</span> <span class="citation_source-journal">Semin. Thromb. Hemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1055%2Fs-2006-939551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=16673263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD28XltFagtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2006&pages=16-31&author=W.+Bode&title=The+structure+of+thrombin%3A+A+Janus-headed+proteinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of thrombin: a Janus-headed proteinase</span></div><div class="casAuthors">Bode, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Thrombosis and Hemostasis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">16-31</span>CODEN:
                <span class="NLM_cas:coden">STHMBV</span>;
        ISSN:<span class="NLM_cas:issn">0094-6176</span>.
    
            (<span class="NLM_cas:orgname">Thieme Medical Publishers, Inc.</span>)
        </div><div class="casAbstract">A review.  Through a series of successive, cascade-like proteinase activation and amplification steps, any vascular injury triggers a rapid burst of α-thrombin (α-I), a trypsin-like serine proteinase.  I, the main executioner of the coagulation cascade, has procoagulant as well as anticoagulant and antifibrinolytic properties.  It exhibits quite diverse physiol. functions, but also gives rise to several thrombotic disorders, such as thromboembolism, myocardial infarction, and stroke, thus making it an attractive target for antithrombotic agents.  I interacts specifically with several protein substrates, receptors, cofactors, inhibitors, carbohydrates, and modulators.  I cleaves fibrinogen, blood-coagulation factors XI (FXI) and FXIII, cofactors V and VIII, and I receptors; uses thrombomodulin to activate protein C and I-activatable-fibrinolysis inhibitor; is inhibited by heparin cofactor II and antithrombin III with the help of acidic carbohydrates; and its activity/specificity is modulated by Na+.  A large no. of crystal structures of α-I in complexes with synthetic polypeptides and protein inhibitors, substrate fragments, cofactors, and carbohydrates have displayed extended recognition sites on the thrombin surface, reflecting the versatility and multifunctional specificity of this remarkable proteinase.  These structures essentially show that the I surface can be subdivided into several functional regions, which recognize different chem. moieties.  By using different combinations of these surface elements, I can interact with a variety of mols. with high specificity, accounting for its multifunctional properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTN3vK3UP3TLVg90H21EOLACvtfcHk0lixnEBfUk-hCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltFagtL0%253D&md5=544cc01df029e6f98432cb1b3a393ecb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-939551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-939551%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DW.%26atitle%3DThe%2520structure%2520of%2520thrombin%253A%2520A%2520Janus-headed%2520proteinase%26jtitle%3DSemin.%2520Thromb.%2520Hemostasis%26date%3D2006%26volume%3D32%26spage%3D16%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Di Cera, E.</span><span> </span><span class="NLM_article-title">Thrombin</span> <span class="citation_source-journal">Mol. Aspects Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1016%2Fj.mam.2008.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=18329094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFOrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=203-254&author=E.+Di+Cera&title=Thrombin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin</span></div><div class="casAuthors">Di Cera, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-254</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Thrombin is a Na+-activated, allosteric serine protease that plays opposing functional roles in blood coagulation.  Binding of Na+ is the major driving force behind the procoagulant, prothrombotic and signaling functions of the enzyme, but is dispensable for cleavage of the anticoagulant protein C. The anticoagulant function of thrombin is under the allosteric control of the cofactor thrombomodulin.  Much has been learned on the mechanism of Na+ binding and recognition of natural substrates by thrombin.  Recent structural advances have shed light on the remarkable mol. plasticity of this enzyme and the mol. underpinnings of thrombin allostery mediated by binding to exosite I and the Na+ site.  This review summarizes our current understanding of the mol. basis of thrombin function and allosteric regulation.  The basic information emerging from recent structural, mutagenesis and kinetic investigation of this important enzyme is that thrombin exists in three forms, E*, E and E:Na+, that interconvert under the influence of ligand binding to distinct domains.  The transition between the Na+-free slow form E and the Na+-bound fast form E:Na+ involves the structure of the enzyme as a whole, and so does the interconversion between the two Na+-free forms E* and E.  E* is most likely an inactive form of thrombin, unable to interact with Na+ and substrate.  The complexity of thrombin function and regulation has gained this enzyme pre-eminence as the prototypic allosteric serine protease.  Thrombin is now looked upon as a model system for the quant. anal. of biol. important enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7AGMa1hrZV7Vg90H21EOLACvtfcHk0lixnEBfUk-hCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFOrsLw%253D&md5=de9bebd7f7bee2afbf1d1dedb9b458e4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2008.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2008.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCera%26aufirst%3DE.%26atitle%3DThrombin%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2008%26volume%3D29%26spage%3D203%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Steinmetzer, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturzebecher, J.</span><span> </span><span class="NLM_article-title">Progress in the development of synthetic thrombin inhibitors as new orally active anticoagulants</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.2174%2F0929867043364540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=15379714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVeltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2297-2321&author=T+Steinmetzerauthor=J.+Sturzebecher&title=Progress+in+the+development+of+synthetic+thrombin+inhibitors+as+new+orally+active+anticoagulants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of synthetic thrombin inhibitors as new orally active anticoagulants</span></div><div class="casAuthors">Steinmetzer, Torsten; Stuerzebecher, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2297-2321</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The trypsin-like serine protease thrombin is a multifunctional key enzyme at the final step of the coagulation cascade and is involved in the regulation of hemostasis and thrombosis.  An increased activation of coagulation can result in severe thromboembolic disorders, one of the major reasons responsible for mortality and morbidity in western world.  Therefore, an effective, safe, and orally available thrombin inhibitor could be a useful anticoagulant drug for the daily prophylaxis of venous and arterial thrombosis and prevention of myocardial infarction for high-risk patients.  Synthetic thrombin inhibitors have a long history; initial compds. were derived from electrophilic ketone- and aldehyde-analogs of arginine.  First potent leads of non-covalent inhibitors were developed in the early 80s, which were further optimized in the 90s, after the x-ray structure of thrombin became available.  In the meantime a huge no. of highly active and selective inhibitors was published, however, only a few of them have an appropriate pharmacokinetic and pharmacodynamic overall profile, which could justify their further development.  Very recently, with Ximelagatran a first orally available thrombin inhibitor was approved in France for the prevention of venous thromboembolic events in major orthopedic surgery after successful clin. phase III.  However, it still has to be awaited, whether the extensive clin. use of Ximelagatran can demonstrate for the first time that direct thrombin inhibitors offer a real benefit in terms of efficacy and safety over established antithrombotic therapies.  This review summarizes the current status of synthetic thrombin inhibitors with a focus on more recently published and promising new compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpmjPQRw9su7Vg90H21EOLACvtfcHk0lixnEBfUk-hCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVeltLk%253D&md5=f510afc34f2f7b162c671e6bd9adad52</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867043364540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364540%26sid%3Dliteratum%253Aachs%26aulast%3DSteinmetzer%26aufirst%3DT%26aulast%3DSturzebecher%26aufirst%3DJ.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520synthetic%2520thrombin%2520inhibitors%2520as%2520new%2520orally%2520active%2520anticoagulants%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D2297%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Saiah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, C.</span><span> </span><span class="NLM_article-title">Small molecule coagulation cascade inhibitors in the clinic</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.2174%2F156802605775009702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=16375748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD28XislSlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1677-1695&author=E.+Saiahauthor=C.+Soares&title=Small+molecule+coagulation+cascade+inhibitors+in+the+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule coagulation cascade inhibitors in the clinic</span></div><div class="casAuthors">Saiah, Eddine; Soares, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1677-1695</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Venous thromboembolic disease, including deep vein thrombosis and pulmonary embolism, is a cause of significant mortality and morbidity.  For several decades, anticoagulant options for the treatment and prevention of thrombosis have been limited mainly to agents such as unfractionated heparin and oral vitamin K antagonists such as warfarin.  Although these therapies have proven benefits, they also have important limitations that result in their under-use in routine clin. practice.  A variety of novel anticoagulants with improved pharmacol. and clin. profiles are in development, offering benefits over traditional therapies.  Specifically, progress has been made in the development of small mol. Factor Xa inhibitors and thrombin inhibitors.  The most advanced drugs reviewed include DPC-423, DPC-602, razaxaban, GSK's 813893, Portola's Xa inhibitors (formerly Millennium), otamixaban, DU-176b, KFA-1982, BAY-59-7939, DX-9065a, YM-150, LY-517717, Exanta, 3DP's thrombin inhibitors, SSR-182289, LB-30057, LB-30870, BIBR-1048 and Merck's thrombin inhibitors.  With their potentially consistent and predictable pharmacol. profile, oral formulation, and decreased need for coagulation monitoring, these new agents will likely increase the use and duration of anticoagulation treatment in thromboembolic disorders and reduce the burden assocd. with long-term management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA1yTRmR_ZfbVg90H21EOLACvtfcHk0lixnEBfUk-hCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislSlsLc%253D&md5=f1f06363e4ec89a2bdbf181a1c58057b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F156802605775009702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605775009702%26sid%3Dliteratum%253Aachs%26aulast%3DSaiah%26aufirst%3DE.%26aulast%3DSoares%26aufirst%3DC.%26atitle%3DSmall%2520molecule%2520coagulation%2520cascade%2520inhibitors%2520in%2520the%2520clinic%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1677%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Smallheer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span> </span><span class="NLM_article-title">Recent advances in coagulation serine protease inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=189-208&author=J.+M.+Smallheerauthor=M.+L.+Quan&title=Recent+advances+in+coagulation+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmallheer%26aufirst%3DJ.%2BM.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26atitle%3DRecent%2520advances%2520in%2520coagulation%2520serine%2520protease%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D189%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Straub, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehrig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span> </span><span class="NLM_article-title">Oral, direct thrombin and factor Xa inhibitors: The replacement of warfarin, leeches and pig intestines?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4574</span><span class="NLM_x">–</span> <span class="NLM_lpage">4590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4574-4590&author=A.+Straubauthor=S.+Roehrigauthor=A.+Hillisch&title=Oral%2C+direct+thrombin+and+factor+Xa+inhibitors%3A+The+replacement+of+warfarin%2C+leeches+and+pig+intestines%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStraub%26aufirst%3DA.%26aulast%3DRoehrig%26aufirst%3DS.%26aulast%3DHillisch%26aufirst%3DA.%26atitle%3DOral%252C%2520direct%2520thrombin%2520and%2520factor%2520Xa%2520inhibitors%253A%2520The%2520replacement%2520of%2520warfarin%252C%2520leeches%2520and%2520pig%2520intestines%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D4574%26epage%3D4590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Tucker, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumma, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisko, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskin, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dancheck, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3210</span><span class="NLM_x">–</span> <span class="NLM_lpage">3219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9801713" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3210-3219&author=T.+J.+Tuckerauthor=S.+F.+Bradyauthor=W.+C.+Lummaauthor=S.+D.+Lewisauthor=S.+J.+Gardellauthor=A.+M.+Naylor-Olsenauthor=Y.+W.+Yanauthor=J.+T.+Siskoauthor=K.+J.+Staufferauthor=B.+J.+Lucasauthor=J.+J.+Lynchauthor=J.+J.+Cookauthor=M.+T.+Stranieriauthor=M.+A.+Holahanauthor=E.+A.+Lyleauthor=E.+P.+Baskinauthor=I.+W.+Chenauthor=K.+B.+Dancheckauthor=J.+A.+Kruegerauthor=C.+M.+Cooperauthor=J.+P.+Vacca&title=Design+and+synthesis+of+a+series+of+potent+and+orally+bioavailable+noncovalent+thrombin+inhibitors+that+utilize+nonbasic+groups+in+the+P1+position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm9801713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9801713%26sid%3Dliteratum%253Aachs%26aulast%3DTucker%26aufirst%3DT.%2BJ.%26aulast%3DBrady%26aufirst%3DS.%2BF.%26aulast%3DLumma%26aufirst%3DW.%2BC.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%2BM.%26aulast%3DYan%26aufirst%3DY.%2BW.%26aulast%3DSisko%26aufirst%3DJ.%2BT.%26aulast%3DStauffer%26aufirst%3DK.%2BJ.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DBaskin%26aufirst%3DE.%2BP.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DDancheck%26aufirst%3DK.%2BB.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DCooper%26aufirst%3DC.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520series%2520of%2520potent%2520and%2520orally%2520bioavailable%2520noncovalent%2520thrombin%2520inhibitors%2520that%2520utilize%2520nonbasic%2520groups%2520in%2520the%2520P1%2520position%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3210%26epage%3D3219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicore, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1N-benzylamides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1353-1357&author=C.+S.+Burgeyauthor=K.+A.+Robinsonauthor=T.+A.+Lyleauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=R.+C.+A.+Isaacsauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=J.+A.+Kruegerauthor=R.+Singhauthor=C.+Miller-Steinauthor=R.+B.+Whiteauthor=B.+Wongauthor=E.+A.+Lyleauthor=M.+T.+Stranieriauthor=J.+J.+Cookauthor=D.+R.+McMastersauthor=J.+M.+Pellicoreauthor=S.+Palauthor=A.+A.+Wallaceauthor=F.+C.+Claytonauthor=D.+Bohnauthor=D.+C.+Welshauthor=J.+J.+Lynchauthor=Y.+W.+Yanauthor=Z.+G.+Chenauthor=L.+Kuoauthor=S.+J.+Gardellauthor=J.+A.+Shaferauthor=J.+P.+Vacca&title=Pharmacokinetic+optimization+of+3-amino-6-chloropyrazinone+acetamide+thrombin+inhibitors.+Implementation+of+P3+pyridine+N-oxides+to+deliver+an+orally+bioavailable+series+containing+P1N-benzylamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DRobinson%26aufirst%3DK.%2BA.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DStranieri%26aufirst%3DM.%2BT.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DPellicore%26aufirst%3DJ.%2BM.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DClayton%26aufirst%3DF.%2BC.%26aulast%3DBohn%26aufirst%3DD.%26aulast%3DWelsh%26aufirst%3DD.%2BC.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DY.%2BW.%26aulast%3DChen%26aufirst%3DZ.%2BG.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DPharmacokinetic%2520optimization%2520of%25203-amino-6-chloropyrazinone%2520acetamide%2520thrombin%2520inhibitors.%2520Implementation%2520of%2520P3%2520pyridine%2520N-oxides%2520to%2520deliver%2520an%2520orally%2520bioavailable%2520series%2520containing%2520P1N-benzylamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1353%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Isaacs, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutrona, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michener, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span> </span><span class="NLM_article-title">P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 position</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1535</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1532-1535&author=R.+C.+A.+Isaacsauthor=C.+L.+Newtonauthor=K.+J.+Cutronaauthor=S.+P.+Mercerauthor=B.+D.+Dorseyauthor=C.+M.+McDonoughauthor=J.+J.+Cookauthor=J.+A.+Kruegerauthor=S.+D.+Lewisauthor=B.+J.+Lucasauthor=E.+A.+Lyleauthor=J.+J.+Lynchauthor=C.+Miller-Steinauthor=M.+T.+Michenerauthor=A.+A.+Wallaceauthor=R.+B.+Whiteauthor=B.+K.+Wong&title=P3+optimization+of+functional+potency%2C+in+vivo+efficacy+and+oral+bioavailability+in+3-aminopyrazinone+thrombin+inhibitors+bearing+non-charged+groups+at+the+P1+position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DR.%2BC.%2BA.%26aulast%3DNewton%26aufirst%3DC.%2BL.%26aulast%3DCutrona%26aufirst%3DK.%2BJ.%26aulast%3DMercer%26aufirst%3DS.%2BP.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMcDonough%26aufirst%3DC.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BA.%26aulast%3DLewis%26aufirst%3DS.%2BD.%26aulast%3DLucas%26aufirst%3DB.%2BJ.%26aulast%3DLyle%26aufirst%3DE.%2BA.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DMichener%26aufirst%3DM.%2BT.%26aulast%3DWallace%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWong%26aufirst%3DB.%2BK.%26atitle%3DP3%2520optimization%2520of%2520functional%2520potency%252C%2520in%2520vivo%2520efficacy%2520and%2520oral%2520bioavailability%2520in%25203-aminopyrazinone%2520thrombin%2520inhibitors%2520bearing%2520non-charged%2520groups%2520at%2520the%2520P1%2520position%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1532%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Straub, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehrig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span> </span><span class="NLM_article-title">Entering the era of non-basic P1 site groups: Discovery of Xarelto (TM) (Rivaroxaban)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.2174%2F156802610790725506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=20166954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1ent7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=257-269&author=A.+Straubauthor=S.+Roehrigauthor=A.+Hillisch&title=Entering+the+era+of+non-basic+P1+site+groups%3A+Discovery+of+Xarelto+%28TM%29+%28Rivaroxaban%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Entering the era of non-basic P1 site groups: discovery of Xarelto (Rivaroxaban)</span></div><div class="casAuthors">Straub, Alexander; Roehrig, Susanne; Hillisch, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-269</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Several clin. candidates have now emerged as a result of an intense search for orally available, antithrombotic factor Xa inhibitors.  This review highlights the discovery of Xarelto (Rivaroxaban) starting from an initial tetrahydrophthalimide screening hit.  The major breakthrough was the finding that a chlorothiophene moiety can undergo an interaction in the S1 binding site thus leading to high potency combined with favorable oral bioavailability.  The binding mode of this P1 moiety is discussed, and further non-basic S1 binders of this new type are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT5ggNM_-LK7Vg90H21EOLACvtfcHk0lhQK6U5Hz-aNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1ent7c%253D&md5=b718422cb8e344222a9935d1ea7b5fd8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F156802610790725506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790725506%26sid%3Dliteratum%253Aachs%26aulast%3DStraub%26aufirst%3DA.%26aulast%3DRoehrig%26aufirst%3DS.%26aulast%3DHillisch%26aufirst%3DA.%26atitle%3DEntering%2520the%2520era%2520of%2520non-basic%2520P1%2520site%2520groups%253A%2520Discovery%2520of%2520Xarelto%2520%2528TM%2529%2520%2528Rivaroxaban%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D257%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bock, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panizzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhamme, I. M. A.</span><span> </span><span class="NLM_article-title">Exosites in the substrate specificity of blood coagulation reactions</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1111%2Fj.1538-7836.2007.02496.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=17635714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFGltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=81-94&issue=Suppl.+1&author=P.+E.+Bockauthor=P.+Panizziauthor=I.+M.+A.+Verhamme&title=Exosites+in+the+substrate+specificity+of+blood+coagulation+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Exosites in the substrate specificity of blood coagulation reactions</span></div><div class="casAuthors">Bock, P. E.; Panizzi, P.; Verhamme, I. M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">81-94</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The specificity of blood coagulation proteinases for substrate, inhibitor, and effector recognition is mediated by exosites on the surfaces of the catalytic domains, phys. sepd. from the catalytic site.  Some thrombin ligands bind specifically to either exosite I or II, while others engage both exosites.  The involvement of different, overlapping constellations of exosite residues enables binding of structurally diverse ligands.  The flexibility of the thrombin structure is central to the mechanism of complex formation and the specificity of exosite interactions.  Encounter complex formation is driven by electrostatic ligand-exosite interactions, followed by conformational rearrangement to a stable complex.  Exosites on some zymogens are in low affinity proexosite states and are expressed concomitant with catalytic site activation.  The requirement for exosite expression controls the specificity of assembly of catalytic complexes on the coagulation pathway, such as the membrane-bound factor Xa·factor Va (prothrombinase) complex, and prevents premature assembly.  Substrate recognition by prothrombinase involves a two-step mechanism with initial docking of prothrombin to exosites, followed by a conformational change to engage the FXa catalytic site.  Prothrombin and its activation intermediates bind prothrombinase in two alternative conformations detd. by the zymogen to proteinase transition that are hypothesized to involve prothrombin (pro)exosite I interactions with FVa, which underpin the sequential activation pathway.  The role of exosites as the major source of substrate specificity has stimulated development of exosite-targeted anticoagulants for treatment of thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCsviTVt8YZLVg90H21EOLACvtfcHk0lhQK6U5Hz-aNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFGltL4%253D&md5=79e7e7dce61d91af62c6a679dcf46a4d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2007.02496.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2007.02496.x%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DP.%2BE.%26aulast%3DPanizzi%26aufirst%3DP.%26aulast%3DVerhamme%26aufirst%3DI.%2BM.%2BA.%26atitle%3DExosites%2520in%2520the%2520substrate%2520specificity%2520of%2520blood%2520coagulation%2520reactions%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2007%26volume%3D5%26issue%3DSuppl.%25201%26spage%3D81%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Olson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub-Segall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedsted, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hérault, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björk, I.</span><span> </span><span class="NLM_article-title">Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1160%2FTH04-06-0384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=15543318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVegs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2004&pages=929-939&author=S.+T.+Olsonauthor=R.+Swansonauthor=E.+Raub-Segallauthor=T.+Bedstedauthor=M.+Sadriauthor=M.+Petitouauthor=J.+P.+H%C3%A9raultauthor=J.+M.+Herbertauthor=I.+Bj%C3%B6rk&title=Accelerating+ability+of+synthetic+oligosaccharides+on+antithrombin+inhibition+of+proteinases+of+the+clotting+and+fibrinolytic+systems.+Comparison+with+heparin+and+low-molecular-weight+heparin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin</span></div><div class="casAuthors">Olson, Steven T.; Swanson, Richard; Raub-Segall, Elke; Bedsted, Tina; Sadri, Morvardi; Petitou, Maurice; Herault, Jean-Pascal; Herbert, Jean-Marc; Bjoerk, Ingemar</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">The abilities of three synthetic oligosaccharides to accelerate antithrombin inhibition of ten clotting or fibrinolytic proteinases were compared with those of unfractionated, fractionated high-affinity and low-mol.-wt. heparins.  The results show that the anticoagulant effects of the latter three heparins under conditions approximating physiol. are exerted almost exclusively by acceleration of the inactivation of thrombin, factor Xa and factor IXa to near diffusion-controlled rate consts. of ∼106 - 107 M-1·s-1.  All other proteinases are inhibited with at least 20-fold lower rate consts.  The anticoagulant ability of the synthetic regular (fondaparinux) and high-affinity (idraparinux) pentasaccharides is due to a common mechanism, involving acceleration of only factor Xa inhibition to rate consts. of ∼106 M-1·s-1.  A synthetic hexadecasaccharide, contg. both the pentasaccharide sequence and a proteinase binding site, exerts its anticoagulant effect by accelerating antithrombin inactivation of both thrombin and factor Xa to rate consts. of ∼106 - 107 M-1·s-1, although thrombin appears to be the more important target.  In contrast, factor IXa inhibition is appreciably less stimulated.  The conformational change of antithrombin induced both by the pentasaccharides and longer heparins contributes substantially, ∼150-500-fold, to accelerating the inactivation of factors Xa, IXa and VIIa and moderately, ∼50-fold, to that of factor XIIa and tissue plasminogen activator inhibition.  The bridging effect due to binding of antithrombin and proteinase to the same, long heparin chain is dominating, ∼1000-3000-fold, for thrombin inhibition and is appreciably smaller, although up to ∼250-350-fold, for the inactivation of factors IXa and XIa.  These results establish the proteinase targets of heparin derivs. currently used in or considered for thrombosis therapy and give new insights into the mechanism of heparin acceleration of antithrombin inhibition of proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8EE8x1bq4bLVg90H21EOLACvtfcHk0lgkXXb-Qhv_Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVegs77O&md5=7139e941c229736a3251bee5db57db94</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1160%2FTH04-06-0384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH04-06-0384%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DS.%2BT.%26aulast%3DSwanson%26aufirst%3DR.%26aulast%3DRaub-Segall%26aufirst%3DE.%26aulast%3DBedsted%26aufirst%3DT.%26aulast%3DSadri%26aufirst%3DM.%26aulast%3DPetitou%26aufirst%3DM.%26aulast%3DH%25C3%25A9rault%26aufirst%3DJ.%2BP.%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26aulast%3DBj%25C3%25B6rk%26aufirst%3DI.%26atitle%3DAccelerating%2520ability%2520of%2520synthetic%2520oligosaccharides%2520on%2520antithrombin%2520inhibition%2520of%2520proteinases%2520of%2520the%2520clotting%2520and%2520fibrinolytic%2520systems.%2520Comparison%2520with%2520heparin%2520and%2520low-molecular-weight%2520heparin%26jtitle%3DThromb.%2520Haemostasis%26date%3D2004%26volume%3D92%26spage%3D929%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">New antithrombin-based anticoagulants</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1002%2Fmed.10058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=14705167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlelsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=151-181&author=U.+R.+Desai&title=New+antithrombin-based+anticoagulants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">New antithrombin-based anticoagulants</span></div><div class="casAuthors">Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-181</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Clin. used anticoagulants are inhibitors of enzymes involved in the coagulation pathway, primarily thrombin and factor Xa.  These agents can be either direct or indirect inhibitors of clotting enzymes.  Heparin-based anticoagulants are indirect inhibitors that enhance the proteinase inhibitory activity of a natural anticoagulant, antithrombin.  Despite its phenomenal success, current anticoagulation therapy suffers from the risk of serious bleeding.  The need for safer and more effective antithrombotic agents clearly exists.  The past decade has seen enormous effort directed toward discovering and/or designing new mols. with anticoagulant activity.  These new mols. can be classified into (a) antithrombin and its mutants, (b) natural polysaccharides, (c) synthetic modified heparins and heparin-mimics, (d) synthetic oligosaccharides, and (e) synthetic non-sugar antithrombin activators.  This review focuses on these efforts in designing or discovering new mols. that act through the antithrombin pathway of anticoagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaN2m5pWF4ErVg90H21EOLACvtfcHk0lgkXXb-Qhv_Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlelsr8%253D&md5=ea7d72a23b2a2424d8dddb8034289b1e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fmed.10058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10058%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DNew%2520antithrombin-based%2520anticoagulants%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2004%26volume%3D24%26spage%3D151%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Di Cera, E.</span><span> </span><span class="NLM_article-title">Thrombin: A paradigm for enzymes allosterically activated by monovalent cations</span> <span class="citation_source-journal">C. R. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1016%2Fj.crvi.2004.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=15656349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOntLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2004&pages=1065-1076&author=E.+Di+Cera&title=Thrombin%3A+A+paradigm+for+enzymes+allosterically+activated+by+monovalent+cations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin: a paradigm for enzymes allosterically activated by monovalent cations</span></div><div class="casAuthors">Di Cera, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Comptes Rendus Biologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1065-1076</span>CODEN:
                <span class="NLM_cas:coden">CRBOCM</span>;
        ISSN:<span class="NLM_cas:issn">1631-0691</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review.  Enzymes activated by monovalent cations are abundantly represented in plants and in the animal world.  The mechanism of activation involves the formation of a ternary intermediate with the enzyme-substrate complex, or the binding of the cation to an allosteric site in the protein.  Thrombin is a Na+-activated enzyme with procoagulant, anticoagulant, and signaling roles.  The binding of Na+ influences thrombin function allosterically and offers a paradigm for regulatory control of protease activity and specificity.  Here, the authors review the mol. basis of thrombin allostery as has recently emerged from mutagenesis and structural studies.  The role of Na+ in blood coagulation and the evolution of serine proteases are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodBkmXnuoI-7Vg90H21EOLACvtfcHk0lgkXXb-Qhv_Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOntLfJ&md5=ed867219f2955b80bdc745a799899bef</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.crvi.2004.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.crvi.2004.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCera%26aufirst%3DE.%26atitle%3DThrombin%253A%2520A%2520paradigm%2520for%2520enzymes%2520allosterically%2520activated%2520by%2520monovalent%2520cations%26jtitle%3DC.%2520R.%2520Biol.%26date%3D2004%26volume%3D327%26spage%3D1065%26epage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Evans, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, J. D.</span><span> </span><span class="NLM_article-title"><i>p</i>-Aminobenzamidine as a fluorescent probe for the active site of serine proteases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">3014</span><span class="NLM_x">–</span> <span class="NLM_lpage">3017</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=3014-3017&author=S.+A.+Evansauthor=S.+T.+Olsonauthor=J.+D.+Shore&title=p-Aminobenzamidine+as+a+fluorescent+probe+for+the+active+site+of+serine+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DS.%2BA.%26aulast%3DOlson%26aufirst%3DS.%2BT.%26aulast%3DShore%26aufirst%3DJ.%2BD.%26atitle%3Dp-Aminobenzamidine%2520as%2520a%2520fluorescent%2520probe%2520for%2520the%2520active%2520site%2520of%2520serine%2520proteases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D3014%26epage%3D3017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ng, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinsey, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiserman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijeyewickrema, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R. N.</span><span> </span><span class="NLM_article-title">The effects of exosite occupancy on the substrate specificity of thrombin</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">489</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=489&publication_year=2009&pages=48-54&author=N.+M.+Ngauthor=N.+S.+Quinseyauthor=A.+Y.+Matthewsauthor=D.+Kaisermanauthor=L.+C.+Wijeyewickremaauthor=P.+I.+Birdauthor=P.+E.+Thompsonauthor=R.+N.+Pike&title=The+effects+of+exosite+occupancy+on+the+substrate+specificity+of+thrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DN.%2BM.%26aulast%3DQuinsey%26aufirst%3DN.%2BS.%26aulast%3DMatthews%26aufirst%3DA.%2BY.%26aulast%3DKaiserman%26aufirst%3DD.%26aulast%3DWijeyewickrema%26aufirst%3DL.%2BC.%26aulast%3DBird%26aufirst%3DP.%2BI.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DPike%26aufirst%3DR.%2BN.%26atitle%3DThe%2520effects%2520of%2520exosite%2520occupancy%2520on%2520the%2520substrate%2520specificity%2520of%2520thrombin%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D489%26spage%3D48%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Desai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boothello, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarsdale, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Interaction of thrombin with sucrose octasulfate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6973</span><span class="NLM_x">–</span> <span class="NLM_lpage">6982</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi2004526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=6973-6982&author=B.+J.+Desaiauthor=R.+S.+Boothelloauthor=A.+Y.+Mehtaauthor=J.+N.+Scarsdaleauthor=H.+T.+Wrightauthor=U.+R.+Desai&title=Interaction+of+thrombin+with+sucrose+octasulfate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi2004526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2004526%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DB.%2BJ.%26aulast%3DBoothello%26aufirst%3DR.%2BS.%26aulast%3DMehta%26aufirst%3DA.%2BY.%26aulast%3DScarsdale%26aufirst%3DJ.%2BN.%26aulast%3DWright%26aufirst%3DH.%2BT.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DInteraction%2520of%2520thrombin%2520with%2520sucrose%2520octasulfate%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D6973%26epage%3D6982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Monien, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghuraman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Novel chemo-enzymatic oligomers of cinnamic acids as direct and indirect inhibitors of coagulation proteinases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7988</span><span class="NLM_x">–</span> <span class="NLM_lpage">7998</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=7988-7998&author=B.+H.+Monienauthor=B.+L.+Henryauthor=A.+Raghuramanauthor=M.+Hindleauthor=U.+R.+Desai&title=Novel+chemo-enzymatic+oligomers+of+cinnamic+acids+as+direct+and+indirect+inhibitors+of+coagulation+proteinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonien%26aufirst%3DB.%2BH.%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DRaghuraman%26aufirst%3DA.%26aulast%3DHindle%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DNovel%2520chemo-enzymatic%2520oligomers%2520of%2520cinnamic%2520acids%2520as%2520direct%2520and%2520indirect%2520inhibitors%2520of%2520coagulation%2520proteinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D7988%26epage%3D7998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monien, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">A novel allosteric pathway of thrombin inhibition. Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">31891</span><span class="NLM_x">–</span> <span class="NLM_lpage">31899</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=31891-31899&author=B.+L.+Henryauthor=B.+H.+Monienauthor=P.+E.+Bockauthor=U.+R.+Desai&title=A+novel+allosteric+pathway+of+thrombin+inhibition.+Exosite+II+mediated+potent+inhibition+of+thrombin+by+chemo-enzymatic%2C+sulfated+dehydropolymers+of+4-hydroxycinnamic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DMonien%26aufirst%3DB.%2BH.%26aulast%3DBock%26aufirst%3DP.%2BE.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DA%2520novel%2520allosteric%2520pathway%2520of%2520thrombin%2520inhibition.%2520Exosite%2520II%2520mediated%2520potent%2520inhibition%2520of%2520thrombin%2520by%2520chemo-enzymatic%252C%2520sulfated%2520dehydropolymers%2520of%25204-hydroxycinnamic%2520acids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D31891%26epage%3D31899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakkar, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Characterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acids</span> <span class="citation_source-journal">Blood Coagulation Fibrinolysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1097%2FMBC.0b013e328304e077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=20523162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitleqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=27-34&author=B.+L.+Henryauthor=J.+N.+Thakkarauthor=E.+J.+Martinauthor=D.+F.+Brophyauthor=U.+R.+Desai&title=Characterization+of+the+plasma+and+blood+anticoagulant+potential+of+structurally+and+mechanistically+novel+oligomers+of+4-hydroxycinnamic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acids</span></div><div class="casAuthors">Henry, Brian L.; Thakkar, Jay N.; Martin, Erika J.; Brophy, Donald F.; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Coagulation & Fibrinolysis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-34</span>CODEN:
                <span class="NLM_cas:coden">BLFIE7</span>;
        ISSN:<span class="NLM_cas:issn">0957-5235</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Recently, we designed sulfated dehydropolymers (DHPs) of 4-hydroxycinnamic acids that displayed interesting anticoagulant properties.  Structurally and mechanistically, sulfated DHPs are radically different from all the anticoagulants studied to date.  To assess whether their unique mechanism and structure is worth exploiting for further rational design of homogeneous DHP-based mols., we investigated their anticoagulant potential in human plasma and blood using a range of clotting assays.  Sulfated DHPs prolong plasma clotting times, prothrombin and activated partial thromboplastin times at concns. comparable to the clin. used low-mol.-wt. heparin, enoxaparin.  Fibrin formation studies on human plasma show that there is a structural dependence of anticoagulant action.  Human whole blood studies using thromboelastog. and hemostasis anal. system indicate that they are 17-140-fold less potent than enoxaparin.  These results demonstrate that sulfated DHPs possess good in-vitro and ex-vivo activity, which will likely be improved through a rational design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybqugq2Ap7LVg90H21EOLACvtfcHk0lgiLI6FFsuqNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitleqsA%253D%253D&md5=f61c7241dafc2299f5abec30d1a926b7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2FMBC.0b013e328304e077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMBC.0b013e328304e077%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DThakkar%26aufirst%3DJ.%2BN.%26aulast%3DMartin%26aufirst%3DE.%2BJ.%26aulast%3DBrophy%26aufirst%3DD.%2BF.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DCharacterization%2520of%2520the%2520plasma%2520and%2520blood%2520anticoagulant%2520potential%2520of%2520structurally%2520and%2520mechanistically%2520novel%2520oligomers%2520of%25204-hydroxycinnamic%2520acids%26jtitle%3DBlood%2520Coagulation%2520Fibrinolysis%26date%3D2009%26volume%3D20%26spage%3D27%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel Aziz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Sulfated, low molecular weight lignins are potent inhibitors of plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1160%2FTH09-07-0454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=20024500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2010&pages=507-515&author=B.+L.+Henryauthor=M.+Abdel+Azizauthor=Q.+Zhouauthor=U.+R.+Desai&title=Sulfated%2C+low+molecular+weight+lignins+are+potent+inhibitors+of+plasmin%2C+in+addition+to+thrombin+and+factor+Xa%3A+Novel+opportunity+for+controlling+complex+pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfated, low-molecular-weight lignins are potent inhibitors of plasmin, in addition to thrombin and factor Xa: novel opportunity for controlling complex pathologies</span></div><div class="casAuthors">Henry, Brian L.; Aziz, May Abdel; Zhou, Qibing; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">507-515</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Recently we prepd. sulfated, low-mol.-wt. lignins (LMWLs) to mimic the biol. activities of heparin and heparan sulfate.  Chemo-enzymically prepd. sulfated LMWLs represent a library of diverse non-sugar, arom. mols. with structures radically different from the heparins, and have been found to potently inhibit thrombin and factor Xa.  To assess their effect on the fibrinolytic system, we studied the interaction of LMWLs with human plasmin.  Enzyme inhibition studies indicate that the three sulfated LMWLs studied inhibit plasmin with IC50 values in the range of 0.24 and 1.3 μM, which are marginally affected in the presence of antithrombin.  Similarly, plasmin degrdn. of polymeric fibrin is also inhibited by sulfated LMWLs.  Michaelis-Menten kinetic studies indicate that maximal velocity of hydrolysis of chromogenic substrates decreases nearly 70% in the presence of LMWLs, while the effect on Michaelis const. is dependent on the nature of the substrate.  Competitive binding studies indicate that the sulfated LMWLs compete with full-length heparin.  Comparison with thrombin-heparin crystal structure identifies an anionic region on plasmin as a plausible sulfated LMWL binding site.  Overall, the chemoenzymic origin coupled with coagulation and fibrinolysis inhibition properties of sulfated LMWLs present novel opportunities for designing new pharmaceutical agents that regulate complex pathologies in which both systems are known to play important roles such as disseminated intravascular coagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvoagpT-SNEbVg90H21EOLACvtfcHk0lgiLI6FFsuqNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKrs7c%253D&md5=4170b8af3158622be2ce7c113d305306</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1160%2FTH09-07-0454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH09-07-0454%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DAbdel%2BAziz%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DSulfated%252C%2520low%2520molecular%2520weight%2520lignins%2520are%2520potent%2520inhibitors%2520of%2520plasmin%252C%2520in%2520addition%2520to%2520thrombin%2520and%2520factor%2520Xa%253A%2520Novel%2520opportunity%2520for%2520controlling%2520complex%2520pathologies%26jtitle%3DThromb.%2520Haemostasis%26date%3D2010%26volume%3D103%26spage%3D507%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Verghese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4126</span><span class="NLM_x">–</span> <span class="NLM_lpage">4129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4126-4129&author=J.+Vergheseauthor=A.+Liangauthor=P.+S.+Sidhuauthor=M.+Hindleauthor=Q.+Zhouauthor=U.+R.+Desai&title=First+steps+in+the+direction+of+synthetic%2C+allosteric%2C+direct+inhibitors+of+thrombin+and+factor+Xa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerghese%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DSidhu%26aufirst%3DP.%2BS.%26aulast%3DHindle%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DFirst%2520steps%2520in%2520the%2520direction%2520of%2520synthetic%252C%2520allosteric%252C%2520direct%2520inhibitors%2520of%2520thrombin%2520and%2520factor%2520Xa%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4126%26epage%3D4129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Sidhu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel Aziz, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Rational design of potent, small, synthetic allosteric inhibitors of thrombin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5531</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2005767" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5522-5531&author=P.+S.+Sidhuauthor=A.+Liangauthor=A.+Y.+Mehtaauthor=M.+H.+Abdel+Azizauthor=Q.+Zhouauthor=U.+R.+Desai&title=Rational+design+of+potent%2C+small%2C+synthetic+allosteric+inhibitors+of+thrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm2005767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2005767%26sid%3Dliteratum%253Aachs%26aulast%3DSidhu%26aufirst%3DP.%2BS.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMehta%26aufirst%3DA.%2BY.%26aulast%3DAbdel%2BAziz%26aufirst%3DM.%2BH.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DRational%2520design%2520of%2520potent%252C%2520small%252C%2520synthetic%2520allosteric%2520inhibitors%2520of%2520thrombin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5522%26epage%3D5531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lovely, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moaddel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, D. H.</span><span> </span><span class="NLM_article-title">Fibrinogen gamma′ chain binds thrombin exosite II</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1046%2Fj.1538-7836.2003.00027.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=12871549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=124-131&author=R.+S.+Lovelyauthor=M.+Moaddelauthor=D.+H.+Farrell&title=Fibrinogen+gamma%E2%80%B2+chain+binds+thrombin+exosite+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fibrinogen γ' chain binds thrombin exosite II</span></div><div class="casAuthors">Lovely, R. S.; Moaddel, M.; Farrell, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-131</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A high-affinity thrombin-binding site in an alternately processed fibrinogen variant, the γA/γ' isoform, is characterized in this report.  The binding site has been shown to be situated between γ' 414 and 427, and Tyr418 and 422 in this part of the γ' chain are known to be sulfated.  A synthetic peptide corresponding to the γ' chain carboxyl terminus is shown to bind thrombin with a Kd = 0.63 ±0.16 μmol L-1.  Maximum binding of this peptide requires neg. charges on Tyr418 and 422.  Competitive binding studies with hirudin peptides, heparin and DNA aptamers specific for thrombin exosites I or II indicate thrombin binds to the γ' peptide via exosite II.  Thus, thrombin binding to the γ' chain leaves exosite I and the active site accessible to substrates.  This may explain why fibrin-bound thrombin can retain enzymic activity, and why fibrin-bound thrombin is heparin-resistant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFMedtHvbS57Vg90H21EOLACvtfcHk0ljqf9FSHP1_Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFyqtb4%253D&md5=d5f66f8fca518eb3dc79a7ff3b12ac7c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1046%2Fj.1538-7836.2003.00027.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1538-7836.2003.00027.x%26sid%3Dliteratum%253Aachs%26aulast%3DLovely%26aufirst%3DR.%2BS.%26aulast%3DMoaddel%26aufirst%3DM.%26aulast%3DFarrell%26aufirst%3DD.%2BH.%26atitle%3DFibrinogen%2520gamma%25E2%2580%25B2%2520chain%2520binds%2520thrombin%2520exosite%2520II%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2003%26volume%3D1%26spage%3D124%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bock, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjork, I.</span><span> </span><span class="NLM_article-title">Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite I</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">19837</span><span class="NLM_x">–</span> <span class="NLM_lpage">19845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=19837-19845&author=P.+E.+Bockauthor=S.+T.+Olsonauthor=I.+Bjork&title=Inactivation+of+thrombin+by+antithrombin+is+accompanied+by+inactivation+of+regulatory+exosite+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DP.%2BE.%26aulast%3DOlson%26aufirst%3DS.%2BT.%26aulast%3DBjork%26aufirst%3DI.%26atitle%3DInactivation%2520of%2520thrombin%2520by%2520antithrombin%2520is%2520accompanied%2520by%2520inactivation%2520of%2520regulatory%2520exosite%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D19837%26epage%3D19845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmon, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaie, A. R.</span><span> </span><span class="NLM_article-title">Influence of arginines 93, 97, and 101 of thrombin to its functional specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span><span class="NLM_issue">36</span><span class="NLM_x">) </span> <span class="NLM_fpage">8969</span><span class="NLM_x">–</span> <span class="NLM_lpage">8976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=8969-8976&issue=36&author=X.+Heauthor=J.+Yeauthor=C.+T.+Esmonauthor=A.+R.+Rezaie&title=Influence+of+arginines+93%2C+97%2C+and+101+of+thrombin+to+its+functional+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DEsmon%26aufirst%3DC.%2BT.%26aulast%3DRezaie%26aufirst%3DA.%2BR.%26atitle%3DInfluence%2520of%2520arginines%252093%252C%252097%252C%2520and%2520101%2520of%2520thrombin%2520to%2520its%2520functional%2520specificity%26jtitle%3DBiochemistry%26date%3D1997%26issue%3D36%26spage%3D8969%26epage%3D8976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaie, A. R.</span><span> </span><span class="NLM_article-title">Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: Possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=17549291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVChsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=899-906&author=L.+Yangauthor=A.+R.+Rezaie&title=Calcium-binding+sites+of+the+thrombin-thrombomodulin-protein+C+complex%3A+Possible+implications+for+the+effect+of+platelet+factor+4+on+the+activation+of+vitamin+K-dependent+coagulation+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors</span></div><div class="casAuthors">Yang, Likui; Rezaie, Alireza R.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">899-906</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">The Ca2+-dependent of protein C activation by thrombin in complex with thrombomodulin (TM) contg. chondroitin sulfate (CS) exhibits satn. at ∼0.5-1 mM Ca2+, but with TM lacking CS, it has a distinct optimum at ∼0.1 mM Ca2+.  Since the substrate protein nC has multiple Ca2+-binding sites, and the co-factor TM also interacts with Ca2+, the basis for differences in Ca2+ effect on protein C activation by thrombin in complex with TM contg. or lacking CS is not known.  In this study, by using full-length and Gla-domainless mutants of protein C whose activation by thrombin is independent of either Ca2+ or both Ca2+ and TM, we demonstrate that (i) the Ca2+ occupancy of a high-affinity binding site in Tm is essential for the high-affinity interaction of the cofactor with thrombin, (ii) the Ca2+ occupancy of a binding site (KD ∼ 50 μM) in the catalytic domain of protein C is required for the substrate recognition by the thrombin-TM complex, however, at this concn. of Ca2+ the Gla domain of protein C is not folded properly and thus interacts with exosite-2 of thrombin in complex with TM that lacks CS but not with TM that contains CS, and finally (iii) platelet factor 4 can non-specifically interact with the Gla domain of protein C and other coagulation factors to influence their activation only at subphysiol. concns. of Ca2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbCk6sxak7LLVg90H21EOLACvtfcHk0lisHLp3xJauuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVChsbY%253D&md5=7a06199554ed46ab8dbd5d0b13a7fbf0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DRezaie%26aufirst%3DA.%2BR.%26atitle%3DCalcium-binding%2520sites%2520of%2520the%2520thrombin-thrombomodulin-protein%2520C%2520complex%253A%2520Possible%2520implications%2520for%2520the%2520effect%2520of%2520platelet%2520factor%25204%2520on%2520the%2520activation%2520of%2520vitamin%2520K-dependent%2520coagulation%2520factors%26jtitle%3DThromb.%2520Haemostasis%26date%3D2007%26volume%3D97%26spage%3D899%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Skordalakes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair-Green, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scully, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husdson, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakkar, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span> </span><span class="NLM_article-title">Inhibition of human α-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2001&pages=549-555&author=E.+Skordalakesauthor=G.+G.+Dodsonauthor=D.+S.+Clair-Greenauthor=C.+A.+Goodwinauthor=M.+F.+Scullyauthor=H.+R.+Husdsonauthor=V.+V.+Kakkarauthor=J.+J.+Deadman&title=Inhibition+of+human+%CE%B1-thrombin+by+a+phosphonate+tripeptide+proceeds+via+a+metastable+pentacoordinated+phosphorus+intermediate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkordalakes%26aufirst%3DE.%26aulast%3DDodson%26aufirst%3DG.%2BG.%26aulast%3DClair-Green%26aufirst%3DD.%2BS.%26aulast%3DGoodwin%26aufirst%3DC.%2BA.%26aulast%3DScully%26aufirst%3DM.%2BF.%26aulast%3DHusdson%26aufirst%3DH.%2BR.%26aulast%3DKakkar%26aufirst%3DV.%2BV.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26atitle%3DInhibition%2520of%2520human%2520%25CE%25B1-thrombin%2520by%2520a%2520phosphonate%2520tripeptide%2520proceeds%2520via%2520a%2520metastable%2520pentacoordinated%2520phosphorus%2520intermediate%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2001%26volume%3D311%26spage%3D549%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ahmed, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakeley, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruickshank, D. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helliwell, J. R.</span><span> </span><span class="NLM_article-title">The determination of protonation states in proteins</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=906-922&author=H.+U.+Ahmedauthor=M.+P.+Blakeleyauthor=M.+Cianciauthor=D.+W.+J.+Cruickshankauthor=J.+A.+Hubbardauthor=J.+R.+Helliwell&title=The+determination+of+protonation+states+in+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DH.%2BU.%26aulast%3DBlakeley%26aufirst%3DM.%2BP.%26aulast%3DCianci%26aufirst%3DM.%26aulast%3DCruickshank%26aufirst%3DD.%2BW.%2BJ.%26aulast%3DHubbard%26aufirst%3DJ.%2BA.%26aulast%3DHelliwell%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520determination%2520of%2520protonation%2520states%2520in%2520proteins%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2007%26volume%3D63%26spage%3D906%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuniga, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tombes, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. K.</span><span> </span><span class="NLM_article-title">Mixed inhibition of P450 3A4 as a chemoprotective mechanism against aflatoxin B1-induced cytotoxicity with <i>cis</i>-terpenones</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700363s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=732-738&author=Q.+Zhouauthor=L.+Zhangauthor=M.+A.+Zunigaauthor=R.+M.+Tombesauthor=J.+K.+Stewart&title=Mixed+inhibition+of+P450+3A4+as+a+chemoprotective+mechanism+against+aflatoxin+B1-induced+cytotoxicity+with+cis-terpenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Ftx700363s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700363s%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZuniga%26aufirst%3DM.%2BA.%26aulast%3DTombes%26aufirst%3DR.%2BM.%26aulast%3DStewart%26aufirst%3DJ.%2BK.%26atitle%3DMixed%2520inhibition%2520of%2520P450%25203A4%2520as%2520a%2520chemoprotective%2520mechanism%2520against%2520aflatoxin%2520B1-induced%2520cytotoxicity%2520with%2520cis-terpenones%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D732%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. J.</span><span> </span><span class="NLM_article-title"><i>cis</i>-Terpenones as an effective chemopreventive agent against aflatoxin B1-induced cytotoxicity and TCDD-induced P450 1A/B activity in HepG2 cells</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1419</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx0601307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=1415-1419&author=Q.+Zhouauthor=H.+Xieauthor=L.+Zhangauthor=J.+K.+Stewartauthor=X.+X.+Guauthor=J.+J.+Ryan&title=cis-Terpenones+as+an+effective+chemopreventive+agent+against+aflatoxin+B1-induced+cytotoxicity+and+TCDD-induced+P450+1A%2FB+activity+in+HepG2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Ftx0601307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx0601307%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DStewart%26aufirst%3DJ.%2BK.%26aulast%3DGu%26aufirst%3DX.%2BX.%26aulast%3DRyan%26aufirst%3DJ.%2BJ.%26atitle%3Dcis-Terpenones%2520as%2520an%2520effective%2520chemopreventive%2520agent%2520against%2520aflatoxin%2520B1-induced%2520cytotoxicity%2520and%2520TCDD-induced%2520P450%25201A%252FB%2520activity%2520in%2520HepG2%2520cells%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2006%26volume%3D19%26spage%3D1415%26epage%3D1419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Liu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">10648</span><span class="NLM_x">–</span> <span class="NLM_lpage">10649</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0735002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos1Kks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=10648-10649&author=C.+C.+Liuauthor=E.+Brustadauthor=W.+Liuauthor=P.+G.+Schultz&title=Crystal+structure+of+a+biosynthetic+sulfo-hirudin+complexed+to+thrombin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Biosynthetic Sulfo-hirudin Complexed to Thrombin</span></div><div class="casAuthors">Liu, Chang C.; Brustad, Eric; Liu, Wenshe; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10648-10649</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The leech-derived anticoagulant hirudin is post-translationally sulfated on tyrosine 63, resulting in a >10-fold increase in its affinity for thrombin.  We report the structure of a biosynthetic sulfo-hirudin complexed to thrombin solved to 1.84 Å resoln. and show that sulfation is responsible for a salt bridge and an extended hydrogen-bond network that taken together account for the increased affinity of sulfo-hirudin for thrombin.  We also identify a divalent cation binding site at the interface between the two subunits of α-thrombin that may modulate the physiol. activity of thrombin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXIk1NhU0PgrVg90H21EOLACvtfcHk0lisHLp3xJauuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos1Kks7g%253D&md5=9983cc5e752d94430b55199a530c0cea</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja0735002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0735002%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DBrustad%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DCrystal%2520structure%2520of%2520a%2520biosynthetic%2520sulfo-hirudin%2520complexed%2520to%2520thrombin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D10648%26epage%3D10649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Carter, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntington, J. A.</span><span> </span><span class="NLM_article-title">Crystal structure of thrombin bound to heparin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">2745</span><span class="NLM_x">–</span> <span class="NLM_lpage">2749</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=2745-2749&author=W.+J.+Carterauthor=E.+Camaauthor=J.+A.+Huntington&title=Crystal+structure+of+thrombin+bound+to+heparin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DW.%2BJ.%26aulast%3DCama%26aufirst%3DE.%26aulast%3DHuntington%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520thrombin%2520bound%2520to%2520heparin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D2745%26epage%3D2749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Verhamme, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollefsen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, P. E.</span><span> </span><span class="NLM_article-title">Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">6788</span><span class="NLM_x">–</span> <span class="NLM_lpage">6798</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=6788-6798&author=I.+M.+Verhammeauthor=S.+T.+Olsonauthor=D.+M.+Tollefsenauthor=P.+E.+Bock&title=Binding+of+exosite+ligands+to+human+thrombin.+Re-evaluation+of+allosteric+linkage+between+thrombin+exosites+I+and+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerhamme%26aufirst%3DI.%2BM.%26aulast%3DOlson%26aufirst%3DS.%2BT.%26aulast%3DTollefsen%26aufirst%3DD.%2BM.%26aulast%3DBock%26aufirst%3DP.%2BE.%26atitle%3DBinding%2520of%2520exosite%2520ligands%2520to%2520human%2520thrombin.%2520Re-evaluation%2520of%2520allosteric%2520linkage%2520between%2520thrombin%2520exosites%2520I%2520and%2520II%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D6788%26epage%3D6798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Pineda, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosesson, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cera, E.</span><span> </span><span class="NLM_article-title">Crystal structure of thrombin in complex with fibrinogen gamma′ peptide</span> <span class="citation_source-journal">Biophys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2007&pages=556-559&author=A.+O.+Pinedaauthor=Z.+W.+Chenauthor=F.+Marinoauthor=F.+S.+Mathewsauthor=M.+W.+Mosessonauthor=E.+Di+Cera&title=Crystal+structure+of+thrombin+in+complex+with+fibrinogen+gamma%E2%80%B2+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPineda%26aufirst%3DA.%2BO.%26aulast%3DChen%26aufirst%3DZ.%2BW.%26aulast%3DMarino%26aufirst%3DF.%26aulast%3DMathews%26aufirst%3DF.%2BS.%26aulast%3DMosesson%26aufirst%3DM.%2BW.%26aulast%3DDi%2BCera%26aufirst%3DE.%26atitle%3DCrystal%2520structure%2520of%2520thrombin%2520in%2520complex%2520with%2520fibrinogen%2520gamma%25E2%2580%25B2%2520peptide%26jtitle%3DBiophys.%2520Chem.%26date%3D2007%26volume%3D125%26spage%3D556%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Sabo, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, M. C.</span><span> </span><span class="NLM_article-title">Conformational analysis of gamma′ peptide (410–427) interactions with thrombin anion binding exosite II</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">7434</span><span class="NLM_x">–</span> <span class="NLM_lpage">7445</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi060360k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=7434-7445&author=T.+M.+Saboauthor=D.+H.+Farrellauthor=M.+C.+Maurer&title=Conformational+analysis+of+gamma%E2%80%B2+peptide+%28410%E2%80%93427%29+interactions+with+thrombin+anion+binding+exosite+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fbi060360k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060360k%26sid%3Dliteratum%253Aachs%26aulast%3DSabo%26aufirst%3DT.%2BM.%26aulast%3DFarrell%26aufirst%3DD.%2BH.%26aulast%3DMaurer%26aufirst%3DM.%2BC.%26atitle%3DConformational%2520analysis%2520of%2520gamma%25E2%2580%25B2%2520peptide%2520%2528410%25E2%2580%2593427%2529%2520interactions%2520with%2520thrombin%2520anion%2520binding%2520exosite%2520II%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D7434%26epage%3D7445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Abdel Aziz, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Identification of the site of binding of sulfated, low molecular weight lignins on thrombin</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">413</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2011&pages=348-352&author=M.+H.+Abdel+Azizauthor=P.+D.+Mosierauthor=U.+R.+Desai&title=Identification+of+the+site+of+binding+of+sulfated%2C+low+molecular+weight+lignins+on+thrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel%2BAziz%26aufirst%3DM.%2BH.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DIdentification%2520of%2520the%2520site%2520of%2520binding%2520of%2520sulfated%252C%2520low%2520molecular%2520weight%2520lignins%2520on%2520thrombin%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D413%26spage%3D348%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Raghuraman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Understanding dermatan sulfate-heparin cofactor II interaction through virtual library screening</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100048y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=281-285&author=A.+Raghuramanauthor=P.+D.+Mosierauthor=U.+R.+Desai&title=Understanding+dermatan+sulfate-heparin+cofactor+II+interaction+through+virtual+library+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fml100048y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100048y%26sid%3Dliteratum%253Aachs%26aulast%3DRaghuraman%26aufirst%3DA.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DUnderstanding%2520dermatan%2520sulfate-heparin%2520cofactor%2520II%2520interaction%2520through%2520virtual%2520library%2520screening%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D281%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Raghuraman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Finding a needle in a haystack: Development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3553</span><span class="NLM_x">–</span> <span class="NLM_lpage">3562</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060092o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3553-3562&author=A.+Raghuramanauthor=P.+D.+Mosierauthor=U.+R.+Desai&title=Finding+a+needle+in+a+haystack%3A+Development+of+a+combinatorial+virtual+screening+approach+for+identifying+high+specificity+heparin%2Fheparan+sulfate+sequence%28s%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm060092o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060092o%26sid%3Dliteratum%253Aachs%26aulast%3DRaghuraman%26aufirst%3DA.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DFinding%2520a%2520needle%2520in%2520a%2520haystack%253A%2520Development%2520of%2520a%2520combinatorial%2520virtual%2520screening%2520approach%2520for%2520identifying%2520high%2520specificity%2520heparin%252Fheparan%2520sulfate%2520sequence%2528s%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3553%26epage%3D3562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Henry, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnasamy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Interaction of antithrombin with sulfated, low molecular weight lignins: Opportunities for potent, selective modulation of antithrombin function</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">20897</span><span class="NLM_x">–</span> <span class="NLM_lpage">20908</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1074%2Fjbc.M109.013359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=19497853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFWrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=20897-20908&author=B.+L.+Henryauthor=J.+Connellauthor=A.+Liangauthor=C.+Krishnasamyauthor=U.+R.+Desai&title=Interaction+of+antithrombin+with+sulfated%2C+low+molecular+weight+lignins%3A+Opportunities+for+potent%2C+selective+modulation+of+antithrombin+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of Antithrombin with Sulfated, Low Molecular Weight Lignins: Opportunities for potent, selective modulation of antithrombin function</span></div><div class="casAuthors">Henry, Brian L.; Connell, Justin; Liang, Aiye; Krishnasamy, Chandravel; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">20897-20908</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Antithrombin, a major regulator of coagulation and angiogenesis, is known to interact with several natural sulfated polysaccharides.  Previously, we prepd. sulfated low mol. wt. variants of natural lignins, called sulfated dehydrogenation polymers (DHPs), which have now been found to exhibit interesting antithrombin binding properties.  Sulfated DHPs represent a library of diverse noncarbohydrate arom. scaffolds that possess structures completely different from heparin and heparan sulfate.  Fluorescence binding studies indicate that sulfated DHPs bind to antithrombin with micromolar affinity under physiol. conditions.  Salt dependence of binding affinity indicates that the antithrombin-sulfated DHP interaction involves a massive 80-87% non-ionic component to the free energy of binding.  Competitive binding studies with heparin pentasaccharide, epicatechin sulfate, and full-length heparin indicate that sulfated DHPs bind to both the pentasaccharide-binding site and extended heparin-binding site of antithrombin.  Affinity capillary electrophoresis resolves a limited no. of peaks of antithrombin co-complexes suggesting preferential binding of selected DHP structures to the serpin.  Computational genetic algorithm-based virtual screening study shows that only one sulfated DHP structure, out of the 11 present in a library of plausible sequences, bound in the heparin-binding site with a high calcd. score supporting selectivity of recognition.  Enzyme inhibition studies indicate that only one of the three sulfated DHPs studied is a potent inhibitor of free factor VIIa in the presence of antithrombin.  Overall, the chemo-enzymic origin and antithrombin binding properties of sulfated DHPs present novel opportunities for potent and selective modulation of the serpin function, esp. for inhibiting the initiation phase of hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJzRobE-rxrVg90H21EOLACvtfcHk0liLNU06Ktdciw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFWrtLs%253D&md5=3bc6731c6b26fd573c57bff3ba2d09fb</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.013359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.013359%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DB.%2BL.%26aulast%3DConnell%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DKrishnasamy%26aufirst%3DC.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DInteraction%2520of%2520antithrombin%2520with%2520sulfated%252C%2520low%2520molecular%2520weight%2520lignins%253A%2520Opportunities%2520for%2520potent%252C%2520selective%2520modulation%2520of%2520antithrombin%2520function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D20897%26epage%3D20908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Desai, U. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björk, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. T.</span><span> </span><span class="NLM_article-title">Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">7478</span><span class="NLM_x">–</span> <span class="NLM_lpage">7487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=7478-7487&author=U.+R.+Desaiauthor=M.+Petitouauthor=I.+Bj%C3%B6rkauthor=S.+T.+Olson&title=Mechanism+of+heparin+activation+of+antithrombin.+Role+of+individual+residues+of+the+pentasaccharide+activating+sequence+in+the+recognition+of+native+and+activated+states+of+antithrombin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DU.%2BR.%26aulast%3DPetitou%26aufirst%3DM.%26aulast%3DBj%25C3%25B6rk%26aufirst%3DI.%26aulast%3DOlson%26aufirst%3DS.%2BT.%26atitle%3DMechanism%2520of%2520heparin%2520activation%2520of%2520antithrombin.%2520Role%2520of%2520individual%2520residues%2520of%2520the%2520pentasaccharide%2520activating%2520sequence%2520in%2520the%2520recognition%2520of%2520native%2520and%2520activated%2520states%2520of%2520antithrombin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D7478%26epage%3D7487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Capila, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Heparin-protein interactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=391-412&author=I.+Capilaauthor=R.+J.+Linhardt&title=Heparin-protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapila%26aufirst%3DI.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DHeparin-protein%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D391%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Gandhi, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancera, R. L.</span><span> </span><span class="NLM_article-title">The structure of glycosaminoglycans and their interactions with proteins</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1111%2Fj.1747-0285.2008.00741.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=19090915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFemtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2008&pages=455-482&author=N.+S.+Gandhiauthor=R.+L.+Mancera&title=The+structure+of+glycosaminoglycans+and+their+interactions+with+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of glycosaminoglycans and their interactions with proteins</span></div><div class="casAuthors">Gandhi, Neha S.; Mancera, Ricardo L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">455-482</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Glycosaminoglycans (GAGs) are important complex carbohydrates that participate in many biol. processes through the regulation of their various protein partners.  Biochem., structural biol., and mol. modeling approaches have assisted in understanding the mol. basis of such interactions, creating an opportunity to capitalize on the large structural diversity of GAGs in the discovery of new drugs.  The complexity of GAG-protein interactions is in part due to the conformational flexibility and underlying sulfation patterns of GAGs, the role of metal ions, and the effect of pH on the affinity of binding.  Here, the authors review the current understanding of the structure of GAGs and their interactions with proteins, including the basic structures and functions of GAGs and their proteoglycans, their clin. significance, the 3-dimensional features of GAGs, their interactions with proteins, and the mol. modeling of heparin-binding sites and GAG-protein interactions.  This review focuses on some key aspects of GAG structure-function relations using classical examples that illustrate the specificity of GAG-protein interactions, such as growth factors, antithrombin, cytokines, and cell adhesion mols.  New approaches to the development of GAG mimetics as possible new glycotherapeutics are also briefly covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9VesUjaoKrVg90H21EOLACvtfcHk0liLNU06Ktdciw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFemtLrF&md5=954f3518d48d0d1ed01b9707540da8b2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2008.00741.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2008.00741.x%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DN.%2BS.%26aulast%3DMancera%26aufirst%3DR.%2BL.%26atitle%3DThe%2520structure%2520of%2520glycosaminoglycans%2520and%2520their%2520interactions%2520with%2520proteins%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2008%26volume%3D72%26spage%3D455%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hu, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zulueta, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, S. C.</span><span> </span><span class="NLM_article-title">Synthesis of 3-<i>O</i>-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1038%2Fnchem.1073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=21697878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslSktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=557-563&author=Y.+P.+Huauthor=S.+Y.+Linauthor=C.+Y.+Huangauthor=M.+M.+Zuluetaauthor=J.+Y.+Liuauthor=W.+Changauthor=S.+C.+Hung&title=Synthesis+of+3-O-sulfonated+heparan+sulfate+octasaccharides+that+inhibit+the+herpes+simplex+virus+type+1+host-cell+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction</span></div><div class="casAuthors">Hu, Yu-Peng; Lin, Shu-Yi; Huang, Cheng-Yen; Zulueta, Medel Manuel L.; Liu, Jing-Yuan; Chang, Wen; Hung, Shang-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">557-563</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cell surface carbohydrates play significant roles in a no. of biol. important processes.  Heparan sulfate, for instance, is a ubiquitously distributed poly-sulfated polysaccharide that is involved, among other things, in the initial step of herpes simplex virus type 1 (HSV-1) infection.  The virus interacts with cell-surface heparan sulfate to facilitate host-cell attachment and entry.  3-O-Sulfonated heparan sulfate has been found to function as an HSV-1 entry receptor.  Achieving a complete understanding of these interactions requires the chem. synthesis of such oligosaccharides, but this remains challenging.  Here, we present a convenient approach for the synthesis of two irregular 3-O-sulfonated heparan sulfate octasaccharides, making use of a key disaccharide intermediate to acquire different building blocks for the oligosaccharide chain assembly.  Despite substantial structural differences, the prepd. 3-O-sulfonated sugars blocked viral infection in a dosage-dependent manner with remarkable similarity to one another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpueHc_-p6T_rVg90H21EOLACvtfcHk0liLNU06Ktdciw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslSktLw%253D&md5=5a5507475f68fcc76cebf345cc7360a7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1073%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%2BP.%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DHuang%26aufirst%3DC.%2BY.%26aulast%3DZulueta%26aufirst%3DM.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DHung%26aufirst%3DS.%2BC.%26atitle%3DSynthesis%2520of%25203-O-sulfonated%2520heparan%2520sulfate%2520octasaccharides%2520that%2520inhibit%2520the%2520herpes%2520simplex%2520virus%2520type%25201%2520host-cell%2520interaction%26jtitle%3DNat.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D557%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Keisu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, T. B.</span><span> </span><span class="NLM_article-title">Drug-induced liver injury in humans: the case of ximelagatran</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1007%2F978-3-642-00663-0_13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=20020269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVymsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=407-418&author=M.+Keisuauthor=T.+B.+Andersson&title=Drug-induced+liver+injury+in+humans%3A+the+case+of+ximelagatran"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced liver injury in humans: the case of ximelagatran</span></div><div class="casAuthors">Keisu, M.; Andersson, T. B.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">Adverse Drug Reactions</span>),
    <span class="NLM_cas:pages">407-418</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Ximelagatran was the first orally available direct thrombin inhibitor under clin. development that also reached the market.  Ximelagatran was tested in an extensive clin. program.  Short-term use (< 12 days) in humans including the phase III clin. trials did not indicate any hepatotoxic potential.  Increased hepatic enzyme levels were first obsd. at a higher frequency when evaluating the long-term (>35 days) use of ximelagatran (incidence of >3 × upper limit of normal (ULN) plasma ALT was 7.9%).  The frequency of elevated total bilirubin levels was similar in the ximelagatran and the comparator groups.  However, the combination of ALT > 3 × ULN and total bilirubin > 2 × ULN was 0.5% among patients treated with ximelagatran and 0.1% among patients in the comparator group.  Symptoms such as fever and rash potentially indicating hypersensitivity (immunol. type of reaction) were low and did not differ between ximelagatran and the comparators.  The withdrawal of ximelagatran from the market and termination of the ximelagatran development program was triggered by safety data from a 35-day study, indicating that severe hepatic injury in a patient could develop after exposure to the drug has been completed and that regular liver function monitoring may not mitigate the possible risk of severe hepatic injury.  As for many drugs causing liver injury, the std. preclin. toxicol. studies provided no indication that ximelagatran affected hepatic functions.  In addn., extensive investigations using human-based in vitro models have not been able to define mechanisms explaining the pattern of hepatic injury obsd. in long-term clin. trials.  A pharmacogenomic study provided evidence that the ALT increases were assocd. with major histocompatibility complex (MHC) alleles DRB1'07 and DQA1*02 suggesting a possible immunogenic pathogenesis.  This example provides important clues to the mechanism of idiosyncratic drug-induced liver toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8MnjfyasU1bVg90H21EOLACvtfcHk0lhoWh70DusxXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVymsr8%253D&md5=8713782d6f002abd9d8f8ca6aa41d7e0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-00663-0_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-00663-0_13%26sid%3Dliteratum%253Aachs%26aulast%3DKeisu%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DT.%2BB.%26atitle%3DDrug-induced%2520liver%2520injury%2520in%2520humans%253A%2520the%2520case%2520of%2520ximelagatran%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2010%26spage%3D407%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Stewart, R. A.</span><span> </span><span class="NLM_article-title">Clinical trials of direct thrombin and factor Xa inhibitors in atrial fibrillation</span> <span class="citation_source-journal">Curr. Opin. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1097%2FHCO.0b013e3283477dbc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=21537165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A280%3ADC%252BC3MrosFWitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=294-299&author=R.+A.+Stewart&title=Clinical+trials+of+direct+thrombin+and+factor+Xa+inhibitors+in+atrial+fibrillation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials of direct thrombin and factor Xa inhibitors in atrial fibrillation</span></div><div class="casAuthors">Stewart Ralph Ah</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in cardiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">294-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  To review the large phase 3 clinical trials that compare direct thrombin or factor Xa inhibitors with dose-adjusted warfarin in patients with atrial fibrillation who have an increased risk of stroke.  RECENT FINDINGS:  In large clinical trials, the oral direct thrombin inhibitor ximelagatran and the long-acting factor Xa inhibitor idraparinux were effective for reducing the risk of thromboembolic stroke, but were not marketed because of liver toxicity and excessive bleeding, respectively.  In separate clinical trials, the oral direct thrombin inhibitor dabigatran etexilate and the short-acting oral factor Xa inhibitor rivaroxaban were noninferior or superior to dose-adjusted warfarin for prevention of thromboembolic stroke and systemic embolism, without increasing the risk of bleeding, and were well tolerated.  Apixaban, another oral factor Xa inhibitor, is effective in reducing thromboembolic stroke compared with aspirin alone.  Results of a trial comparing apixaban with dose-adjusted warfarin are awaited.  SUMMARY:  Dabigatran and rivaroxaban are effective, safe alternatives to dose-adjusted warfarin for reducing thromboembolic risk in patients with atrial fibrillation at high risk of stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx4ePwplhfgcNIRw0GKUoEfW6udTcc2eb94fGfXHoWPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrosFWitQ%253D%253D&md5=77d68d4f6838b446aa14aa81b3bd10ec</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1097%2FHCO.0b013e3283477dbc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHCO.0b013e3283477dbc%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DR.%2BA.%26atitle%3DClinical%2520trials%2520of%2520direct%2520thrombin%2520and%2520factor%2520Xa%2520inhibitors%2520in%2520atrial%2520fibrillation%26jtitle%3DCurr.%2520Opin.%2520Cardiol.%26date%3D2011%26volume%3D26%26spage%3D294%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Lovely, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rein, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jouihan, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshkov, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakke, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, D. H.</span><span> </span><span class="NLM_article-title">GammaA/gamma′ fibrinogen inhibits thrombin-induced platelet aggregation</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=18989528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVGlsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2008&pages=837-846&author=R.+S.+Lovelyauthor=C.+M.+Reinauthor=T.+C.+Whiteauthor=S.+A.+Jouihanauthor=L.+K.+Boshkovauthor=A.+C.+Bakkeauthor=O.+J.+McCartyauthor=D.+H.+Farrell&title=GammaA%2Fgamma%E2%80%B2+fibrinogen+inhibits+thrombin-induced+platelet+aggregation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">γA/γ' fibrinogen inhibits thrombin-induced platelet aggregation</span></div><div class="casAuthors">Lovely, Rehana S.; Rein, Chantelle M.; White, Tara C.; Jouihan, Sari A.; Boshkov, Lynn K.; Bakke, Antony C.; McCarty, Owen J.; Farrell, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">837-846</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">The minor γA/γ' fibrinogen isoform contains a high affinity binding site for thrombin exosite II that is lacking in the major γA/γA fibrinogen isoform.  We therefore investigated the biol. consequences of the γ' chain binding to thrombin.  Thrombin-induced platelet aggregation was inhibited by γA/γ' fibrinogen.  Carboxyl terminal peptide fragment γ'410-427 from the γ' chain was also inhibitory, with an IC50 of ∼200 μM in whole blood plasma.  Deletion of the peptide from either the amino or carboxyl end significantly decreased inhibition.  In contrast to thrombin-induced platelet aggregation, aggregation induced by epinephrine, ADP, arachidonic acid, or SFLLRN peptide showed little inhibition by the γ' peptide.  The inhibition of thrombin-induced platelet aggregation was not due to direct inhibition of the thrombin active site, since cleavage of a small peptidyl substrate was 91% of normal even in the presence of 1 mM γ'410-427.  The γ'410-427 peptide blocked platelet adhesion to immobilized thrombin under both static and flow conditions, blocked sol. thrombin binding to platelet GPIbα, and inhibited PAR1 cleavage by thrombin.  These results suggest that the γ' chain of fibrinogen inhibits thrombin-induced platelet aggregation by binding to thrombin exosite II.  Thrombin that is bound to the γ' chain is thereby prevented from activating platelets, while retaining its amidolytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjEBsVTE_Lv7Vg90H21EOLACvtfcHk0lhoWh70DusxXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVGlsrfE&md5=a9695160f21959339543a583d12e8547</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovely%26aufirst%3DR.%2BS.%26aulast%3DRein%26aufirst%3DC.%2BM.%26aulast%3DWhite%26aufirst%3DT.%2BC.%26aulast%3DJouihan%26aufirst%3DS.%2BA.%26aulast%3DBoshkov%26aufirst%3DL.%2BK.%26aulast%3DBakke%26aufirst%3DA.%2BC.%26aulast%3DMcCarty%26aufirst%3DO.%2BJ.%26aulast%3DFarrell%26aufirst%3DD.%2BH.%26atitle%3DGammaA%252Fgamma%25E2%2580%25B2%2520fibrinogen%2520inhibits%2520thrombin-induced%2520platelet%2520aggregation%26jtitle%3DThromb.%2520Haemostasis%26date%3D2008%26volume%3D100%26spage%3D837%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Adams, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everse, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, K. G.</span><span> </span><span class="NLM_article-title">Predicting the pharmacology of thrombin inhibitors</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm300670q&amp;key=10.1046%2Fj.1538-7836.2003.00127.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm300670q&amp;key=12871372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300670q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFSgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=1024-1027&author=T.+E.+Adamsauthor=S.+J.+Everseauthor=K.+G.+Mann&title=Predicting+the+pharmacology+of+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting the pharmacology of thrombin inhibitors</span></div><div class="casAuthors">Adams, T. E.; Everse, S. J.; Mann, K. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1024-1027</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Thrombotic disorders can lead to uncontrolled thrombin generation and clot formation within the circulatory system leading to vascular thrombosis.  Direct inhibitors of thrombin have been developed and tested in clin. trials for the treatment of a variety of these thrombotic disorders.  The bleeding complications obsd. during these trials have raised questions about their clin. use.  The development of a computer-based model of coagulation using the kinetic rates of individual reactions and concns. of the constituents involved in each reaction within blood has made it possible to study coagulation pathologies in silico.  We present an extension of our initial model of coagulation to include several specific thrombin inhibitors.  Using this model we have studied the effect of a variety of inhibitors on thrombin generation and compared these results with the clin. obsd. data.  The data suggest that numerical models will be useful in predicting the effectiveness of inhibitors of coagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSj1Mo6EPK67Vg90H21EOLACvtfcHk0li6rjS8zxwavg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFSgtbc%253D&md5=082fc651e040a9afc41a46e9565b1833</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1538-7836.2003.00127.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1538-7836.2003.00127.x%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DT.%2BE.%26aulast%3DEverse%26aufirst%3DS.%2BJ.%26aulast%3DMann%26aufirst%3DK.%2BG.%26atitle%3DPredicting%2520the%2520pharmacology%2520of%2520thrombin%2520inhibitors%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2003%26volume%3D1%26spage%3D1024%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQ0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQ0','PDB','3EQ0'); return false;">PDB: 3EQ0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H8D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H8D','PDB','1H8D'); return false;">PDB: 1H8D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UUF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UUF','PDB','2UUF'); return false;">PDB: 2UUF</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i19"><a href="/doi/suppl/10.1021/jm300670q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_52683"></div></div></div></div></div><hr /></hr><p class="last">Thrombin inhibition by sulfated benzofuran dimer (SBD) <b>12a</b>; thrombin inhibition by SBDs; inhibition of recombinant wild-type and mutant thrombins by <b>12a</b>; putative binding mode for <b>12a</b>; GOLD binding site definitions for <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQ0">3EQ0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H8D">1H8D</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UUF">2UUF</a>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300670q/suppl_file/jm300670q_si_001.pdf">jm300670q_si_001.pdf (2.25 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300670q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-15%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm300670q" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300670q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679950b86b483d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
